<SEC-DOCUMENT>0001438934-25-002253.txt : 20250828
<SEC-HEADER>0001438934-25-002253.hdr.sgml : 20250828
<ACCEPTANCE-DATETIME>20250828065541
ACCESSION NUMBER:		0001438934-25-002253
CONFORMED SUBMISSION TYPE:	N-PX
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20250630
FILED AS OF DATE:		20250828
DATE AS OF CHANGE:		20250828
EFFECTIVENESS DATE:		20250828

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BlackRock Health Sciences Trust
		CENTRAL INDEX KEY:			0001314966
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		N-PX
		SEC ACT:		1940 Act
		SEC FILE NUMBER:	811-21702
		FILM NUMBER:		251267449

	BUSINESS ADDRESS:	
		STREET 1:		100 BELLEVUE PARKWAY
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19809
		BUSINESS PHONE:		(888) 825-2257

	MAIL ADDRESS:	
		STREET 1:		100 BELLEVUE PARKWAY
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19809
</SEC-HEADER>
<DOCUMENT>
<TYPE>N-PX
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?>
<edgarSubmission xmlns:com="http://www.sec.gov/edgar/common" xmlns="http://www.sec.gov/edgar/npx">
  <headerData>
    <submissionType>N-PX</submissionType>
    <filerInfo>
      <registrantType>RMIC</registrantType>
      <liveTestFlag>LIVE</liveTestFlag>
      <filer>
        <issuerCredentials>
          <cik>0001314966</cik>
          <ccc>XXXXXXXX</ccc>
        </issuerCredentials>
      </filer>
      <investmentCompanyType>N-2</investmentCompanyType>
      <periodOfReport>06/30/2025</periodOfReport>
    </filerInfo>
  </headerData>
  <formData>
    <coverPage>
      <yearOrQuarter>YEAR</yearOrQuarter>
      <reportCalendarYear>2025</reportCalendarYear>
      <reportingPerson>
        <name>BlackRock Health Sciences Trust</name>
        <phoneNumber>800-882-0052</phoneNumber>
        <address>
          <com:street1>100 Bellevue Parkway</com:street1>
          <com:city>Wilmington</com:city>
          <com:stateOrCountry>DE</com:stateOrCountry>
          <com:zipCode>19809</com:zipCode>
        </address>
      </reportingPerson>
      <agentForService>
        <name>John Perlowski</name>
        <address>
          <com:street1>50 Hudson Yards</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10001</com:zipCode>
        </address>
      </agentForService>
      <reportInfo>
        <reportType>FUND VOTING REPORT</reportType>
      </reportInfo>
      <fileNumber>811-21702</fileNumber>
      <explanatoryInformation>
        <explanatoryChoice>N</explanatoryChoice>
      </explanatoryInformation>
    </coverPage>
    <summaryPage>
      <otherIncludedManagersCount>1</otherIncludedManagersCount>
      <otherManagers2>
        <investmentManagers>
          <serialNo>19</serialNo>
          <form13FFileNumber>028-04295</form13FFileNumber>
          <crdNumber>000106614</crdNumber>
          <secFileNumber>801-47710</secFileNumber>
          <leiNumber>5493001LN9MRM6A35J74</leiNumber>
          <name>BlackRock Advisors, LLC</name>
        </investmentManagers>
      </otherManagers2>
    </summaryPage>
    <seriesPage>
      <seriesCount>0</seriesCount>
    </seriesPage>
    <signaturePage>
      <reportingPerson>BlackRock Health Sciences Trust</reportingPerson>
      <txSignature>John Perlowski</txSignature>
      <txPrintedSignature>John Perlowski</txPrintedSignature>
      <txTitle>Chief Executive Officer</txTitle>
      <txAsOfDate>08/28/2025</txAsOfDate>
    </signaturePage>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>PROXY VOTING RECORD
<SEQUENCE>2
<FILENAME>BRDWLB_0001314966_2025.xml
<DESCRIPTION>VOTE TABLE
<TEXT>
<XML>
<?xml version="1.0" encoding="us-ascii"?><inf:proxyVoteTable xmlns:inf="http://www.sec.gov/edgar/document/npxproxy/informationtable">
<!--VoteTableSchemaVersion:X0300-->
<inf:proxyTable><inf:issuerName>4D MOLECULAR THERAPEUTICS, INC.</inf:issuerName><inf:cusip>35104E100</inf:cusip><inf:isin>US35104E1001</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>Election of Class II director to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Jacob Chacko, M.D., MBA</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11778</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11778</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>4D MOLECULAR THERAPEUTICS, INC.</inf:issuerName><inf:cusip>35104E100</inf:cusip><inf:isin>US35104E1001</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>Election of Class II director to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Susannah Gray, MBA</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11778</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11778</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>4D MOLECULAR THERAPEUTICS, INC.</inf:issuerName><inf:cusip>35104E100</inf:cusip><inf:isin>US35104E1001</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>Election of Class II director to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Charles Theuer, M.D., Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11778</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11778</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>4D MOLECULAR THERAPEUTICS, INC.</inf:issuerName><inf:cusip>35104E100</inf:cusip><inf:isin>US35104E1001</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>Ratification of the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11778</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11778</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>4D MOLECULAR THERAPEUTICS, INC.</inf:issuerName><inf:cusip>35104E100</inf:cusip><inf:isin>US35104E1001</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers ("say-on-pay vote").</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11778</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11778</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>4D MOLECULAR THERAPEUTICS, INC.</inf:issuerName><inf:cusip>35104E100</inf:cusip><inf:isin>US35104E1001</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>Approval, on an advisory, non-binding basis, of the frequency of future advisory say-on-pay votes.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11778</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>1 YEAR</inf:howVoted><inf:sharesVoted>11778</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ABBOTT LABORATORIES</inf:issuerName><inf:cusip>002824100</inf:cusip><inf:isin>US0028241000</inf:isin><inf:meetingDate>04/25/2025</inf:meetingDate><inf:voteDescription>Election of Director: R. J. Alpern</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66397</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66397</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ABBOTT LABORATORIES</inf:issuerName><inf:cusip>002824100</inf:cusip><inf:isin>US0028241000</inf:isin><inf:meetingDate>04/25/2025</inf:meetingDate><inf:voteDescription>Election of Director: C. Babineaux-Fontenot</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66397</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66397</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ABBOTT LABORATORIES</inf:issuerName><inf:cusip>002824100</inf:cusip><inf:isin>US0028241000</inf:isin><inf:meetingDate>04/25/2025</inf:meetingDate><inf:voteDescription>Election of Director: S. E. Blount</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66397</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66397</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ABBOTT LABORATORIES</inf:issuerName><inf:cusip>002824100</inf:cusip><inf:isin>US0028241000</inf:isin><inf:meetingDate>04/25/2025</inf:meetingDate><inf:voteDescription>Election of Director: R. B. Ford</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66397</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66397</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ABBOTT LABORATORIES</inf:issuerName><inf:cusip>002824100</inf:cusip><inf:isin>US0028241000</inf:isin><inf:meetingDate>04/25/2025</inf:meetingDate><inf:voteDescription>Election of Director: P. Gonzalez</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66397</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66397</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ABBOTT LABORATORIES</inf:issuerName><inf:cusip>002824100</inf:cusip><inf:isin>US0028241000</inf:isin><inf:meetingDate>04/25/2025</inf:meetingDate><inf:voteDescription>Election of Director: M. A. Kumbier</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66397</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66397</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ABBOTT LABORATORIES</inf:issuerName><inf:cusip>002824100</inf:cusip><inf:isin>US0028241000</inf:isin><inf:meetingDate>04/25/2025</inf:meetingDate><inf:voteDescription>Election of Director: D. W. McDew</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66397</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66397</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ABBOTT LABORATORIES</inf:issuerName><inf:cusip>002824100</inf:cusip><inf:isin>US0028241000</inf:isin><inf:meetingDate>04/25/2025</inf:meetingDate><inf:voteDescription>Election of Director: N. McKinstry</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66397</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>66397</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ABBOTT LABORATORIES</inf:issuerName><inf:cusip>002824100</inf:cusip><inf:isin>US0028241000</inf:isin><inf:meetingDate>04/25/2025</inf:meetingDate><inf:voteDescription>Election of Director: M. G. O'Grady</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66397</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66397</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ABBOTT LABORATORIES</inf:issuerName><inf:cusip>002824100</inf:cusip><inf:isin>US0028241000</inf:isin><inf:meetingDate>04/25/2025</inf:meetingDate><inf:voteDescription>Election of Director: M. F. Roman</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66397</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66397</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ABBOTT LABORATORIES</inf:issuerName><inf:cusip>002824100</inf:cusip><inf:isin>US0028241000</inf:isin><inf:meetingDate>04/25/2025</inf:meetingDate><inf:voteDescription>Election of Director: D. J. Starks</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66397</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66397</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ABBOTT LABORATORIES</inf:issuerName><inf:cusip>002824100</inf:cusip><inf:isin>US0028241000</inf:isin><inf:meetingDate>04/25/2025</inf:meetingDate><inf:voteDescription>Election of Director: J. G. Stratton</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66397</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66397</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ABBOTT LABORATORIES</inf:issuerName><inf:cusip>002824100</inf:cusip><inf:isin>US0028241000</inf:isin><inf:meetingDate>04/25/2025</inf:meetingDate><inf:voteDescription>Ratification of Ernst &amp; Young LLP As Auditors</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66397</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66397</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ABBOTT LABORATORIES</inf:issuerName><inf:cusip>002824100</inf:cusip><inf:isin>US0028241000</inf:isin><inf:meetingDate>04/25/2025</inf:meetingDate><inf:voteDescription>Say on Pay - An Advisory Vote on the Approval of Executive Compensation</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66397</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66397</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ABBVIE INC.</inf:issuerName><inf:cusip>00287Y109</inf:cusip><inf:isin>US00287Y1091</inf:isin><inf:meetingDate>05/09/2025</inf:meetingDate><inf:voteDescription>Election of Class I Director: William H.L. Burnside</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>153901</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>153901</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ABBVIE INC.</inf:issuerName><inf:cusip>00287Y109</inf:cusip><inf:isin>US00287Y1091</inf:isin><inf:meetingDate>05/09/2025</inf:meetingDate><inf:voteDescription>Election of Class I Director: Thomas C. Freyman</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>153901</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>153901</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ABBVIE INC.</inf:issuerName><inf:cusip>00287Y109</inf:cusip><inf:isin>US00287Y1091</inf:isin><inf:meetingDate>05/09/2025</inf:meetingDate><inf:voteDescription>Election of Class I Director: Brett J. Hart</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>153901</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>153901</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ABBVIE INC.</inf:issuerName><inf:cusip>00287Y109</inf:cusip><inf:isin>US00287Y1091</inf:isin><inf:meetingDate>05/09/2025</inf:meetingDate><inf:voteDescription>Election of Class I Director: Edward J. Rapp</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>153901</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>153901</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ABBVIE INC.</inf:issuerName><inf:cusip>00287Y109</inf:cusip><inf:isin>US00287Y1091</inf:isin><inf:meetingDate>05/09/2025</inf:meetingDate><inf:voteDescription>Ratification of Ernst &amp; Young LLP as AbbVie's independent registered public accounting firm for 2025</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>153901</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>153901</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ABBVIE INC.</inf:issuerName><inf:cusip>00287Y109</inf:cusip><inf:isin>US00287Y1091</inf:isin><inf:meetingDate>05/09/2025</inf:meetingDate><inf:voteDescription>Say on Pay - An advisory vote on the approval of executive compensation</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>153901</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>153901</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ABBVIE INC.</inf:issuerName><inf:cusip>00287Y109</inf:cusip><inf:isin>US00287Y1091</inf:isin><inf:meetingDate>05/09/2025</inf:meetingDate><inf:voteDescription>Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>153901</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>153901</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ABBVIE INC.</inf:issuerName><inf:cusip>00287Y109</inf:cusip><inf:isin>US00287Y1091</inf:isin><inf:meetingDate>05/09/2025</inf:meetingDate><inf:voteDescription>Stockholder Proposal - to Implement Simple Majority Vote</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>153901</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>153901</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AC IMMUNE SA</inf:issuerName><inf:cusip>H00263105</inf:cusip><inf:isin>CH0329023102</inf:isin><inf:meetingDate>06/19/2025</inf:meetingDate><inf:voteDescription>Approval of 2024 IFRS Consolidated Financial Statements, 2024 Statutory Financial Statements</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6464</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6464</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AC IMMUNE SA</inf:issuerName><inf:cusip>H00263105</inf:cusip><inf:isin>CH0329023102</inf:isin><inf:meetingDate>06/19/2025</inf:meetingDate><inf:voteDescription>Advisory vote on the 2024 Compensation Report</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6464</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>6464</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AC IMMUNE SA</inf:issuerName><inf:cusip>H00263105</inf:cusip><inf:isin>CH0329023102</inf:isin><inf:meetingDate>06/19/2025</inf:meetingDate><inf:voteDescription>Appropriation of Losses</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6464</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6464</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AC IMMUNE SA</inf:issuerName><inf:cusip>H00263105</inf:cusip><inf:isin>CH0329023102</inf:isin><inf:meetingDate>06/19/2025</inf:meetingDate><inf:voteDescription>Discharge of the Members of the Board of Directors and the Executive Committee</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6464</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6464</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AC IMMUNE SA</inf:issuerName><inf:cusip>H00263105</inf:cusip><inf:isin>CH0329023102</inf:isin><inf:meetingDate>06/19/2025</inf:meetingDate><inf:voteDescription>Binding vote on Maximum Aggregate Compensation for Members of the Board of Directors from the AGM 2025 to the AGM 2026</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6464</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>6464</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AC IMMUNE SA</inf:issuerName><inf:cusip>H00263105</inf:cusip><inf:isin>CH0329023102</inf:isin><inf:meetingDate>06/19/2025</inf:meetingDate><inf:voteDescription>Binding vote on Maximum Aggregate Compensation for Members of the Executive Committee for the Financial Year 2026</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6464</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6464</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AC IMMUNE SA</inf:issuerName><inf:cusip>H00263105</inf:cusip><inf:isin>CH0329023102</inf:isin><inf:meetingDate>06/19/2025</inf:meetingDate><inf:voteDescription>Re-election of Director: Monika B&#xFC;tler</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6464</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6464</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AC IMMUNE SA</inf:issuerName><inf:cusip>H00263105</inf:cusip><inf:isin>CH0329023102</inf:isin><inf:meetingDate>06/19/2025</inf:meetingDate><inf:voteDescription>Re-election of Director: Carl June</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6464</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6464</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AC IMMUNE SA</inf:issuerName><inf:cusip>H00263105</inf:cusip><inf:isin>CH0329023102</inf:isin><inf:meetingDate>06/19/2025</inf:meetingDate><inf:voteDescription>Re-election of Director: Andrea Pfeifer</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6464</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6464</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AC IMMUNE SA</inf:issuerName><inf:cusip>H00263105</inf:cusip><inf:isin>CH0329023102</inf:isin><inf:meetingDate>06/19/2025</inf:meetingDate><inf:voteDescription>Re-election of Director: Roy Twyman</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6464</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6464</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AC IMMUNE SA</inf:issuerName><inf:cusip>H00263105</inf:cusip><inf:isin>CH0329023102</inf:isin><inf:meetingDate>06/19/2025</inf:meetingDate><inf:voteDescription>Election of Member of the Board: Ren&#xE9;e Aguiar-Lucander</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6464</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6464</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AC IMMUNE SA</inf:issuerName><inf:cusip>H00263105</inf:cusip><inf:isin>CH0329023102</inf:isin><inf:meetingDate>06/19/2025</inf:meetingDate><inf:voteDescription>Election of Member and Chair of the Board: Martin Z&#xFC;gel</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6464</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6464</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AC IMMUNE SA</inf:issuerName><inf:cusip>H00263105</inf:cusip><inf:isin>CH0329023102</inf:isin><inf:meetingDate>06/19/2025</inf:meetingDate><inf:voteDescription>Re-election of Member of the Compensation, Nomination &amp; Corporate Governance Committee: Monika B&#xFC;tler</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6464</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6464</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AC IMMUNE SA</inf:issuerName><inf:cusip>H00263105</inf:cusip><inf:isin>CH0329023102</inf:isin><inf:meetingDate>06/19/2025</inf:meetingDate><inf:voteDescription>Re-election of Member of the Compensation, Nomination &amp; Corporate Governance Committee: Roy Twyman</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6464</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6464</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AC IMMUNE SA</inf:issuerName><inf:cusip>H00263105</inf:cusip><inf:isin>CH0329023102</inf:isin><inf:meetingDate>06/19/2025</inf:meetingDate><inf:voteDescription>Election of Martin Z&#xFC;gel as Member of the Compensation, Nomination &amp; Corporate Governance Committee</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6464</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6464</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AC IMMUNE SA</inf:issuerName><inf:cusip>H00263105</inf:cusip><inf:isin>CH0329023102</inf:isin><inf:meetingDate>06/19/2025</inf:meetingDate><inf:voteDescription>Re-election of PricewaterhouseCoopers SA (Pully) as Statutory Auditors</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6464</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6464</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AC IMMUNE SA</inf:issuerName><inf:cusip>H00263105</inf:cusip><inf:isin>CH0329023102</inf:isin><inf:meetingDate>06/19/2025</inf:meetingDate><inf:voteDescription>Re-election of Reymond &amp; Associ&#xE9;s Attorneys (Lausanne) as Independent Proxy</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6464</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6464</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AC IMMUNE SA</inf:issuerName><inf:cusip>H00263105</inf:cusip><inf:isin>CH0329023102</inf:isin><inf:meetingDate>06/19/2025</inf:meetingDate><inf:voteDescription>Capital band (Article 3a)</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6464</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>6464</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AC IMMUNE SA</inf:issuerName><inf:cusip>H00263105</inf:cusip><inf:isin>CH0329023102</inf:isin><inf:meetingDate>06/19/2025</inf:meetingDate><inf:voteDescription>Increase and amendment of conditional share capital for employee-benefit plans (Article 3c paras. 1 and 3)</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6464</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6464</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AC IMMUNE SA</inf:issuerName><inf:cusip>H00263105</inf:cusip><inf:isin>CH0329023102</inf:isin><inf:meetingDate>06/19/2025</inf:meetingDate><inf:voteDescription>If a new agenda item or a new proposal for an existing agenda item is put before the meeting, I/we hereby authorize and instruct the Independent Proxy to vote as follows</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6464</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>ABSTAIN</inf:howVoted><inf:sharesVoted>6464</inf:sharesVoted><inf:managementRecommendation>NONE</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AGILENT TECHNOLOGIES, INC.</inf:issuerName><inf:cusip>00846U101</inf:cusip><inf:isin>US00846U1016</inf:isin><inf:meetingDate>03/13/2025</inf:meetingDate><inf:voteDescription>Election of Director for a three-year term: Otis W. Brawley, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>15171</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>15171</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AGILENT TECHNOLOGIES, INC.</inf:issuerName><inf:cusip>00846U101</inf:cusip><inf:isin>US00846U1016</inf:isin><inf:meetingDate>03/13/2025</inf:meetingDate><inf:voteDescription>Election of Director for a three-year term: Mikael Dolsten, M.D., Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>15171</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>15171</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AGILENT TECHNOLOGIES, INC.</inf:issuerName><inf:cusip>00846U101</inf:cusip><inf:isin>US00846U1016</inf:isin><inf:meetingDate>03/13/2025</inf:meetingDate><inf:voteDescription>To approve, on a non-binding advisory basis, the compensation of our named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>15171</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>15171</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AGILENT TECHNOLOGIES, INC.</inf:issuerName><inf:cusip>00846U101</inf:cusip><inf:isin>US00846U1016</inf:isin><inf:meetingDate>03/13/2025</inf:meetingDate><inf:voteDescription>To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>15171</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>15171</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AGILENT TECHNOLOGIES, INC.</inf:issuerName><inf:cusip>00846U101</inf:cusip><inf:isin>US00846U1016</inf:isin><inf:meetingDate>03/13/2025</inf:meetingDate><inf:voteDescription>To approve the amendments to Agilent's Second Amended and Restated Certificate of Incorporation to remove supermajority voting requirements.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>15171</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>15171</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AGILENT TECHNOLOGIES, INC.</inf:issuerName><inf:cusip>00846U101</inf:cusip><inf:isin>US00846U1016</inf:isin><inf:meetingDate>03/13/2025</inf:meetingDate><inf:voteDescription>To elect each director annually.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>15171</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>15171</inf:sharesVoted><inf:managementRecommendation>NONE</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Approval of the operating and financial review of Alcon Inc., the annual financial statements of Alcon Inc. and the consolidated financial statements for 2024</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Discharge of the members of the Board of Directors and the members of the Executive Committee</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Appropriation of earnings and declaration of dividend as per the balance sheet of Alcon Inc. of December 31, 2024</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Consultative vote on the 2024 Report on Non-Financial Matters</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Consultative vote on the 2024 Compensation Report</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Binding vote on the maximum aggregate amount of compensation of the Board of Directors for the next term of office, i.e. from the 2025 Annual General Meeting to the 2026 Annual General Meeting</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Binding vote on the maximum aggregate amount of compensation of the Executive Committee for the following financial year, i.e. 2026</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Re-election of F. Michael Ball (as Member and Chair)</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Re-election of Lynn D. Bleil (as Member)</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Re-election of Arthur Cummings (as Member)</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Re-election of David J. Endicott (as Member)</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Re-election of Thomas Glanzmann (as Member)</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Re-election of D. Keith Grossman (as Member)</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Re-election of Scott Maw (as Member)</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Re-election of Karen May (as Member)</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Re-election of Ines P&#xBF;schel (as Member)</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Re-election of Dieter Sp&#xBF;i (as Member)</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Deborah Di Sanzo (as Member)</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Re-election of the member of the Compensation Committee: Thomas Glanzmann</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Re-election of the member of the Compensation Committee: Scott Maw</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Re-election of the member of the Compensation Committee: Karen May</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Re-election of the member of the Compensation Committee: Ines P&#xBF;schel</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Re-election of the independent representative, Hartmann Dreyer, Attorneys-at-law</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Re-election of the statutory auditors, PricewaterhouseCoopers SA, Geneva</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALCON INC.</inf:issuerName><inf:cusip>H01301128</inf:cusip><inf:isin>CH0432492467</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>General instruction in case of new agenda items or proposals put forth during the Annual General Meeting (please check one box only) * If you vote FOR, you will be voting in accordance with the recommendation of the Board of Directors. ** If you vote AGAINST, you will be voting against the new agenda items or proposals. *** If you vote ABSTAIN, you will abstain from voting.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32610</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>ABSTAIN</inf:howVoted><inf:sharesVoted>32610</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALIGN TECHNOLOGY, INC.</inf:issuerName><inf:cusip>016255101</inf:cusip><inf:isin>US0162551016</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Kevin T. Conroy</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALIGN TECHNOLOGY, INC.</inf:issuerName><inf:cusip>016255101</inf:cusip><inf:isin>US0162551016</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Kevin J. Dallas</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALIGN TECHNOLOGY, INC.</inf:issuerName><inf:cusip>016255101</inf:cusip><inf:isin>US0162551016</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Joseph M. Hogan</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALIGN TECHNOLOGY, INC.</inf:issuerName><inf:cusip>016255101</inf:cusip><inf:isin>US0162551016</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Joseph Lacob</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>8170</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALIGN TECHNOLOGY, INC.</inf:issuerName><inf:cusip>016255101</inf:cusip><inf:isin>US0162551016</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: C. Raymond Larkin, Jr</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALIGN TECHNOLOGY, INC.</inf:issuerName><inf:cusip>016255101</inf:cusip><inf:isin>US0162551016</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: George J. Morrow</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALIGN TECHNOLOGY, INC.</inf:issuerName><inf:cusip>016255101</inf:cusip><inf:isin>US0162551016</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Anne M. Myong</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALIGN TECHNOLOGY, INC.</inf:issuerName><inf:cusip>016255101</inf:cusip><inf:isin>US0162551016</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Mojdeh Poul</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALIGN TECHNOLOGY, INC.</inf:issuerName><inf:cusip>016255101</inf:cusip><inf:isin>US0162551016</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Andrea L. Saia</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALIGN TECHNOLOGY, INC.</inf:issuerName><inf:cusip>016255101</inf:cusip><inf:isin>US0162551016</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Susan E. Siegel</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALIGN TECHNOLOGY, INC.</inf:issuerName><inf:cusip>016255101</inf:cusip><inf:isin>US0162551016</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Advisory Vote to Approve the Compensation of our Named Executive Officers</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALIGN TECHNOLOGY, INC.</inf:issuerName><inf:cusip>016255101</inf:cusip><inf:isin>US0162551016</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Ratification of Appointment of Independent Registered Public Accounting Firm</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALIGN TECHNOLOGY, INC.</inf:issuerName><inf:cusip>016255101</inf:cusip><inf:isin>US0162551016</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Replacement of Supermajority Provisions in our Charter with a Simple Majority Vote</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALIGN TECHNOLOGY, INC.</inf:issuerName><inf:cusip>016255101</inf:cusip><inf:isin>US0162551016</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Approval of an Amendment to the Align Technology, Inc. 2005 Incentive Plan</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALIGN TECHNOLOGY, INC.</inf:issuerName><inf:cusip>016255101</inf:cusip><inf:isin>US0162551016</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Advisory Vote to Allow Stockholders Owning 25% of our Stock to Call a Special Meeting</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALIGN TECHNOLOGY, INC.</inf:issuerName><inf:cusip>016255101</inf:cusip><inf:isin>US0162551016</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Support for Shareholder Ability to Call for a Special Shareholder Meeting</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType></inf:voteCategory><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>8170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>8170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALKERMES PLC</inf:issuerName><inf:cusip>G01767105</inf:cusip><inf:isin>IE00B56GVS15</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve a one-year term until the Company's 2026 annual general meeting of shareholders: Shane M. Cooke</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12700</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12700</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALKERMES PLC</inf:issuerName><inf:cusip>G01767105</inf:cusip><inf:isin>IE00B56GVS15</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve a one-year term until the Company's 2026 annual general meeting of shareholders: Richard B. Gaynor, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12700</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12700</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALKERMES PLC</inf:issuerName><inf:cusip>G01767105</inf:cusip><inf:isin>IE00B56GVS15</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve a one-year term until the Company's 2026 annual general meeting of shareholders: Cato T. Laurencin, M.D., Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12700</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12700</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALKERMES PLC</inf:issuerName><inf:cusip>G01767105</inf:cusip><inf:isin>IE00B56GVS15</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve a one-year term until the Company's 2026 annual general meeting of shareholders: Nancy S. Lurker</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12700</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12700</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALKERMES PLC</inf:issuerName><inf:cusip>G01767105</inf:cusip><inf:isin>IE00B56GVS15</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve a one-year term until the Company's 2026 annual general meeting of shareholders: Brian P. McKeon</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12700</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12700</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALKERMES PLC</inf:issuerName><inf:cusip>G01767105</inf:cusip><inf:isin>IE00B56GVS15</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve a one-year term until the Company's 2026 annual general meeting of shareholders: Richard F. Pops</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12700</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12700</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALKERMES PLC</inf:issuerName><inf:cusip>G01767105</inf:cusip><inf:isin>IE00B56GVS15</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve a one-year term until the Company's 2026 annual general meeting of shareholders: Nancy L. Snyderman, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12700</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12700</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALKERMES PLC</inf:issuerName><inf:cusip>G01767105</inf:cusip><inf:isin>IE00B56GVS15</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve a one-year term until the Company's 2026 annual general meeting of shareholders: Frank Anders Wilson</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12700</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12700</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALKERMES PLC</inf:issuerName><inf:cusip>G01767105</inf:cusip><inf:isin>IE00B56GVS15</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve a one-year term until the Company's 2026 annual general meeting of shareholders: Christopher I. Wright, M.D., Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12700</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12700</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALKERMES PLC</inf:issuerName><inf:cusip>G01767105</inf:cusip><inf:isin>IE00B56GVS15</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12700</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12700</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALKERMES PLC</inf:issuerName><inf:cusip>G01767105</inf:cusip><inf:isin>IE00B56GVS15</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize, in a binding vote, the Audit and Risk committee of the Board to set the independent auditor and accounting firm's remuneration.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12700</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12700</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALKERMES PLC</inf:issuerName><inf:cusip>G01767105</inf:cusip><inf:isin>IE00B56GVS15</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12700</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12700</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALKERMES PLC</inf:issuerName><inf:cusip>G01767105</inf:cusip><inf:isin>IE00B56GVS15</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>To renew Board authority to allot and issue shares under Irish law.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12700</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12700</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALKERMES PLC</inf:issuerName><inf:cusip>G01767105</inf:cusip><inf:isin>IE00B56GVS15</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>To renew Board authority to disapply the statutory pre-emption rights that would otherwise apply under Irish law.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12700</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12700</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALLOGENE THERAPEUTICS, INC.</inf:issuerName><inf:cusip>019770106</inf:cusip><inf:isin>US0197701065</inf:isin><inf:meetingDate>06/18/2025</inf:meetingDate><inf:voteDescription>Election of Director: Elizabeth Barrett</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>83601</inf:sharesVoted><inf:sharesOnLoan>24500</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>83601</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALLOGENE THERAPEUTICS, INC.</inf:issuerName><inf:cusip>019770106</inf:cusip><inf:isin>US0197701065</inf:isin><inf:meetingDate>06/18/2025</inf:meetingDate><inf:voteDescription>Election of Director: Arie Belldegrun, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>83601</inf:sharesVoted><inf:sharesOnLoan>24500</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>83601</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALLOGENE THERAPEUTICS, INC.</inf:issuerName><inf:cusip>019770106</inf:cusip><inf:isin>US0197701065</inf:isin><inf:meetingDate>06/18/2025</inf:meetingDate><inf:voteDescription>Election of Director: David Chang, M.D., Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>83601</inf:sharesVoted><inf:sharesOnLoan>24500</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>83601</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALLOGENE THERAPEUTICS, INC.</inf:issuerName><inf:cusip>019770106</inf:cusip><inf:isin>US0197701065</inf:isin><inf:meetingDate>06/18/2025</inf:meetingDate><inf:voteDescription>To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>83601</inf:sharesVoted><inf:sharesOnLoan>24500</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>83601</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALLOGENE THERAPEUTICS, INC.</inf:issuerName><inf:cusip>019770106</inf:cusip><inf:isin>US0197701065</inf:isin><inf:meetingDate>06/18/2025</inf:meetingDate><inf:voteDescription>To ratify the selection by the Audit Committee of the Board of Directors of Ernst &amp; Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>83601</inf:sharesVoted><inf:sharesOnLoan>24500</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>83601</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALNYLAM PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>02043Q107</inf:cusip><inf:isin>US02043Q1076</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Class III Director of Alnylam to serve for a term ending in 2028: Carolyn R. Bertozzi, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>29036</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>29036</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALNYLAM PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>02043Q107</inf:cusip><inf:isin>US02043Q1076</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Class III Director of Alnylam to serve for a term ending in 2028: Margaret A. Hamburg, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>29036</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>29036</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALNYLAM PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>02043Q107</inf:cusip><inf:isin>US02043Q1076</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Class III Director of Alnylam to serve for a term ending in 2028: Colleen F. Reitan</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>29036</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>29036</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALNYLAM PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>02043Q107</inf:cusip><inf:isin>US02043Q1076</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Class III Director of Alnylam to serve for a term ending in 2028: Amy W. Schulman</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>29036</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>29036</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALNYLAM PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>02043Q107</inf:cusip><inf:isin>US02043Q1076</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>To approve an Amendment to our Restated Certificate of Incorporation allowing for officer exculpation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>29036</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>29036</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALNYLAM PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>02043Q107</inf:cusip><inf:isin>US02043Q1076</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>To approve the second amended and restated 2018 Stock Incentive Plan.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>29036</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>29036</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALNYLAM PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>02043Q107</inf:cusip><inf:isin>US02043Q1076</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>29036</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>29036</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ALNYLAM PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>02043Q107</inf:cusip><inf:isin>US02043Q1076</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>29036</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>29036</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AMGEN INC.</inf:issuerName><inf:cusip>031162100</inf:cusip><inf:isin>US0311621009</inf:isin><inf:meetingDate>05/23/2025</inf:meetingDate><inf:voteDescription>Election of Director for a term of office expiring at the 2026 annual meeting of stockholders: Dr. Wanda M. Austin</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21296</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21296</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AMGEN INC.</inf:issuerName><inf:cusip>031162100</inf:cusip><inf:isin>US0311621009</inf:isin><inf:meetingDate>05/23/2025</inf:meetingDate><inf:voteDescription>Election of Director for a term of office expiring at the 2026 annual meeting of stockholders: Mr. Robert A. Bradway</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21296</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21296</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AMGEN INC.</inf:issuerName><inf:cusip>031162100</inf:cusip><inf:isin>US0311621009</inf:isin><inf:meetingDate>05/23/2025</inf:meetingDate><inf:voteDescription>Election of Director for a term of office expiring at the 2026 annual meeting of stockholders: Dr. Michael V. Drake</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21296</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21296</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AMGEN INC.</inf:issuerName><inf:cusip>031162100</inf:cusip><inf:isin>US0311621009</inf:isin><inf:meetingDate>05/23/2025</inf:meetingDate><inf:voteDescription>Election of Director for a term of office expiring at the 2026 annual meeting of stockholders: Dr. Brian J. Druker</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21296</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21296</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AMGEN INC.</inf:issuerName><inf:cusip>031162100</inf:cusip><inf:isin>US0311621009</inf:isin><inf:meetingDate>05/23/2025</inf:meetingDate><inf:voteDescription>Election of Director for a term of office expiring at the 2026 annual meeting of stockholders: Mr. Robert A. Eckert</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21296</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21296</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AMGEN INC.</inf:issuerName><inf:cusip>031162100</inf:cusip><inf:isin>US0311621009</inf:isin><inf:meetingDate>05/23/2025</inf:meetingDate><inf:voteDescription>Election of Director for a term of office expiring at the 2026 annual meeting of stockholders: Mr. Greg C. Garland</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21296</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21296</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AMGEN INC.</inf:issuerName><inf:cusip>031162100</inf:cusip><inf:isin>US0311621009</inf:isin><inf:meetingDate>05/23/2025</inf:meetingDate><inf:voteDescription>Election of Director for a term of office expiring at the 2026 annual meeting of stockholders: Mr. Charles M. Holley, Jr.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21296</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21296</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AMGEN INC.</inf:issuerName><inf:cusip>031162100</inf:cusip><inf:isin>US0311621009</inf:isin><inf:meetingDate>05/23/2025</inf:meetingDate><inf:voteDescription>Election of Director for a term of office expiring at the 2026 annual meeting of stockholders: Dr. S. Omar Ishrak</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21296</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21296</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AMGEN INC.</inf:issuerName><inf:cusip>031162100</inf:cusip><inf:isin>US0311621009</inf:isin><inf:meetingDate>05/23/2025</inf:meetingDate><inf:voteDescription>Election of Director for a term of office expiring at the 2026 annual meeting of stockholders: Dr. Tyler Jacks</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21296</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21296</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AMGEN INC.</inf:issuerName><inf:cusip>031162100</inf:cusip><inf:isin>US0311621009</inf:isin><inf:meetingDate>05/23/2025</inf:meetingDate><inf:voteDescription>Election of Director for a term of office expiring at the 2026 annual meeting of stockholders: Dr. Mary E. Klotman</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21296</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21296</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AMGEN INC.</inf:issuerName><inf:cusip>031162100</inf:cusip><inf:isin>US0311621009</inf:isin><inf:meetingDate>05/23/2025</inf:meetingDate><inf:voteDescription>Election of Director for a term of office expiring at the 2026 annual meeting of stockholders: Ms. Ellen J. Kullman</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21296</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21296</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AMGEN INC.</inf:issuerName><inf:cusip>031162100</inf:cusip><inf:isin>US0311621009</inf:isin><inf:meetingDate>05/23/2025</inf:meetingDate><inf:voteDescription>Election of Director for a term of office expiring at the 2026 annual meeting of stockholders: Ms. Amy E. Miles</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21296</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21296</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AMGEN INC.</inf:issuerName><inf:cusip>031162100</inf:cusip><inf:isin>US0311621009</inf:isin><inf:meetingDate>05/23/2025</inf:meetingDate><inf:voteDescription>Advisory vote to approve our executive compensation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21296</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21296</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AMGEN INC.</inf:issuerName><inf:cusip>031162100</inf:cusip><inf:isin>US0311621009</inf:isin><inf:meetingDate>05/23/2025</inf:meetingDate><inf:voteDescription>To ratify the selection of Ernst &amp; Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21296</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21296</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ARCELLX, INC.</inf:issuerName><inf:cusip>03940C100</inf:cusip><inf:isin>US03940C1009</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>Election of Class III Director to hold office until our 2028 annual meeting of stockholders and until their respective successors are elected and qualified: Rami Elghandour</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>15514</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>15514</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ARCELLX, INC.</inf:issuerName><inf:cusip>03940C100</inf:cusip><inf:isin>US03940C1009</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>Election of Class III Director to hold office until our 2028 annual meeting of stockholders and until their respective successors are elected and qualified: David Lubner</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>15514</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>WITHHOLD</inf:howVoted><inf:sharesVoted>15514</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ARCELLX, INC.</inf:issuerName><inf:cusip>03940C100</inf:cusip><inf:isin>US03940C1009</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>Election of Class III Director to hold office until our 2028 annual meeting of stockholders and until their respective successors are elected and qualified: Kristin Myers</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>15514</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>15514</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ARCELLX, INC.</inf:issuerName><inf:cusip>03940C100</inf:cusip><inf:isin>US03940C1009</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>15514</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>15514</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ARCELLX, INC.</inf:issuerName><inf:cusip>03940C100</inf:cusip><inf:isin>US03940C1009</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>15514</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>15514</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ARGENX SE</inf:issuerName><inf:cusip>04016X101</inf:cusip><inf:isin>US04016X1019</inf:isin><inf:meetingDate>05/27/2025</inf:meetingDate><inf:voteDescription>The 2024 remuneration report</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16263</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16263</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ARGENX SE</inf:issuerName><inf:cusip>04016X101</inf:cusip><inf:isin>US04016X1019</inf:isin><inf:meetingDate>05/27/2025</inf:meetingDate><inf:voteDescription>Adoption of the 2024 annual accounts</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16263</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16263</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ARGENX SE</inf:issuerName><inf:cusip>04016X101</inf:cusip><inf:isin>US04016X1019</inf:isin><inf:meetingDate>05/27/2025</inf:meetingDate><inf:voteDescription>Allocation of profits of the Company in the financial year 2024 to the retained earnings of the Company</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16263</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16263</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ARGENX SE</inf:issuerName><inf:cusip>04016X101</inf:cusip><inf:isin>US04016X1019</inf:isin><inf:meetingDate>05/27/2025</inf:meetingDate><inf:voteDescription>Proposal to release the members of the board of directors from liability for their respective duties carried out in the financial year 2024</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16263</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16263</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ARGENX SE</inf:issuerName><inf:cusip>04016X101</inf:cusip><inf:isin>US04016X1019</inf:isin><inf:meetingDate>05/27/2025</inf:meetingDate><inf:voteDescription>Adoption of the remuneration policy</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16263</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16263</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ARGENX SE</inf:issuerName><inf:cusip>04016X101</inf:cusip><inf:isin>US04016X1019</inf:isin><inf:meetingDate>05/27/2025</inf:meetingDate><inf:voteDescription>Re-appointment of Anthony Rosenberg as non-executive director to the board of directors of the Company, for a two-year term</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16263</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16263</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ARGENX SE</inf:issuerName><inf:cusip>04016X101</inf:cusip><inf:isin>US04016X1019</inf:isin><inf:meetingDate>05/27/2025</inf:meetingDate><inf:voteDescription>Authorization of the board of directors to issue shares and grant rights to subscribe for shares in the share capital of the Company up to a maximum of 10% of the outstanding capital at the date of the general meeting for a period of 18 months from the general meeting and to limit or exclude statutory pre-emptive rights</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16263</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16263</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASCENDIS PHARMA A S</inf:issuerName><inf:cusip>04351P101</inf:cusip><inf:isin>US04351P1012</inf:isin><inf:meetingDate>05/27/2025</inf:meetingDate><inf:voteDescription>Election of Chairman of the Meeting</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6459</inf:sharesVoted><inf:sharesOnLoan>3000</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6459</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASCENDIS PHARMA A S</inf:issuerName><inf:cusip>04351P101</inf:cusip><inf:isin>US04351P1012</inf:isin><inf:meetingDate>05/27/2025</inf:meetingDate><inf:voteDescription>Presentation of Audited Annual Report with Auditor's Statement for Approval and Discharge of the Board of Directors and Management</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6459</inf:sharesVoted><inf:sharesOnLoan>3000</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6459</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASCENDIS PHARMA A S</inf:issuerName><inf:cusip>04351P101</inf:cusip><inf:isin>US04351P1012</inf:isin><inf:meetingDate>05/27/2025</inf:meetingDate><inf:voteDescription>Resolution on Application of Profits or Covering of Losses as per the Adopted Annual Report</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6459</inf:sharesVoted><inf:sharesOnLoan>3000</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6459</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASCENDIS PHARMA A S</inf:issuerName><inf:cusip>04351P101</inf:cusip><inf:isin>US04351P1012</inf:isin><inf:meetingDate>05/27/2025</inf:meetingDate><inf:voteDescription>Re-election of Albert Cha</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6459</inf:sharesVoted><inf:sharesOnLoan>3000</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6459</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASCENDIS PHARMA A S</inf:issuerName><inf:cusip>04351P101</inf:cusip><inf:isin>US04351P1012</inf:isin><inf:meetingDate>05/27/2025</inf:meetingDate><inf:voteDescription>Re-election of Lars Holtug</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6459</inf:sharesVoted><inf:sharesOnLoan>3000</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6459</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASCENDIS PHARMA A S</inf:issuerName><inf:cusip>04351P101</inf:cusip><inf:isin>US04351P1012</inf:isin><inf:meetingDate>05/27/2025</inf:meetingDate><inf:voteDescription>Re-election of Jan Moller Mikkelsen</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6459</inf:sharesVoted><inf:sharesOnLoan>3000</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6459</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASCENDIS PHARMA A S</inf:issuerName><inf:cusip>04351P101</inf:cusip><inf:isin>US04351P1012</inf:isin><inf:meetingDate>05/27/2025</inf:meetingDate><inf:voteDescription>Re-election of Lisa Jane Morrison</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6459</inf:sharesVoted><inf:sharesOnLoan>3000</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6459</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASCENDIS PHARMA A S</inf:issuerName><inf:cusip>04351P101</inf:cusip><inf:isin>US04351P1012</inf:isin><inf:meetingDate>05/27/2025</inf:meetingDate><inf:voteDescription>Re-election of William Carl Fairey Jr</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6459</inf:sharesVoted><inf:sharesOnLoan>3000</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6459</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASCENDIS PHARMA A S</inf:issuerName><inf:cusip>04351P101</inf:cusip><inf:isin>US04351P1012</inf:isin><inf:meetingDate>05/27/2025</inf:meetingDate><inf:voteDescription>Re-election of Siham Imani</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6459</inf:sharesVoted><inf:sharesOnLoan>3000</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6459</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASCENDIS PHARMA A S</inf:issuerName><inf:cusip>04351P101</inf:cusip><inf:isin>US04351P1012</inf:isin><inf:meetingDate>05/27/2025</inf:meetingDate><inf:voteDescription>Election of State-authorized Public Auditor</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6459</inf:sharesVoted><inf:sharesOnLoan>3000</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6459</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASCENDIS PHARMA A S</inf:issuerName><inf:cusip>04351P101</inf:cusip><inf:isin>US04351P1012</inf:isin><inf:meetingDate>05/27/2025</inf:meetingDate><inf:voteDescription>Prolongation of authorization contained in article 4 d (2) in the articles of association</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6459</inf:sharesVoted><inf:sharesOnLoan>3000</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6459</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASCENDIS PHARMA A S</inf:issuerName><inf:cusip>04351P101</inf:cusip><inf:isin>US04351P1012</inf:isin><inf:meetingDate>05/27/2025</inf:meetingDate><inf:voteDescription>Authorization to issue warrants</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6459</inf:sharesVoted><inf:sharesOnLoan>3000</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>6459</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASCENDIS PHARMA A S</inf:issuerName><inf:cusip>04351P101</inf:cusip><inf:isin>US04351P1012</inf:isin><inf:meetingDate>05/27/2025</inf:meetingDate><inf:voteDescription>Amendment of article 12 in the articles of association</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6459</inf:sharesVoted><inf:sharesOnLoan>3000</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6459</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO RECEIVE THE COMPANYS ACCOUNTS THE REPORTS OF THE DIRECTORS AND AUDITOR AND THE STRATEGIC REPORT FOR THE YEAR ENDED 31 DECEMBER 2024</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO CONFIRM THE 2024 INTERIM DIVIDENDS</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO RE-APPOINT PRICEWATERHOUSECOOPERS LLP AS AUDITOR</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO AUTHORISE THE DIRECTORS TO AGREE THE REMUNERATION OF THE AUDITOR</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO ELECT OR RE-ELECT MICHEL DEMARE</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO ELECT OR RE-ELECT PASCAL SORIOT</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO ELECT OR RE-ELECT ARADHANA SARIN</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO ELECT OR RE-ELECT PHILIP BROADLEY</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO ELECT OR RE-ELECT EUAN ASHLEY</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO ELECT OR RE-ELECT BIRGIT CONIX</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO ELECT OR RE-ELECT RENE HAAS</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO ELECT OR RE-ELECT KAREN KNUDSEN</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO ELECT OR RE-ELECT DIANA LAYFIELD</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO ELECT OR RE-ELECT ANNA MANZ</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO ELECT OR RE-ELECT SHERI MCCOY</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO ELECT OR RE-ELECT TONY MOK</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO ELECT OR RE-ELECT NAZNEEN RAHMAN</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO ELECT OR RE-ELECT MARCUS WALLENBERG</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO APPROVE THE ANNUAL STATEMENT OF THE CHAIR OF THE REMUNERATION COMMITTEE AND THE ANNUAL REPORT ON REMUNERATION FOR THE YEAR ENDED 31 DECEMBER 2024</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO AUTHORISE LIMITED POLITICAL DONATIONS</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO AUTHORISE THE DIRECTORS TO ALLOT SHARES</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO AUTHORISE THE DIRECTORS TO DISAPPLY PRE-EMPTION RIGHTS</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO AUTHORISE THE DIRECTORS TO FURTHER DISAPPLY PRE-EMPTION RIGHTS FOR ACQUISITIONS AND SPECIFIED CAPITAL INVESTMENTS</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO AUTHORISE THE COMPANY TO PURCHASE ITS OWN SHARES</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ASTRAZENECA PLC</inf:issuerName><inf:cusip>G0593M107</inf:cusip><inf:isin>GB0009895292</inf:isin><inf:meetingDate>04/11/2025</inf:meetingDate><inf:voteDescription>TO REDUCE THE NOTICE PERIOD FOR GENERAL MEETINGS</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24744</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24744</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AUTOLUS THERAPEUTICS PLC</inf:issuerName><inf:cusip>05280R100</inf:cusip><inf:isin>US05280R1005</inf:isin><inf:meetingDate>06/26/2025</inf:meetingDate><inf:voteDescription>To receive and adopt the Company's accounts for the financial year ended 31 December 2024 and the associated reports of the Directors and auditors (the "2024 Annual Report and Accounts").</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>64258</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>64258</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AUTOLUS THERAPEUTICS PLC</inf:issuerName><inf:cusip>05280R100</inf:cusip><inf:isin>US05280R1005</inf:isin><inf:meetingDate>06/26/2025</inf:meetingDate><inf:voteDescription>To approve the Directors' remuneration report (excluding the Directors' remuneration policy set out on pages 39 to 52 of Directors' remuneration report), which is set out on pages 36 to 65 of the 2024 Annual Report and Accounts.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>64258</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>64258</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AUTOLUS THERAPEUTICS PLC</inf:issuerName><inf:cusip>05280R100</inf:cusip><inf:isin>US05280R1005</inf:isin><inf:meetingDate>06/26/2025</inf:meetingDate><inf:voteDescription>To approve the Directors' remuneration policy set out on pages 39 to 52 within the Directors' remuneration report contained in the 2024 Annual Report and Accounts, which will take effect immediately after the end of the AGM.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>64258</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>64258</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AUTOLUS THERAPEUTICS PLC</inf:issuerName><inf:cusip>05280R100</inf:cusip><inf:isin>US05280R1005</inf:isin><inf:meetingDate>06/26/2025</inf:meetingDate><inf:voteDescription>To re-appoint Ernst &amp; Young LLP as auditors of the Company to hold office from the conclusion of the 2025 AGM until the conclusion of the 2026 AGM and to authorise the Directors to determine the auditors' remuneration.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>64258</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>64258</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AUTOLUS THERAPEUTICS PLC</inf:issuerName><inf:cusip>05280R100</inf:cusip><inf:isin>US05280R1005</inf:isin><inf:meetingDate>06/26/2025</inf:meetingDate><inf:voteDescription>To re-elect Dr. R Iannone as a Director.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>64258</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>64258</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AUTOLUS THERAPEUTICS PLC</inf:issuerName><inf:cusip>05280R100</inf:cusip><inf:isin>US05280R1005</inf:isin><inf:meetingDate>06/26/2025</inf:meetingDate><inf:voteDescription>To re-elect Dr. R Rao as a Director.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>64258</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>64258</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AUTOLUS THERAPEUTICS PLC</inf:issuerName><inf:cusip>05280R100</inf:cusip><inf:isin>US05280R1005</inf:isin><inf:meetingDate>06/26/2025</inf:meetingDate><inf:voteDescription>To approve the Autolus Therapeutics plc Employee Share Purchase Plan with Sharesave Sub-Plan adopted by the Board on 20 May 2025 (the "Purchase Plan"), with 3,000,000 (three million) Shares (as defined therein) available for issuance under the Purchase Plan, and with the directors authorised to do all acts and things as are or may be necessary or expedient to carry the same into effect, notwithstanding that the directors may be interested in the same.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>64258</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>64258</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AVIDITY BIOSCIENCES, INC.</inf:issuerName><inf:cusip>05370A108</inf:cusip><inf:isin>US05370A1088</inf:isin><inf:meetingDate>06/10/2025</inf:meetingDate><inf:voteDescription>Election of Class II Director for a three-year term that expires at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Arthur Levin, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17918</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>17918</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AVIDITY BIOSCIENCES, INC.</inf:issuerName><inf:cusip>05370A108</inf:cusip><inf:isin>US05370A1088</inf:isin><inf:meetingDate>06/10/2025</inf:meetingDate><inf:voteDescription>Election of Class II Director for a three-year term that expires at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Simona Skerjanec</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17918</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>17918</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AVIDITY BIOSCIENCES, INC.</inf:issuerName><inf:cusip>05370A108</inf:cusip><inf:isin>US05370A1088</inf:isin><inf:meetingDate>06/10/2025</inf:meetingDate><inf:voteDescription>Election of Class II Director for a three-year term that expires at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Tamar Thompson</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17918</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>WITHHOLD</inf:howVoted><inf:sharesVoted>17918</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AVIDITY BIOSCIENCES, INC.</inf:issuerName><inf:cusip>05370A108</inf:cusip><inf:isin>US05370A1088</inf:isin><inf:meetingDate>06/10/2025</inf:meetingDate><inf:voteDescription>To ratify the appointment of Deloitte &amp; Touche LLP as our independent public accounting firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17918</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>17918</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>AVIDITY BIOSCIENCES, INC.</inf:issuerName><inf:cusip>05370A108</inf:cusip><inf:isin>US05370A1088</inf:isin><inf:meetingDate>06/10/2025</inf:meetingDate><inf:voteDescription>To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17918</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>17918</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BEAM THERAPEUTICS INC.</inf:issuerName><inf:cusip>07373V105</inf:cusip><inf:isin>US07373V1052</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Election of Class II Director for three-year terms ending at our Annual Meeting of Stockholders to be held in 2028: Mark Fishman, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>14124</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>14124</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BEAM THERAPEUTICS INC.</inf:issuerName><inf:cusip>07373V105</inf:cusip><inf:isin>US07373V1052</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Election of Class II Director for three-year terms ending at our Annual Meeting of Stockholders to be held in 2028: Carole Ho, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>14124</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>14124</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BEAM THERAPEUTICS INC.</inf:issuerName><inf:cusip>07373V105</inf:cusip><inf:isin>US07373V1052</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Election of Class II Director for three-year terms ending at our Annual Meeting of Stockholders to be held in 2028: Kathleen Walsh</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>14124</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>14124</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BEAM THERAPEUTICS INC.</inf:issuerName><inf:cusip>07373V105</inf:cusip><inf:isin>US07373V1052</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Ratify the appointment of Deloitte &amp; Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>14124</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>14124</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BEAM THERAPEUTICS INC.</inf:issuerName><inf:cusip>07373V105</inf:cusip><inf:isin>US07373V1052</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Approve, on an advisory basis, the compensation of our named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>14124</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>14124</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BECTON, DICKINSON AND COMPANY</inf:issuerName><inf:cusip>075887109</inf:cusip><inf:isin>US0758871091</inf:isin><inf:meetingDate>01/28/2025</inf:meetingDate><inf:voteDescription>Election of Director: William M. Brown</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>33686</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>33686</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BECTON, DICKINSON AND COMPANY</inf:issuerName><inf:cusip>075887109</inf:cusip><inf:isin>US0758871091</inf:isin><inf:meetingDate>01/28/2025</inf:meetingDate><inf:voteDescription>Election of Director: Catherine M. Burzik</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>33686</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>33686</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BECTON, DICKINSON AND COMPANY</inf:issuerName><inf:cusip>075887109</inf:cusip><inf:isin>US0758871091</inf:isin><inf:meetingDate>01/28/2025</inf:meetingDate><inf:voteDescription>Election of Director: Carrie Byington</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>33686</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>33686</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BECTON, DICKINSON AND COMPANY</inf:issuerName><inf:cusip>075887109</inf:cusip><inf:isin>US0758871091</inf:isin><inf:meetingDate>01/28/2025</inf:meetingDate><inf:voteDescription>Election of Director: R. Andrew Eckert</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>33686</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>33686</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BECTON, DICKINSON AND COMPANY</inf:issuerName><inf:cusip>075887109</inf:cusip><inf:isin>US0758871091</inf:isin><inf:meetingDate>01/28/2025</inf:meetingDate><inf:voteDescription>Election of Director: Claire M. Fraser</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>33686</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>33686</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BECTON, DICKINSON AND COMPANY</inf:issuerName><inf:cusip>075887109</inf:cusip><inf:isin>US0758871091</inf:isin><inf:meetingDate>01/28/2025</inf:meetingDate><inf:voteDescription>Election of Director: Jeffrey W. Henderson</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>33686</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>33686</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BECTON, DICKINSON AND COMPANY</inf:issuerName><inf:cusip>075887109</inf:cusip><inf:isin>US0758871091</inf:isin><inf:meetingDate>01/28/2025</inf:meetingDate><inf:voteDescription>Election of Director: Christopher Jones</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>33686</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>33686</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BECTON, DICKINSON AND COMPANY</inf:issuerName><inf:cusip>075887109</inf:cusip><inf:isin>US0758871091</inf:isin><inf:meetingDate>01/28/2025</inf:meetingDate><inf:voteDescription>Election of Director: Thomas E. Polen</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>33686</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>33686</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BECTON, DICKINSON AND COMPANY</inf:issuerName><inf:cusip>075887109</inf:cusip><inf:isin>US0758871091</inf:isin><inf:meetingDate>01/28/2025</inf:meetingDate><inf:voteDescription>Election of Director: Timothy M. Ring</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>33686</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>33686</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BECTON, DICKINSON AND COMPANY</inf:issuerName><inf:cusip>075887109</inf:cusip><inf:isin>US0758871091</inf:isin><inf:meetingDate>01/28/2025</inf:meetingDate><inf:voteDescription>Election of Director: Bertram L. Scott</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>33686</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>33686</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BECTON, DICKINSON AND COMPANY</inf:issuerName><inf:cusip>075887109</inf:cusip><inf:isin>US0758871091</inf:isin><inf:meetingDate>01/28/2025</inf:meetingDate><inf:voteDescription>Election of Director: Joanne Waldstreicher</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>33686</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>33686</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BECTON, DICKINSON AND COMPANY</inf:issuerName><inf:cusip>075887109</inf:cusip><inf:isin>US0758871091</inf:isin><inf:meetingDate>01/28/2025</inf:meetingDate><inf:voteDescription>Ratification of the selection of the independent registered public accounting firm.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>33686</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>33686</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BECTON, DICKINSON AND COMPANY</inf:issuerName><inf:cusip>075887109</inf:cusip><inf:isin>US0758871091</inf:isin><inf:meetingDate>01/28/2025</inf:meetingDate><inf:voteDescription>Advisory vote to approve named executive officer compensation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>33686</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>33686</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BEIGENE LTD</inf:issuerName><inf:cusip>07725L102</inf:cusip><inf:isin>US07725L1026</inf:isin><inf:meetingDate>04/28/2025</inf:meetingDate><inf:voteDescription>Special Resolution: THAT a special resolution that the deregistration of the Company in the Cayman Islands and the continuation of the Company to Switzerland be and hereby is approved and authorized (the "Continuation").</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>EXTRAORDINARY TRANSACTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6675</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6675</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BEIGENE LTD</inf:issuerName><inf:cusip>07725L102</inf:cusip><inf:isin>US07725L1026</inf:isin><inf:meetingDate>04/28/2025</inf:meetingDate><inf:voteDescription>Special Resolution: Subject to, and effective only upon, (i) the approval of Resolution 1, (ii) the deregistration of the Company from the Register of Companies in the Cayman Islands and (iii) the simultaneous registration of the Continuation with the Swiss Commercial Register, THAT: 1. The seventh amended and restated memorandum and articles of association be amended and restated in the form set forth in Exhibit A to the proxy statement/prospectus (the "Proposed Swiss Articles") to be ... (due to space limits, see proxy material for full proposal)</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6675</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6675</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BEIGENE LTD</inf:issuerName><inf:cusip>07725L102</inf:cusip><inf:isin>US07725L1026</inf:isin><inf:meetingDate>04/28/2025</inf:meetingDate><inf:voteDescription>Ordinary Resolution: Subject to the approval of the Continuation and as required by Swiss law, THAT the election of Ernst &amp; Young AG to serve as the Company's statutory auditor (for Swiss legal purposes) until the Company's first annual general meeting following the completion of the Continuation and provide the related audit services and the authorization to board of directors to fix the remuneration of Ernst &amp; Young AG be and hereby is approved and authorized.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6675</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6675</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIO-TECHNE CORP</inf:issuerName><inf:cusip>09073M104</inf:cusip><inf:isin>US09073M1045</inf:isin><inf:meetingDate>10/24/2024</inf:meetingDate><inf:voteDescription>To set the number of Directors at nine.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16718</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16718</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIO-TECHNE CORP</inf:issuerName><inf:cusip>09073M104</inf:cusip><inf:isin>US09073M1045</inf:isin><inf:meetingDate>10/24/2024</inf:meetingDate><inf:voteDescription>Election of Director: Robert V. Baumgartner</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16718</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16718</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIO-TECHNE CORP</inf:issuerName><inf:cusip>09073M104</inf:cusip><inf:isin>US09073M1045</inf:isin><inf:meetingDate>10/24/2024</inf:meetingDate><inf:voteDescription>Election of Director: Julie L. Bushman</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16718</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16718</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIO-TECHNE CORP</inf:issuerName><inf:cusip>09073M104</inf:cusip><inf:isin>US09073M1045</inf:isin><inf:meetingDate>10/24/2024</inf:meetingDate><inf:voteDescription>Election of Director: Judith Klimovsky</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16718</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16718</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIO-TECHNE CORP</inf:issuerName><inf:cusip>09073M104</inf:cusip><inf:isin>US09073M1045</inf:isin><inf:meetingDate>10/24/2024</inf:meetingDate><inf:voteDescription>Election of Director: John L. Higgins</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16718</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16718</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIO-TECHNE CORP</inf:issuerName><inf:cusip>09073M104</inf:cusip><inf:isin>US09073M1045</inf:isin><inf:meetingDate>10/24/2024</inf:meetingDate><inf:voteDescription>Election of Director: Kim Kelderman</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16718</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16718</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIO-TECHNE CORP</inf:issuerName><inf:cusip>09073M104</inf:cusip><inf:isin>US09073M1045</inf:isin><inf:meetingDate>10/24/2024</inf:meetingDate><inf:voteDescription>Election of Director: Alpna Seth</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16718</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16718</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIO-TECHNE CORP</inf:issuerName><inf:cusip>09073M104</inf:cusip><inf:isin>US09073M1045</inf:isin><inf:meetingDate>10/24/2024</inf:meetingDate><inf:voteDescription>Election of Director: Rupert Vessey</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16718</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16718</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIO-TECHNE CORP</inf:issuerName><inf:cusip>09073M104</inf:cusip><inf:isin>US09073M1045</inf:isin><inf:meetingDate>10/24/2024</inf:meetingDate><inf:voteDescription>Election of Director: Joseph D. Keegan</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16718</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16718</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIO-TECHNE CORP</inf:issuerName><inf:cusip>09073M104</inf:cusip><inf:isin>US09073M1045</inf:isin><inf:meetingDate>10/24/2024</inf:meetingDate><inf:voteDescription>Election of Director: Roeland Nusse</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16718</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16718</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIO-TECHNE CORP</inf:issuerName><inf:cusip>09073M104</inf:cusip><inf:isin>US09073M1045</inf:isin><inf:meetingDate>10/24/2024</inf:meetingDate><inf:voteDescription>Approve, on an advisory basis, the compensation of our executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16718</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16718</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIO-TECHNE CORP</inf:issuerName><inf:cusip>09073M104</inf:cusip><inf:isin>US09073M1045</inf:isin><inf:meetingDate>10/24/2024</inf:meetingDate><inf:voteDescription>Ratify the appointment of KPMG, LLP as the Company's independent registered public accounting firm for the 2025 fiscal year.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16718</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16718</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOGEN INC.</inf:issuerName><inf:cusip>09062X103</inf:cusip><inf:isin>US09062X1037</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Caroline D. Dorsa</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>19041</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>19041</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOGEN INC.</inf:issuerName><inf:cusip>09062X103</inf:cusip><inf:isin>US09062X1037</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. Freire</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>19041</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>19041</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOGEN INC.</inf:issuerName><inf:cusip>09062X103</inf:cusip><inf:isin>US09062X1037</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: William A. Hawkins</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>19041</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>19041</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOGEN INC.</inf:issuerName><inf:cusip>09062X103</inf:cusip><inf:isin>US09062X1037</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. Langer</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>19041</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>19041</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOGEN INC.</inf:issuerName><inf:cusip>09062X103</inf:cusip><inf:isin>US09062X1037</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. Mantas</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>19041</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>19041</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOGEN INC.</inf:issuerName><inf:cusip>09062X103</inf:cusip><inf:isin>US09062X1037</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Lloyd Minor</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>19041</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>19041</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOGEN INC.</inf:issuerName><inf:cusip>09062X103</inf:cusip><inf:isin>US09062X1037</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Menelas Pangalos</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>19041</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>19041</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOGEN INC.</inf:issuerName><inf:cusip>09062X103</inf:cusip><inf:isin>US09062X1037</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Monish Patolawala</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>19041</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>19041</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOGEN INC.</inf:issuerName><inf:cusip>09062X103</inf:cusip><inf:isin>US09062X1037</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. Rowinsky</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>19041</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>19041</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOGEN INC.</inf:issuerName><inf:cusip>09062X103</inf:cusip><inf:isin>US09062X1037</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. Sherwin</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>19041</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>19041</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOGEN INC.</inf:issuerName><inf:cusip>09062X103</inf:cusip><inf:isin>US09062X1037</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. Viehbacher</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>19041</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>19041</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOGEN INC.</inf:issuerName><inf:cusip>09062X103</inf:cusip><inf:isin>US09062X1037</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>19041</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>19041</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOGEN INC.</inf:issuerName><inf:cusip>09062X103</inf:cusip><inf:isin>US09062X1037</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>Say on Pay - To hold an advisory vote on executive compensation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>19041</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>19041</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOHAVEN LTD</inf:issuerName><inf:cusip>G1110E107</inf:cusip><inf:isin>VGG1110E1079</inf:isin><inf:meetingDate>05/05/2025</inf:meetingDate><inf:voteDescription>Election of Director for a term expiring at the 2028 Annual Meeting of shareholders: Vlad Coric, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17625</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>17625</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOHAVEN LTD</inf:issuerName><inf:cusip>G1110E107</inf:cusip><inf:isin>VGG1110E1079</inf:isin><inf:meetingDate>05/05/2025</inf:meetingDate><inf:voteDescription>Election of Director for a term expiring at the 2028 Annual Meeting of shareholders: Kishan Mehta</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17625</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>17625</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOHAVEN LTD</inf:issuerName><inf:cusip>G1110E107</inf:cusip><inf:isin>VGG1110E1079</inf:isin><inf:meetingDate>05/05/2025</inf:meetingDate><inf:voteDescription>Ratification of appointment of Ernst &amp; Young LLP as independent auditors for fiscal year 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17625</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>17625</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOHAVEN LTD</inf:issuerName><inf:cusip>G1110E107</inf:cusip><inf:isin>VGG1110E1079</inf:isin><inf:meetingDate>05/05/2025</inf:meetingDate><inf:voteDescription>A non-binding advisory vote on the compensation of the Company's named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17625</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>17625</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOMARIN PHARMACEUTICAL INC.</inf:issuerName><inf:cusip>09061G101</inf:cusip><inf:isin>US09061G1013</inf:isin><inf:meetingDate>05/20/2025</inf:meetingDate><inf:voteDescription>Election of Director: Elizabeth M. Anderson</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21076</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21076</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOMARIN PHARMACEUTICAL INC.</inf:issuerName><inf:cusip>09061G101</inf:cusip><inf:isin>US09061G1013</inf:isin><inf:meetingDate>05/20/2025</inf:meetingDate><inf:voteDescription>Election of Director: Barbara W. Bodem</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21076</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21076</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOMARIN PHARMACEUTICAL INC.</inf:issuerName><inf:cusip>09061G101</inf:cusip><inf:isin>US09061G1013</inf:isin><inf:meetingDate>05/20/2025</inf:meetingDate><inf:voteDescription>Election of Director: Athena Countouriotis</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21076</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21076</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOMARIN PHARMACEUTICAL INC.</inf:issuerName><inf:cusip>09061G101</inf:cusip><inf:isin>US09061G1013</inf:isin><inf:meetingDate>05/20/2025</inf:meetingDate><inf:voteDescription>Election of Director: Willard Dere</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21076</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21076</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOMARIN PHARMACEUTICAL INC.</inf:issuerName><inf:cusip>09061G101</inf:cusip><inf:isin>US09061G1013</inf:isin><inf:meetingDate>05/20/2025</inf:meetingDate><inf:voteDescription>Election of Director: Mark J. Enyedy</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21076</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21076</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOMARIN PHARMACEUTICAL INC.</inf:issuerName><inf:cusip>09061G101</inf:cusip><inf:isin>US09061G1013</inf:isin><inf:meetingDate>05/20/2025</inf:meetingDate><inf:voteDescription>Election of Director: Alexander Hardy</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21076</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21076</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOMARIN PHARMACEUTICAL INC.</inf:issuerName><inf:cusip>09061G101</inf:cusip><inf:isin>US09061G1013</inf:isin><inf:meetingDate>05/20/2025</inf:meetingDate><inf:voteDescription>Election of Director: Maykin Ho</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21076</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21076</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOMARIN PHARMACEUTICAL INC.</inf:issuerName><inf:cusip>09061G101</inf:cusip><inf:isin>US09061G1013</inf:isin><inf:meetingDate>05/20/2025</inf:meetingDate><inf:voteDescription>Election of Director: Robert J. Hombach</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21076</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21076</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOMARIN PHARMACEUTICAL INC.</inf:issuerName><inf:cusip>09061G101</inf:cusip><inf:isin>US09061G1013</inf:isin><inf:meetingDate>05/20/2025</inf:meetingDate><inf:voteDescription>Election of Director: Richard A. Meier</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21076</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21076</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOMARIN PHARMACEUTICAL INC.</inf:issuerName><inf:cusip>09061G101</inf:cusip><inf:isin>US09061G1013</inf:isin><inf:meetingDate>05/20/2025</inf:meetingDate><inf:voteDescription>Election of Director: Timothy P. Walbert</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21076</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21076</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOMARIN PHARMACEUTICAL INC.</inf:issuerName><inf:cusip>09061G101</inf:cusip><inf:isin>US09061G1013</inf:isin><inf:meetingDate>05/20/2025</inf:meetingDate><inf:voteDescription>To ratify the selection of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21076</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21076</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOMARIN PHARMACEUTICAL INC.</inf:issuerName><inf:cusip>09061G101</inf:cusip><inf:isin>US09061G1013</inf:isin><inf:meetingDate>05/20/2025</inf:meetingDate><inf:voteDescription>To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21076</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21076</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIOMARIN PHARMACEUTICAL INC.</inf:issuerName><inf:cusip>09061G101</inf:cusip><inf:isin>US09061G1013</inf:isin><inf:meetingDate>05/20/2025</inf:meetingDate><inf:voteDescription>To approve an amendment to the Company's 2017 Equity Incentive Plan, as amended.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21076</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21076</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIONTECH SE</inf:issuerName><inf:cusip>09075V102</inf:cusip><inf:isin>US09075V1026</inf:isin><inf:meetingDate>05/16/2025</inf:meetingDate><inf:voteDescription>Resolution on the appropriation of the balance sheet profit for the 2024 financial year</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>7725</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>7725</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIONTECH SE</inf:issuerName><inf:cusip>09075V102</inf:cusip><inf:isin>US09075V1026</inf:isin><inf:meetingDate>05/16/2025</inf:meetingDate><inf:voteDescription>Resolution on the approval of the actions of the Management Board</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>7725</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>7725</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIONTECH SE</inf:issuerName><inf:cusip>09075V102</inf:cusip><inf:isin>US09075V1026</inf:isin><inf:meetingDate>05/16/2025</inf:meetingDate><inf:voteDescription>Resolution on the approval of the actions of the Supervisory Board</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>7725</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>7725</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIONTECH SE</inf:issuerName><inf:cusip>09075V102</inf:cusip><inf:isin>US09075V1026</inf:isin><inf:meetingDate>05/16/2025</inf:meetingDate><inf:voteDescription>Resolution on the appointment of the auditor and the group auditor for the 2025 financial year as well as the auditor for any audit or review of interim financial information; election of the auditor of the sustainability reporting for the 2025 financial year - Resolution on the appointment of the auditor and the group auditor for the 2025 financial year as well as the auditor for any audit or review of interim financial information</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>7725</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>7725</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIONTECH SE</inf:issuerName><inf:cusip>09075V102</inf:cusip><inf:isin>US09075V1026</inf:isin><inf:meetingDate>05/16/2025</inf:meetingDate><inf:voteDescription>Resolution on the appointment of the auditor and the group auditor for the 2025 financial year as well as the auditor for any audit or review of interim financial information; election of the auditor of the sustainability reporting for the 2025 financial year - election of the auditor of the sustainability reporting for the 2025 financial year</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>7725</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>7725</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIONTECH SE</inf:issuerName><inf:cusip>09075V102</inf:cusip><inf:isin>US09075V1026</inf:isin><inf:meetingDate>05/16/2025</inf:meetingDate><inf:voteDescription>Resolution on the approval of the Compensation Report</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>7725</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>7725</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BIONTECH SE</inf:issuerName><inf:cusip>09075V102</inf:cusip><inf:isin>US09075V1026</inf:isin><inf:meetingDate>05/16/2025</inf:meetingDate><inf:voteDescription>Resolution on the cancellation of the existing Authorized Capital 2021 and the creation of a new Authorized Capital 2025 with the possibility of excluding subscription rights and corresponding amendment to the Articles of Association</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>7725</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>7725</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BLUEPRINT MEDICINES CORPORATION</inf:issuerName><inf:cusip>09627Y109</inf:cusip><inf:isin>US09627Y1091</inf:isin><inf:meetingDate>06/18/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Jeffrey Albers</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>15552</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>15552</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BLUEPRINT MEDICINES CORPORATION</inf:issuerName><inf:cusip>09627Y109</inf:cusip><inf:isin>US09627Y1091</inf:isin><inf:meetingDate>06/18/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Mark Goldberg, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>15552</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>15552</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BLUEPRINT MEDICINES CORPORATION</inf:issuerName><inf:cusip>09627Y109</inf:cusip><inf:isin>US09627Y1091</inf:isin><inf:meetingDate>06/18/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: John Tsai, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>15552</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>15552</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BLUEPRINT MEDICINES CORPORATION</inf:issuerName><inf:cusip>09627Y109</inf:cusip><inf:isin>US09627Y1091</inf:isin><inf:meetingDate>06/18/2025</inf:meetingDate><inf:voteDescription>Approval of a non-binding advisory vote on the compensation paid to our named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>15552</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>15552</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BLUEPRINT MEDICINES CORPORATION</inf:issuerName><inf:cusip>09627Y109</inf:cusip><inf:isin>US09627Y1091</inf:isin><inf:meetingDate>06/18/2025</inf:meetingDate><inf:voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>15552</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>15552</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BOSTON SCIENTIFIC CORPORATION</inf:issuerName><inf:cusip>101137107</inf:cusip><inf:isin>US1011371077</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Yoshiaki Fujimori</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>369994</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>369994</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BOSTON SCIENTIFIC CORPORATION</inf:issuerName><inf:cusip>101137107</inf:cusip><inf:isin>US1011371077</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: David C. Habiger</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>369994</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>369994</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BOSTON SCIENTIFIC CORPORATION</inf:issuerName><inf:cusip>101137107</inf:cusip><inf:isin>US1011371077</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Edward J. Ludwig</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>369994</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>369994</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BOSTON SCIENTIFIC CORPORATION</inf:issuerName><inf:cusip>101137107</inf:cusip><inf:isin>US1011371077</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Michael F. Mahoney</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>369994</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>369994</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BOSTON SCIENTIFIC CORPORATION</inf:issuerName><inf:cusip>101137107</inf:cusip><inf:isin>US1011371077</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Jessica L. Mega</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>369994</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>369994</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BOSTON SCIENTIFIC CORPORATION</inf:issuerName><inf:cusip>101137107</inf:cusip><inf:isin>US1011371077</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Susan E. Morano</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>369994</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>369994</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BOSTON SCIENTIFIC CORPORATION</inf:issuerName><inf:cusip>101137107</inf:cusip><inf:isin>US1011371077</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Cheryl Pegus</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>369994</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>369994</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BOSTON SCIENTIFIC CORPORATION</inf:issuerName><inf:cusip>101137107</inf:cusip><inf:isin>US1011371077</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: John E. Sununu</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>369994</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>369994</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BOSTON SCIENTIFIC CORPORATION</inf:issuerName><inf:cusip>101137107</inf:cusip><inf:isin>US1011371077</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: David S. Wichmann</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>369994</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>369994</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BOSTON SCIENTIFIC CORPORATION</inf:issuerName><inf:cusip>101137107</inf:cusip><inf:isin>US1011371077</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Ellen M. Zane</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>369994</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>369994</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BOSTON SCIENTIFIC CORPORATION</inf:issuerName><inf:cusip>101137107</inf:cusip><inf:isin>US1011371077</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>To approve, on a non-binding, advisory basis, the compensation of our named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>369994</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>369994</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BOSTON SCIENTIFIC CORPORATION</inf:issuerName><inf:cusip>101137107</inf:cusip><inf:isin>US1011371077</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>To ratify the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the 2025 fiscal year.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>369994</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>369994</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BOSTON SCIENTIFIC CORPORATION</inf:issuerName><inf:cusip>101137107</inf:cusip><inf:isin>US1011371077</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Stockholder proposal titled "Support Simple Majority Vote."</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>369994</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>369994</inf:sharesVoted><inf:managementRecommendation>NONE</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRIDGEBIO PHARMA, INC.</inf:issuerName><inf:cusip>10806X102</inf:cusip><inf:isin>US10806X1028</inf:isin><inf:meetingDate>06/20/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Neil Kumar, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16735</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16735</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRIDGEBIO PHARMA, INC.</inf:issuerName><inf:cusip>10806X102</inf:cusip><inf:isin>US10806X1028</inf:isin><inf:meetingDate>06/20/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Charles Homcy, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16735</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16735</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRIDGEBIO PHARMA, INC.</inf:issuerName><inf:cusip>10806X102</inf:cusip><inf:isin>US10806X1028</inf:isin><inf:meetingDate>06/20/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Douglas A. Dachille</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16735</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16735</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRIDGEBIO PHARMA, INC.</inf:issuerName><inf:cusip>10806X102</inf:cusip><inf:isin>US10806X1028</inf:isin><inf:meetingDate>06/20/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Ronald J. Daniels</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16735</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16735</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRIDGEBIO PHARMA, INC.</inf:issuerName><inf:cusip>10806X102</inf:cusip><inf:isin>US10806X1028</inf:isin><inf:meetingDate>06/20/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Andrew W. Lo, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16735</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16735</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRIDGEBIO PHARMA, INC.</inf:issuerName><inf:cusip>10806X102</inf:cusip><inf:isin>US10806X1028</inf:isin><inf:meetingDate>06/20/2025</inf:meetingDate><inf:voteDescription>To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16735</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16735</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRIDGEBIO PHARMA, INC.</inf:issuerName><inf:cusip>10806X102</inf:cusip><inf:isin>US10806X1028</inf:isin><inf:meetingDate>06/20/2025</inf:meetingDate><inf:voteDescription>To ratify the selection of Deloitte &amp; Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16735</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16735</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRIDGEBIO PHARMA, INC.</inf:issuerName><inf:cusip>10806X102</inf:cusip><inf:isin>US10806X1028</inf:isin><inf:meetingDate>06/20/2025</inf:meetingDate><inf:voteDescription>To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 5,000,000 shares.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16735</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16735</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRIDGEBIO PHARMA, INC.</inf:issuerName><inf:cusip>10806X102</inf:cusip><inf:isin>US10806X1028</inf:isin><inf:meetingDate>06/20/2025</inf:meetingDate><inf:voteDescription>To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to include an officer exculpation provision that limits the liability of certain of our officers as permitted under current Delaware law.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16735</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16735</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRIDGEBIO PHARMA, INC.</inf:issuerName><inf:cusip>10806X102</inf:cusip><inf:isin>US10806X1028</inf:isin><inf:meetingDate>06/20/2025</inf:meetingDate><inf:voteDescription>To approve the adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve any of the above proposals.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16735</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16735</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRISTOL-MYERS SQUIBB COMPANY</inf:issuerName><inf:cusip>110122108</inf:cusip><inf:isin>US1101221083</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Peter J. Arduini</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>172080</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>172080</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRISTOL-MYERS SQUIBB COMPANY</inf:issuerName><inf:cusip>110122108</inf:cusip><inf:isin>US1101221083</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Deepak L. Bhatt, M.D., M.P.H., M.B.A.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>172080</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>172080</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRISTOL-MYERS SQUIBB COMPANY</inf:issuerName><inf:cusip>110122108</inf:cusip><inf:isin>US1101221083</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Christopher S. Boerner, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>172080</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>172080</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRISTOL-MYERS SQUIBB COMPANY</inf:issuerName><inf:cusip>110122108</inf:cusip><inf:isin>US1101221083</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Julia A. Haller, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>172080</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>172080</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRISTOL-MYERS SQUIBB COMPANY</inf:issuerName><inf:cusip>110122108</inf:cusip><inf:isin>US1101221083</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Manuel Hidalgo Medina, M.D., Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>172080</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>172080</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRISTOL-MYERS SQUIBB COMPANY</inf:issuerName><inf:cusip>110122108</inf:cusip><inf:isin>US1101221083</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Michael R. McMullen</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>172080</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>172080</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRISTOL-MYERS SQUIBB COMPANY</inf:issuerName><inf:cusip>110122108</inf:cusip><inf:isin>US1101221083</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Paula A. Price</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>172080</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>172080</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRISTOL-MYERS SQUIBB COMPANY</inf:issuerName><inf:cusip>110122108</inf:cusip><inf:isin>US1101221083</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Derica W. Rice</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>172080</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>172080</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRISTOL-MYERS SQUIBB COMPANY</inf:issuerName><inf:cusip>110122108</inf:cusip><inf:isin>US1101221083</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Theodore R. Samuels</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>172080</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>172080</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRISTOL-MYERS SQUIBB COMPANY</inf:issuerName><inf:cusip>110122108</inf:cusip><inf:isin>US1101221083</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Karen H. Vousden, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>172080</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>172080</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRISTOL-MYERS SQUIBB COMPANY</inf:issuerName><inf:cusip>110122108</inf:cusip><inf:isin>US1101221083</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Phyllis R. Yale</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>172080</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>172080</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRISTOL-MYERS SQUIBB COMPANY</inf:issuerName><inf:cusip>110122108</inf:cusip><inf:isin>US1101221083</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Advisory Vote to Approve the Compensation of our Named Executive Officers</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>172080</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>172080</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRISTOL-MYERS SQUIBB COMPANY</inf:issuerName><inf:cusip>110122108</inf:cusip><inf:isin>US1101221083</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Ratification of the Appointment of an Independent Registered Public Accounting Firm</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>172080</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>172080</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRISTOL-MYERS SQUIBB COMPANY</inf:issuerName><inf:cusip>110122108</inf:cusip><inf:isin>US1101221083</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Shareholder Proposal on Corporate Financial Sustainability</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>172080</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>172080</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>BRISTOL-MYERS SQUIBB COMPANY</inf:issuerName><inf:cusip>110122108</inf:cusip><inf:isin>US1101221083</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Shareholder Proposal on a Request to Cease DEI Efforts</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIVERSITY, EQUITY, AND INCLUSION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>172080</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>172080</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>CENCORA, INC.</inf:issuerName><inf:cusip>03073E105</inf:cusip><inf:isin>US03073E1055</inf:isin><inf:meetingDate>03/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Ornella Barra</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24158</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24158</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>CENCORA, INC.</inf:issuerName><inf:cusip>03073E105</inf:cusip><inf:isin>US03073E1055</inf:isin><inf:meetingDate>03/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Werner Baumann</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24158</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24158</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>CENCORA, INC.</inf:issuerName><inf:cusip>03073E105</inf:cusip><inf:isin>US03073E1055</inf:isin><inf:meetingDate>03/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Frank K. Clyburn</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24158</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24158</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>CENCORA, INC.</inf:issuerName><inf:cusip>03073E105</inf:cusip><inf:isin>US03073E1055</inf:isin><inf:meetingDate>03/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Steven H. Collis</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24158</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24158</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>CENCORA, INC.</inf:issuerName><inf:cusip>03073E105</inf:cusip><inf:isin>US03073E1055</inf:isin><inf:meetingDate>03/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: D. Mark Durcan</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24158</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24158</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>CENCORA, INC.</inf:issuerName><inf:cusip>03073E105</inf:cusip><inf:isin>US03073E1055</inf:isin><inf:meetingDate>03/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Lon R. Greenberg</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24158</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24158</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>CENCORA, INC.</inf:issuerName><inf:cusip>03073E105</inf:cusip><inf:isin>US03073E1055</inf:isin><inf:meetingDate>03/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Lorence H. Kim, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24158</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24158</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>CENCORA, INC.</inf:issuerName><inf:cusip>03073E105</inf:cusip><inf:isin>US03073E1055</inf:isin><inf:meetingDate>03/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Robert P. Mauch</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24158</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24158</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>CENCORA, INC.</inf:issuerName><inf:cusip>03073E105</inf:cusip><inf:isin>US03073E1055</inf:isin><inf:meetingDate>03/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Redonda G. Miller, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24158</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24158</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>CENCORA, INC.</inf:issuerName><inf:cusip>03073E105</inf:cusip><inf:isin>US03073E1055</inf:isin><inf:meetingDate>03/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Dennis M. Nally</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24158</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24158</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>CENCORA, INC.</inf:issuerName><inf:cusip>03073E105</inf:cusip><inf:isin>US03073E1055</inf:isin><inf:meetingDate>03/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Lauren M. Tyler</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24158</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24158</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>CENCORA, INC.</inf:issuerName><inf:cusip>03073E105</inf:cusip><inf:isin>US03073E1055</inf:isin><inf:meetingDate>03/06/2025</inf:meetingDate><inf:voteDescription>Advisory vote to approve the fiscal 2024 compensation of Cencora, Inc.'s named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24158</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24158</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>CENCORA, INC.</inf:issuerName><inf:cusip>03073E105</inf:cusip><inf:isin>US03073E1055</inf:isin><inf:meetingDate>03/06/2025</inf:meetingDate><inf:voteDescription>Ratify the appointment of Ernst &amp; Young LLP as Cencora, Inc.'s independent registered public accounting firm for fiscal 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24158</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24158</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>CG ONCOLOGY, INC.</inf:issuerName><inf:cusip>156944100</inf:cusip><inf:isin>US1569441009</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>Election of Class I Director to hold office until the 2028 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Arthur Kuan</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>5223</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>5223</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>CG ONCOLOGY, INC.</inf:issuerName><inf:cusip>156944100</inf:cusip><inf:isin>US1569441009</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>Election of Class I Director to hold office until the 2028 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: James J. Mul&#xE9;</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>5223</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>WITHHOLD</inf:howVoted><inf:sharesVoted>5223</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>CG ONCOLOGY, INC.</inf:issuerName><inf:cusip>156944100</inf:cusip><inf:isin>US1569441009</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>Election of Class I Director to hold office until the 2028 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Leonard Post</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>5223</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>5223</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>CG ONCOLOGY, INC.</inf:issuerName><inf:cusip>156944100</inf:cusip><inf:isin>US1569441009</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>To ratify the appointment by the Audit Committee of the Board of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>5223</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>5223</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DAIICHI SANKYO COMPANY,LIMITED</inf:issuerName><inf:cusip>J11257102</inf:cusip><inf:isin>JP3475350009</inf:isin><inf:meetingDate>06/23/2025</inf:meetingDate><inf:voteDescription>Please reference meeting materials.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>57800</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DAIICHI SANKYO COMPANY,LIMITED</inf:issuerName><inf:cusip>J11257102</inf:cusip><inf:isin>JP3475350009</inf:isin><inf:meetingDate>06/23/2025</inf:meetingDate><inf:voteDescription>Approve Appropriation of Surplus</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>57800</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>57800</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DAIICHI SANKYO COMPANY,LIMITED</inf:issuerName><inf:cusip>J11257102</inf:cusip><inf:isin>JP3475350009</inf:isin><inf:meetingDate>06/23/2025</inf:meetingDate><inf:voteDescription>Appoint a Director Manabe, Sunao</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>57800</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>57800</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DAIICHI SANKYO COMPANY,LIMITED</inf:issuerName><inf:cusip>J11257102</inf:cusip><inf:isin>JP3475350009</inf:isin><inf:meetingDate>06/23/2025</inf:meetingDate><inf:voteDescription>Appoint a Director Okuzawa, Hiroyuki</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>57800</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>57800</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DAIICHI SANKYO COMPANY,LIMITED</inf:issuerName><inf:cusip>J11257102</inf:cusip><inf:isin>JP3475350009</inf:isin><inf:meetingDate>06/23/2025</inf:meetingDate><inf:voteDescription>Appoint a Director Matsumoto, Takashi</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>57800</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>57800</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DAIICHI SANKYO COMPANY,LIMITED</inf:issuerName><inf:cusip>J11257102</inf:cusip><inf:isin>JP3475350009</inf:isin><inf:meetingDate>06/23/2025</inf:meetingDate><inf:voteDescription>Appoint a Director Komatsu, Yasuhiro</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>57800</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>57800</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DAIICHI SANKYO COMPANY,LIMITED</inf:issuerName><inf:cusip>J11257102</inf:cusip><inf:isin>JP3475350009</inf:isin><inf:meetingDate>06/23/2025</inf:meetingDate><inf:voteDescription>Appoint a Director Nishii, Takaaki</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>57800</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>57800</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DAIICHI SANKYO COMPANY,LIMITED</inf:issuerName><inf:cusip>J11257102</inf:cusip><inf:isin>JP3475350009</inf:isin><inf:meetingDate>06/23/2025</inf:meetingDate><inf:voteDescription>Appoint a Director Homma, Yo</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>57800</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>57800</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DAIICHI SANKYO COMPANY,LIMITED</inf:issuerName><inf:cusip>J11257102</inf:cusip><inf:isin>JP3475350009</inf:isin><inf:meetingDate>06/23/2025</inf:meetingDate><inf:voteDescription>Appoint a Director Joseph Kenneth Keller</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>57800</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>57800</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DAIICHI SANKYO COMPANY,LIMITED</inf:issuerName><inf:cusip>J11257102</inf:cusip><inf:isin>JP3475350009</inf:isin><inf:meetingDate>06/23/2025</inf:meetingDate><inf:voteDescription>Appoint a Director Ueno, Shizuko</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>57800</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>57800</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DAIICHI SANKYO COMPANY,LIMITED</inf:issuerName><inf:cusip>J11257102</inf:cusip><inf:isin>JP3475350009</inf:isin><inf:meetingDate>06/23/2025</inf:meetingDate><inf:voteDescription>Appoint a Director Watanabe, Akihiro</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>57800</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>57800</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DAIICHI SANKYO COMPANY,LIMITED</inf:issuerName><inf:cusip>J11257102</inf:cusip><inf:isin>JP3475350009</inf:isin><inf:meetingDate>06/23/2025</inf:meetingDate><inf:voteDescription>Appoint a Director Kinoshita, Reiko</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>57800</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>57800</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DAIICHI SANKYO COMPANY,LIMITED</inf:issuerName><inf:cusip>J11257102</inf:cusip><inf:isin>JP3475350009</inf:isin><inf:meetingDate>06/23/2025</inf:meetingDate><inf:voteDescription>Appoint a Corporate Auditor Yokoyama, Terumichi</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>57800</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>57800</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DAIICHI SANKYO COMPANY,LIMITED</inf:issuerName><inf:cusip>J11257102</inf:cusip><inf:isin>JP3475350009</inf:isin><inf:meetingDate>06/23/2025</inf:meetingDate><inf:voteDescription>Appoint a Corporate Auditor Watanabe, Masako</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>57800</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>57800</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DANAHER CORPORATION</inf:issuerName><inf:cusip>235851102</inf:cusip><inf:isin>US2358511028</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Rainer M. Blair</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>64241</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>64241</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DANAHER CORPORATION</inf:issuerName><inf:cusip>235851102</inf:cusip><inf:isin>US2358511028</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Feroz Dewan</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>64241</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>64241</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DANAHER CORPORATION</inf:issuerName><inf:cusip>235851102</inf:cusip><inf:isin>US2358511028</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Linda Filler</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>64241</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>64241</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DANAHER CORPORATION</inf:issuerName><inf:cusip>235851102</inf:cusip><inf:isin>US2358511028</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Charles W. Lamanna</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>64241</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>64241</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DANAHER CORPORATION</inf:issuerName><inf:cusip>235851102</inf:cusip><inf:isin>US2358511028</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Teri List</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>64241</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>64241</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DANAHER CORPORATION</inf:issuerName><inf:cusip>235851102</inf:cusip><inf:isin>US2358511028</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Jessica L. Mega, MD, MPH</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>64241</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>64241</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DANAHER CORPORATION</inf:issuerName><inf:cusip>235851102</inf:cusip><inf:isin>US2358511028</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Mitchell P. Rales</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>64241</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>64241</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DANAHER CORPORATION</inf:issuerName><inf:cusip>235851102</inf:cusip><inf:isin>US2358511028</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Steven M. Rales</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>64241</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>64241</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DANAHER CORPORATION</inf:issuerName><inf:cusip>235851102</inf:cusip><inf:isin>US2358511028</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane Sanders</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>64241</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>64241</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DANAHER CORPORATION</inf:issuerName><inf:cusip>235851102</inf:cusip><inf:isin>US2358511028</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: John T. Schwieters</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>64241</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>64241</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DANAHER CORPORATION</inf:issuerName><inf:cusip>235851102</inf:cusip><inf:isin>US2358511028</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Alan G. Spoon</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>64241</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>64241</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DANAHER CORPORATION</inf:issuerName><inf:cusip>235851102</inf:cusip><inf:isin>US2358511028</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Raymond C. Stevens, Ph.D</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>64241</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>64241</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DANAHER CORPORATION</inf:issuerName><inf:cusip>235851102</inf:cusip><inf:isin>US2358511028</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Elias A. Zerhouni, MD</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>64241</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>64241</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DANAHER CORPORATION</inf:issuerName><inf:cusip>235851102</inf:cusip><inf:isin>US2358511028</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>To ratify the selection of Ernst &amp; Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>64241</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>64241</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DANAHER CORPORATION</inf:issuerName><inf:cusip>235851102</inf:cusip><inf:isin>US2358511028</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>To approve on an advisory basis the Company's named executive officer compensation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>64241</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>64241</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DENALI THERAPEUTICS INC.</inf:issuerName><inf:cusip>24823R105</inf:cusip><inf:isin>US24823R1059</inf:isin><inf:meetingDate>06/03/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Julian Baker</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>20283</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>20283</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DENALI THERAPEUTICS INC.</inf:issuerName><inf:cusip>24823R105</inf:cusip><inf:isin>US24823R1059</inf:isin><inf:meetingDate>06/03/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Peter Klein</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>20283</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>20283</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DENALI THERAPEUTICS INC.</inf:issuerName><inf:cusip>24823R105</inf:cusip><inf:isin>US24823R1059</inf:isin><inf:meetingDate>06/03/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Steve Krognes</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>20283</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>ABSTAIN</inf:howVoted><inf:sharesVoted>20283</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DENALI THERAPEUTICS INC.</inf:issuerName><inf:cusip>24823R105</inf:cusip><inf:isin>US24823R1059</inf:isin><inf:meetingDate>06/03/2025</inf:meetingDate><inf:voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>20283</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>20283</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DENALI THERAPEUTICS INC.</inf:issuerName><inf:cusip>24823R105</inf:cusip><inf:isin>US24823R1059</inf:isin><inf:meetingDate>06/03/2025</inf:meetingDate><inf:voteDescription>Advisory vote on executive compensation</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>20283</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>20283</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DEXCOM, INC.</inf:issuerName><inf:cusip>252131107</inf:cusip><inf:isin>US2521311074</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until our 2026 annual meeting of stockholders: Kevin R. Sayer</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>26328</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>26328</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DEXCOM, INC.</inf:issuerName><inf:cusip>252131107</inf:cusip><inf:isin>US2521311074</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until our 2026 annual meeting of stockholders: Steven R. Altman</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>26328</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>26328</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DEXCOM, INC.</inf:issuerName><inf:cusip>252131107</inf:cusip><inf:isin>US2521311074</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until our 2026 annual meeting of stockholders: Nicholas Augustinos</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>26328</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>26328</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DEXCOM, INC.</inf:issuerName><inf:cusip>252131107</inf:cusip><inf:isin>US2521311074</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until our 2026 annual meeting of stockholders: Richard A. Collins</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>26328</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>26328</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DEXCOM, INC.</inf:issuerName><inf:cusip>252131107</inf:cusip><inf:isin>US2521311074</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until our 2026 annual meeting of stockholders: Karen Dahut</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>26328</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>ABSTAIN</inf:howVoted><inf:sharesVoted>26328</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DEXCOM, INC.</inf:issuerName><inf:cusip>252131107</inf:cusip><inf:isin>US2521311074</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until our 2026 annual meeting of stockholders: Rimma Driscoll</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>26328</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>26328</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DEXCOM, INC.</inf:issuerName><inf:cusip>252131107</inf:cusip><inf:isin>US2521311074</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until our 2026 annual meeting of stockholders: Mark G. Foletta</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>26328</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>26328</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DEXCOM, INC.</inf:issuerName><inf:cusip>252131107</inf:cusip><inf:isin>US2521311074</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until our 2026 annual meeting of stockholders: Ren&#xE9;e Gal&#xE1;</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>26328</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>26328</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DEXCOM, INC.</inf:issuerName><inf:cusip>252131107</inf:cusip><inf:isin>US2521311074</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until our 2026 annual meeting of stockholders: Bridgette P. Heller</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>26328</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>26328</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DEXCOM, INC.</inf:issuerName><inf:cusip>252131107</inf:cusip><inf:isin>US2521311074</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until our 2026 annual meeting of stockholders: Kyle Malady</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>26328</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>26328</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DEXCOM, INC.</inf:issuerName><inf:cusip>252131107</inf:cusip><inf:isin>US2521311074</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>To ratify the selection by the Audit Committee of our Board of Directors of Deloitte &amp; Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>26328</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>26328</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DEXCOM, INC.</inf:issuerName><inf:cusip>252131107</inf:cusip><inf:isin>US2521311074</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2024.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>26328</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>26328</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DEXCOM, INC.</inf:issuerName><inf:cusip>252131107</inf:cusip><inf:isin>US2521311074</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>To approve our Amended and Restated 2015 Equity Incentive Plan (as amended and restated) to, among other things, increase the number of shares reserved for issuance thereunder by 3,400,000 shares.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>26328</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>26328</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DEXCOM, INC.</inf:issuerName><inf:cusip>252131107</inf:cusip><inf:isin>US2521311074</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>To approve our Amended and Restated 2015 Employee Stock Purchase Plan to, among other things, increase the number of shares reserved for issuance thereunder by 8,000,000 shares.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>26328</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>26328</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DISC MEDICINE, INC.</inf:issuerName><inf:cusip>254604101</inf:cusip><inf:isin>US2546041011</inf:isin><inf:meetingDate>06/11/2025</inf:meetingDate><inf:voteDescription>Election of Class II Director: Georges Gemayel, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>7440</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>7440</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DISC MEDICINE, INC.</inf:issuerName><inf:cusip>254604101</inf:cusip><inf:isin>US2546041011</inf:isin><inf:meetingDate>06/11/2025</inf:meetingDate><inf:voteDescription>Election of Class II Director: Mark Chin, M.S., M.B.A.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>7440</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>7440</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DISC MEDICINE, INC.</inf:issuerName><inf:cusip>254604101</inf:cusip><inf:isin>US2546041011</inf:isin><inf:meetingDate>06/11/2025</inf:meetingDate><inf:voteDescription>Election of Class II Director: Liam Ratcliffe, M.D., Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>7440</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>WITHHOLD</inf:howVoted><inf:sharesVoted>7440</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DISC MEDICINE, INC.</inf:issuerName><inf:cusip>254604101</inf:cusip><inf:isin>US2546041011</inf:isin><inf:meetingDate>06/11/2025</inf:meetingDate><inf:voteDescription>To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>7440</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>7440</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DISC MEDICINE, INC.</inf:issuerName><inf:cusip>254604101</inf:cusip><inf:isin>US2546041011</inf:isin><inf:meetingDate>06/11/2025</inf:meetingDate><inf:voteDescription>To recommend, by a non-binding advisory vote, the frequency of future advisory votes on the compensation paid to the Company's named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>7440</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>1 YEAR</inf:howVoted><inf:sharesVoted>7440</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DISC MEDICINE, INC.</inf:issuerName><inf:cusip>254604101</inf:cusip><inf:isin>US2546041011</inf:isin><inf:meetingDate>06/11/2025</inf:meetingDate><inf:voteDescription>To ratify the appointment of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>7440</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>7440</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DYNE THERAPEUTICS, INC.</inf:issuerName><inf:cusip>26818M108</inf:cusip><inf:isin>US26818M1080</inf:isin><inf:meetingDate>05/30/2025</inf:meetingDate><inf:voteDescription>Election of Class II Director to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Edward Hurwitz</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24506</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>WITHHOLD</inf:howVoted><inf:sharesVoted>24506</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DYNE THERAPEUTICS, INC.</inf:issuerName><inf:cusip>26818M108</inf:cusip><inf:isin>US26818M1080</inf:isin><inf:meetingDate>05/30/2025</inf:meetingDate><inf:voteDescription>Election of Class II Director to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Dirk Kersten</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24506</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>WITHHOLD</inf:howVoted><inf:sharesVoted>24506</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DYNE THERAPEUTICS, INC.</inf:issuerName><inf:cusip>26818M108</inf:cusip><inf:isin>US26818M1080</inf:isin><inf:meetingDate>05/30/2025</inf:meetingDate><inf:voteDescription>To vote, on an advisory basis, to approve the compensation of our named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24506</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24506</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DYNE THERAPEUTICS, INC.</inf:issuerName><inf:cusip>26818M108</inf:cusip><inf:isin>US26818M1080</inf:isin><inf:meetingDate>05/30/2025</inf:meetingDate><inf:voteDescription>To hold an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24506</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>1 YEAR</inf:howVoted><inf:sharesVoted>24506</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>DYNE THERAPEUTICS, INC.</inf:issuerName><inf:cusip>26818M108</inf:cusip><inf:isin>US26818M1080</inf:isin><inf:meetingDate>05/30/2025</inf:meetingDate><inf:voteDescription>To ratify the appointment of Deloitte &amp; Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24506</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24506</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EDGEWISE THERAPEUTICS INC</inf:issuerName><inf:cusip>28036F105</inf:cusip><inf:isin>US28036F1057</inf:isin><inf:meetingDate>06/13/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Alan Russell, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21650</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21650</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EDGEWISE THERAPEUTICS INC</inf:issuerName><inf:cusip>28036F105</inf:cusip><inf:isin>US28036F1057</inf:isin><inf:meetingDate>06/13/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Arlene Morris</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21650</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>ABSTAIN</inf:howVoted><inf:sharesVoted>21650</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EDGEWISE THERAPEUTICS INC</inf:issuerName><inf:cusip>28036F105</inf:cusip><inf:isin>US28036F1057</inf:isin><inf:meetingDate>06/13/2025</inf:meetingDate><inf:voteDescription>Ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21650</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21650</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EDGEWISE THERAPEUTICS INC</inf:issuerName><inf:cusip>28036F105</inf:cusip><inf:isin>US28036F1057</inf:isin><inf:meetingDate>06/13/2025</inf:meetingDate><inf:voteDescription>Conduct an advisory vote on the compensation of our named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21650</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21650</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EDGEWISE THERAPEUTICS INC</inf:issuerName><inf:cusip>28036F105</inf:cusip><inf:isin>US28036F1057</inf:isin><inf:meetingDate>06/13/2025</inf:meetingDate><inf:voteDescription>Conduct an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21650</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>1 YEAR</inf:howVoted><inf:sharesVoted>21650</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EDWARDS LIFESCIENCES CORPORATION</inf:issuerName><inf:cusip>28176E108</inf:cusip><inf:isin>US28176E1082</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director: Leslie C. Davis</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>130720</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>130720</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EDWARDS LIFESCIENCES CORPORATION</inf:issuerName><inf:cusip>28176E108</inf:cusip><inf:isin>US28176E1082</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director: David T. Feinberg, MD</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>130720</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>130720</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EDWARDS LIFESCIENCES CORPORATION</inf:issuerName><inf:cusip>28176E108</inf:cusip><inf:isin>US28176E1082</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director: Kieran T. Gallahue</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>130720</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>130720</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EDWARDS LIFESCIENCES CORPORATION</inf:issuerName><inf:cusip>28176E108</inf:cusip><inf:isin>US28176E1082</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director: Leslie S. Heisz</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>130720</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>130720</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EDWARDS LIFESCIENCES CORPORATION</inf:issuerName><inf:cusip>28176E108</inf:cusip><inf:isin>US28176E1082</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director: Paul A. LaViolette</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>130720</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>130720</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EDWARDS LIFESCIENCES CORPORATION</inf:issuerName><inf:cusip>28176E108</inf:cusip><inf:isin>US28176E1082</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director: Steven R. Loranger</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>130720</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>130720</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EDWARDS LIFESCIENCES CORPORATION</inf:issuerName><inf:cusip>28176E108</inf:cusip><inf:isin>US28176E1082</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director: Ramona Sequeira</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>130720</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>130720</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EDWARDS LIFESCIENCES CORPORATION</inf:issuerName><inf:cusip>28176E108</inf:cusip><inf:isin>US28176E1082</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director: Nicholas J. Valeriani</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>130720</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>130720</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EDWARDS LIFESCIENCES CORPORATION</inf:issuerName><inf:cusip>28176E108</inf:cusip><inf:isin>US28176E1082</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director: Bernard J. Zovighian</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>130720</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>130720</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EDWARDS LIFESCIENCES CORPORATION</inf:issuerName><inf:cusip>28176E108</inf:cusip><inf:isin>US28176E1082</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Advisory Vote to Approve Named Executive Officer Compensation</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>130720</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>130720</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EDWARDS LIFESCIENCES CORPORATION</inf:issuerName><inf:cusip>28176E108</inf:cusip><inf:isin>US28176E1082</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Ratification of Appointment of Independent Registered Public Accounting Firm</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>130720</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>130720</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EDWARDS LIFESCIENCES CORPORATION</inf:issuerName><inf:cusip>28176E108</inf:cusip><inf:isin>US28176E1082</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Approval of the Amendment and Restatement of the Company's 2001 Employee Stock Purchase Plan for United States Employees (the "U.S. ESPP") to Increase the Total Number of Shares of Common Stock Available for Issuance under the U.S. ESPP by 4,200,000 Shares</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>130720</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>130720</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EDWARDS LIFESCIENCES CORPORATION</inf:issuerName><inf:cusip>28176E108</inf:cusip><inf:isin>US28176E1082</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Approval of the Amendment and Restatement of the Company's 2001 Employee Stock Purchase Plan for International Employees (the"International ESPP") to Increase the Total Number of Shares of Common Stock Available for Issuance under the International ESPP by 1,460,000 Shares</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>130720</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>130720</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ELEVANCE HEALTH, INC.</inf:issuerName><inf:cusip>036752103</inf:cusip><inf:isin>US0367521038</inf:isin><inf:meetingDate>05/14/2025</inf:meetingDate><inf:voteDescription>Election of Director: Susan D. DeVore</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>26558</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>26558</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ELEVANCE HEALTH, INC.</inf:issuerName><inf:cusip>036752103</inf:cusip><inf:isin>US0367521038</inf:isin><inf:meetingDate>05/14/2025</inf:meetingDate><inf:voteDescription>Election of Director: Bahija Jallal</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>26558</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>26558</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ELEVANCE HEALTH, INC.</inf:issuerName><inf:cusip>036752103</inf:cusip><inf:isin>US0367521038</inf:isin><inf:meetingDate>05/14/2025</inf:meetingDate><inf:voteDescription>Election of Director: Ryan M. Schneider</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>26558</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>26558</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ELEVANCE HEALTH, INC.</inf:issuerName><inf:cusip>036752103</inf:cusip><inf:isin>US0367521038</inf:isin><inf:meetingDate>05/14/2025</inf:meetingDate><inf:voteDescription>Advisory vote to approve the compensation of our named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>26558</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>26558</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ELEVANCE HEALTH, INC.</inf:issuerName><inf:cusip>036752103</inf:cusip><inf:isin>US0367521038</inf:isin><inf:meetingDate>05/14/2025</inf:meetingDate><inf:voteDescription>To ratify the appointment of Ernst &amp; Young LLP as the independent registered public accounting firm for 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>26558</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>26558</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ELEVANCE HEALTH, INC.</inf:issuerName><inf:cusip>036752103</inf:cusip><inf:isin>US0367521038</inf:isin><inf:meetingDate>05/14/2025</inf:meetingDate><inf:voteDescription>Shareholder proposal requesting report on the effectiveness of Diversity, Equity and Inclusion efforts.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE</inf:categoryType></inf:voteCategory><inf:voteCategory><inf:categoryType>DIVERSITY, EQUITY, AND INCLUSION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>26558</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>26558</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ELI LILLY AND COMPANY</inf:issuerName><inf:cusip>532457108</inf:cusip><inf:isin>US5324571083</inf:isin><inf:meetingDate>05/05/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve a three-year term: Ralph Alvarez</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>56668</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>56668</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ELI LILLY AND COMPANY</inf:issuerName><inf:cusip>532457108</inf:cusip><inf:isin>US5324571083</inf:isin><inf:meetingDate>05/05/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve a three-year term: Mary Lynne Hedley</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>56668</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>56668</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ELI LILLY AND COMPANY</inf:issuerName><inf:cusip>532457108</inf:cusip><inf:isin>US5324571083</inf:isin><inf:meetingDate>05/05/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve a three-year term: Kimberly Johnson</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>56668</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>56668</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ELI LILLY AND COMPANY</inf:issuerName><inf:cusip>532457108</inf:cusip><inf:isin>US5324571083</inf:isin><inf:meetingDate>05/05/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve a three-year term: Juan Luciano</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>56668</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>56668</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ELI LILLY AND COMPANY</inf:issuerName><inf:cusip>532457108</inf:cusip><inf:isin>US5324571083</inf:isin><inf:meetingDate>05/05/2025</inf:meetingDate><inf:voteDescription>Approval, on an advisory basis, of the compensation paid to the company's named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>56668</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>56668</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ELI LILLY AND COMPANY</inf:issuerName><inf:cusip>532457108</inf:cusip><inf:isin>US5324571083</inf:isin><inf:meetingDate>05/05/2025</inf:meetingDate><inf:voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as the independent auditor for 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>56668</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>56668</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ELI LILLY AND COMPANY</inf:issuerName><inf:cusip>532457108</inf:cusip><inf:isin>US5324571083</inf:isin><inf:meetingDate>05/05/2025</inf:meetingDate><inf:voteDescription>Approval of amendments to the company's Articles of Incorporation to eliminate the classified board structure.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>56668</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>56668</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ELI LILLY AND COMPANY</inf:issuerName><inf:cusip>532457108</inf:cusip><inf:isin>US5324571083</inf:isin><inf:meetingDate>05/05/2025</inf:meetingDate><inf:voteDescription>Approval of amendments to the company's Articles of Incorporation to eliminate supermajority voting provisions.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>56668</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>56668</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EXACT SCIENCES CORPORATION</inf:issuerName><inf:cusip>30063P105</inf:cusip><inf:isin>US30063P1057</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for one-year term (to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Michael Barber</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31331</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31331</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EXACT SCIENCES CORPORATION</inf:issuerName><inf:cusip>30063P105</inf:cusip><inf:isin>US30063P1057</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for one-year term (to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Paul Clancy</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31331</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31331</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EXACT SCIENCES CORPORATION</inf:issuerName><inf:cusip>30063P105</inf:cusip><inf:isin>US30063P1057</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for one-year term (to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Daniel Levangie</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31331</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31331</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EXACT SCIENCES CORPORATION</inf:issuerName><inf:cusip>30063P105</inf:cusip><inf:isin>US30063P1057</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for one-year term (to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Kevin Conroy</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31331</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31331</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EXACT SCIENCES CORPORATION</inf:issuerName><inf:cusip>30063P105</inf:cusip><inf:isin>US30063P1057</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for one-year term (to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Shacey Petrovic</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31331</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31331</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EXACT SCIENCES CORPORATION</inf:issuerName><inf:cusip>30063P105</inf:cusip><inf:isin>US30063P1057</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for one-year term (to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Kimberly Popovits</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31331</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31331</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EXACT SCIENCES CORPORATION</inf:issuerName><inf:cusip>30063P105</inf:cusip><inf:isin>US30063P1057</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for one-year term (to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Katherine Zanotti</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31331</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31331</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EXACT SCIENCES CORPORATION</inf:issuerName><inf:cusip>30063P105</inf:cusip><inf:isin>US30063P1057</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31331</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31331</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EXACT SCIENCES CORPORATION</inf:issuerName><inf:cusip>30063P105</inf:cusip><inf:isin>US30063P1057</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>To approve, on an advisory basis, the compensation of our named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31331</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31331</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EXACT SCIENCES CORPORATION</inf:issuerName><inf:cusip>30063P105</inf:cusip><inf:isin>US30063P1057</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>To approve the 2025 Omnibus Long-Term Incentive Plan.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31331</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31331</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EXACT SCIENCES CORPORATION</inf:issuerName><inf:cusip>30063P105</inf:cusip><inf:isin>US30063P1057</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>To approve an Amendment to the 2010 Employee Stock Purchase Plan to add 4,000,000 shares of stock to the pool of shares available for purchase by employees.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31331</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31331</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>EXACT SCIENCES CORPORATION</inf:issuerName><inf:cusip>30063P105</inf:cusip><inf:isin>US30063P1057</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>To vote on a shareholder proposal concerning the adoption of a director election resignation governance policy, if properly presented.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>31331</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>31331</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GE HEALTHCARE TECHNOLOGIES INC.</inf:issuerName><inf:cusip>36266G107</inf:cusip><inf:isin>US36266G1076</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>Election of Director: Peter J. Arduini</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66438</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66438</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GE HEALTHCARE TECHNOLOGIES INC.</inf:issuerName><inf:cusip>36266G107</inf:cusip><inf:isin>US36266G1076</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>Election of Director: H. Lawrence Culp, Jr.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66438</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66438</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GE HEALTHCARE TECHNOLOGIES INC.</inf:issuerName><inf:cusip>36266G107</inf:cusip><inf:isin>US36266G1076</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>Election of Director: Rodney F. Hochman</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66438</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66438</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GE HEALTHCARE TECHNOLOGIES INC.</inf:issuerName><inf:cusip>36266G107</inf:cusip><inf:isin>US36266G1076</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>Election of Director: Lloyd W. Howell, Jr.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66438</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66438</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GE HEALTHCARE TECHNOLOGIES INC.</inf:issuerName><inf:cusip>36266G107</inf:cusip><inf:isin>US36266G1076</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>Election of Director: Risa Lavizzo-Mourey</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66438</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66438</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GE HEALTHCARE TECHNOLOGIES INC.</inf:issuerName><inf:cusip>36266G107</inf:cusip><inf:isin>US36266G1076</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>Election of Director: Catherine Lesjak</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66438</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66438</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GE HEALTHCARE TECHNOLOGIES INC.</inf:issuerName><inf:cusip>36266G107</inf:cusip><inf:isin>US36266G1076</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>Election of Director: Anne T. Madden</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66438</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66438</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GE HEALTHCARE TECHNOLOGIES INC.</inf:issuerName><inf:cusip>36266G107</inf:cusip><inf:isin>US36266G1076</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>Election of Director: Tomislav Mihaljevic</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66438</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66438</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GE HEALTHCARE TECHNOLOGIES INC.</inf:issuerName><inf:cusip>36266G107</inf:cusip><inf:isin>US36266G1076</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>Election of Director: William J. Stromberg</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66438</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66438</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GE HEALTHCARE TECHNOLOGIES INC.</inf:issuerName><inf:cusip>36266G107</inf:cusip><inf:isin>US36266G1076</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>Election of Director: Phoebe L. Yang</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66438</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66438</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GE HEALTHCARE TECHNOLOGIES INC.</inf:issuerName><inf:cusip>36266G107</inf:cusip><inf:isin>US36266G1076</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>Approval of our named executive officers' compensation in an advisory vote.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66438</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66438</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GE HEALTHCARE TECHNOLOGIES INC.</inf:issuerName><inf:cusip>36266G107</inf:cusip><inf:isin>US36266G1076</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>Ratification of the appointment of Deloitte &amp; Touche LLP as our independent auditor for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>66438</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>66438</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GE HEALTHCARE TECHNOLOGIES INC.</inf:issuerName><inf:cusip>36266G107</inf:cusip><inf:isin>US36266G1076</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>Stockholder proposal regarding stockholder ratification of certain termination pay arrangements, if properly presented.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>66438</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>66438</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GILEAD SCIENCES, INC.</inf:issuerName><inf:cusip>375558103</inf:cusip><inf:isin>US3755581036</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for the next year and until their successors are elected and qualified: Jacqueline K. Barton, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>145990</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>145990</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GILEAD SCIENCES, INC.</inf:issuerName><inf:cusip>375558103</inf:cusip><inf:isin>US3755581036</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for the next year and until their successors are elected and qualified: Jeffrey A. Bluestone, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>145990</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>145990</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GILEAD SCIENCES, INC.</inf:issuerName><inf:cusip>375558103</inf:cusip><inf:isin>US3755581036</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for the next year and until their successors are elected and qualified: Sandra J. Horning, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>145990</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>145990</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GILEAD SCIENCES, INC.</inf:issuerName><inf:cusip>375558103</inf:cusip><inf:isin>US3755581036</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for the next year and until their successors are elected and qualified: Kelly A. Kramer</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>145990</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>145990</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GILEAD SCIENCES, INC.</inf:issuerName><inf:cusip>375558103</inf:cusip><inf:isin>US3755581036</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for the next year and until their successors are elected and qualified: Ted W. Love, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>145990</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>145990</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GILEAD SCIENCES, INC.</inf:issuerName><inf:cusip>375558103</inf:cusip><inf:isin>US3755581036</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for the next year and until their successors are elected and qualified: Harish Manwani</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>145990</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>145990</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GILEAD SCIENCES, INC.</inf:issuerName><inf:cusip>375558103</inf:cusip><inf:isin>US3755581036</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for the next year and until their successors are elected and qualified: Daniel P. O'Day</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>145990</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>145990</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GILEAD SCIENCES, INC.</inf:issuerName><inf:cusip>375558103</inf:cusip><inf:isin>US3755581036</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for the next year and until their successors are elected and qualified: Javier J. Rodriguez</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>145990</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>145990</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GILEAD SCIENCES, INC.</inf:issuerName><inf:cusip>375558103</inf:cusip><inf:isin>US3755581036</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve for the next year and until their successors are elected and qualified: Anthony Welters</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>145990</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>145990</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GILEAD SCIENCES, INC.</inf:issuerName><inf:cusip>375558103</inf:cusip><inf:isin>US3755581036</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>To ratify the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>145990</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>145990</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GILEAD SCIENCES, INC.</inf:issuerName><inf:cusip>375558103</inf:cusip><inf:isin>US3755581036</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>145990</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>145990</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GILEAD SCIENCES, INC.</inf:issuerName><inf:cusip>375558103</inf:cusip><inf:isin>US3755581036</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>To vote on a stockholder proposal requesting the CEO pay ratio factor be included in the Company's executive compensation programs, if properly presented at the Annual Meeting.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIVERSITY, EQUITY, AND INCLUSION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>145990</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>145990</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GILEAD SCIENCES, INC.</inf:issuerName><inf:cusip>375558103</inf:cusip><inf:isin>US3755581036</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>145990</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>145990</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GILEAD SCIENCES, INC.</inf:issuerName><inf:cusip>375558103</inf:cusip><inf:isin>US3755581036</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>To vote on a stockholder proposal requesting a comprehensive human rights policy and human rights due diligence process, if properly presented at the Annual Meeting.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>145990</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>145990</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GILEAD SCIENCES, INC.</inf:issuerName><inf:cusip>375558103</inf:cusip><inf:isin>US3755581036</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>To vote on a stockholder proposal requesting a report on the risks of the Company's DEI practices for contractors, if properly presented at the Annual Meeting.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>145990</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>145990</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GLAUKOS CORPORATION</inf:issuerName><inf:cusip>377322102</inf:cusip><inf:isin>US3773221029</inf:isin><inf:meetingDate>05/29/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Mark J. Foley</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>14615</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>14615</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GLAUKOS CORPORATION</inf:issuerName><inf:cusip>377322102</inf:cusip><inf:isin>US3773221029</inf:isin><inf:meetingDate>05/29/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: David F. Hoffmeister</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>14615</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>14615</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GLAUKOS CORPORATION</inf:issuerName><inf:cusip>377322102</inf:cusip><inf:isin>US3773221029</inf:isin><inf:meetingDate>05/29/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Gilbert H. Kliman, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>14615</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>14615</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GLAUKOS CORPORATION</inf:issuerName><inf:cusip>377322102</inf:cusip><inf:isin>US3773221029</inf:isin><inf:meetingDate>05/29/2025</inf:meetingDate><inf:voteDescription>Approval, on an advisory basis, of the compensation of the Company's named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>14615</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>14615</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GLAUKOS CORPORATION</inf:issuerName><inf:cusip>377322102</inf:cusip><inf:isin>US3773221029</inf:isin><inf:meetingDate>05/29/2025</inf:meetingDate><inf:voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>14615</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>14615</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GUARDANT HEALTH, INC.</inf:issuerName><inf:cusip>40131M109</inf:cusip><inf:isin>US40131M1099</inf:isin><inf:meetingDate>06/18/2025</inf:meetingDate><inf:voteDescription>Election of Class I Director: Vijaya Gadde</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24415</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24415</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GUARDANT HEALTH, INC.</inf:issuerName><inf:cusip>40131M109</inf:cusip><inf:isin>US40131M1099</inf:isin><inf:meetingDate>06/18/2025</inf:meetingDate><inf:voteDescription>Election of Class I Director: Roberto Mignone</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24415</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24415</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GUARDANT HEALTH, INC.</inf:issuerName><inf:cusip>40131M109</inf:cusip><inf:isin>US40131M1099</inf:isin><inf:meetingDate>06/18/2025</inf:meetingDate><inf:voteDescription>Election of Class I Director: Myrtle Potter</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24415</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24415</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GUARDANT HEALTH, INC.</inf:issuerName><inf:cusip>40131M109</inf:cusip><inf:isin>US40131M1099</inf:isin><inf:meetingDate>06/18/2025</inf:meetingDate><inf:voteDescription>Election of Class I Director: Musa Tariq</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24415</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24415</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GUARDANT HEALTH, INC.</inf:issuerName><inf:cusip>40131M109</inf:cusip><inf:isin>US40131M1099</inf:isin><inf:meetingDate>06/18/2025</inf:meetingDate><inf:voteDescription>Ratification of the appointment of Deloitte &amp; Touche LLP as Guardant Health, Inc.'s independent registered public accounting firm for the year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24415</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24415</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>GUARDANT HEALTH, INC.</inf:issuerName><inf:cusip>40131M109</inf:cusip><inf:isin>US40131M1099</inf:isin><inf:meetingDate>06/18/2025</inf:meetingDate><inf:voteDescription>Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24415</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24415</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HCA HEALTHCARE, INC.</inf:issuerName><inf:cusip>40412C101</inf:cusip><inf:isin>US40412C1018</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Thomas F. Frist III</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6153</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6153</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HCA HEALTHCARE, INC.</inf:issuerName><inf:cusip>40412C101</inf:cusip><inf:isin>US40412C1018</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Samuel N. Hazen</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6153</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6153</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HCA HEALTHCARE, INC.</inf:issuerName><inf:cusip>40412C101</inf:cusip><inf:isin>US40412C1018</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Robert J. Dennis</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6153</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6153</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HCA HEALTHCARE, INC.</inf:issuerName><inf:cusip>40412C101</inf:cusip><inf:isin>US40412C1018</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Nancy-Ann DeParle</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6153</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6153</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HCA HEALTHCARE, INC.</inf:issuerName><inf:cusip>40412C101</inf:cusip><inf:isin>US40412C1018</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: William R. Frist</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6153</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6153</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HCA HEALTHCARE, INC.</inf:issuerName><inf:cusip>40412C101</inf:cusip><inf:isin>US40412C1018</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Hugh F. Johnston</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6153</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6153</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HCA HEALTHCARE, INC.</inf:issuerName><inf:cusip>40412C101</inf:cusip><inf:isin>US40412C1018</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Michael W. Michelson</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6153</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6153</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HCA HEALTHCARE, INC.</inf:issuerName><inf:cusip>40412C101</inf:cusip><inf:isin>US40412C1018</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Wayne J. Riley, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6153</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6153</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HCA HEALTHCARE, INC.</inf:issuerName><inf:cusip>40412C101</inf:cusip><inf:isin>US40412C1018</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Andrea B. Smith</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6153</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6153</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HCA HEALTHCARE, INC.</inf:issuerName><inf:cusip>40412C101</inf:cusip><inf:isin>US40412C1018</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>To ratify the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6153</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6153</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HCA HEALTHCARE, INC.</inf:issuerName><inf:cusip>40412C101</inf:cusip><inf:isin>US40412C1018</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Advisory vote to approve named executive officer compensation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6153</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6153</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HCA HEALTHCARE, INC.</inf:issuerName><inf:cusip>40412C101</inf:cusip><inf:isin>US40412C1018</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>To approve the First Amendment to the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6153</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6153</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HCA HEALTHCARE, INC.</inf:issuerName><inf:cusip>40412C101</inf:cusip><inf:isin>US40412C1018</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>To approve an amendment to our amended and restated certificate of incorporation to provide for the exculpation of officers as permitted by Delaware law.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6153</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6153</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HCA HEALTHCARE, INC.</inf:issuerName><inf:cusip>40412C101</inf:cusip><inf:isin>US40412C1018</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Stockholder proposal, if properly presented at the meeting, regarding lavish golden parachutes.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>6153</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>6153</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HCA HEALTHCARE, INC.</inf:issuerName><inf:cusip>40412C101</inf:cusip><inf:isin>US40412C1018</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Stockholder proposal, if properly presented at the meeting, regarding an amendment to Patient Safety and Quality of Care Committee charter.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>6153</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>6153</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HCA HEALTHCARE, INC.</inf:issuerName><inf:cusip>40412C101</inf:cusip><inf:isin>US40412C1018</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Stockholder proposal, if properly presented at the meeting, regarding report on acquisition strategy.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>6153</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>6153</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HUMANA INC.</inf:issuerName><inf:cusip>444859102</inf:cusip><inf:isin>US4448591028</inf:isin><inf:meetingDate>04/17/2025</inf:meetingDate><inf:voteDescription>Election of Director: Raquel C. Bono, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>18525</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>18525</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HUMANA INC.</inf:issuerName><inf:cusip>444859102</inf:cusip><inf:isin>US4448591028</inf:isin><inf:meetingDate>04/17/2025</inf:meetingDate><inf:voteDescription>Election of Director: Frank A. D'Amelio</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>18525</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>18525</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HUMANA INC.</inf:issuerName><inf:cusip>444859102</inf:cusip><inf:isin>US4448591028</inf:isin><inf:meetingDate>04/17/2025</inf:meetingDate><inf:voteDescription>Election of Director: David T. Feinberg, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>18525</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>18525</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HUMANA INC.</inf:issuerName><inf:cusip>444859102</inf:cusip><inf:isin>US4448591028</inf:isin><inf:meetingDate>04/17/2025</inf:meetingDate><inf:voteDescription>Election of Director: Wayne A. I. Frederick, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>18525</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>18525</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HUMANA INC.</inf:issuerName><inf:cusip>444859102</inf:cusip><inf:isin>US4448591028</inf:isin><inf:meetingDate>04/17/2025</inf:meetingDate><inf:voteDescription>Election of Director: John W. Garratt</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>18525</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>18525</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HUMANA INC.</inf:issuerName><inf:cusip>444859102</inf:cusip><inf:isin>US4448591028</inf:isin><inf:meetingDate>04/17/2025</inf:meetingDate><inf:voteDescription>Election of Director: Kurt J. Hilzinger</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>18525</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>18525</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HUMANA INC.</inf:issuerName><inf:cusip>444859102</inf:cusip><inf:isin>US4448591028</inf:isin><inf:meetingDate>04/17/2025</inf:meetingDate><inf:voteDescription>Election of Director: Karen W. Katz</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>18525</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>18525</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HUMANA INC.</inf:issuerName><inf:cusip>444859102</inf:cusip><inf:isin>US4448591028</inf:isin><inf:meetingDate>04/17/2025</inf:meetingDate><inf:voteDescription>Election of Director: Marcy S. Klevorn</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>18525</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>18525</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HUMANA INC.</inf:issuerName><inf:cusip>444859102</inf:cusip><inf:isin>US4448591028</inf:isin><inf:meetingDate>04/17/2025</inf:meetingDate><inf:voteDescription>Election of Director: Jorge S. Mesquita</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>18525</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>18525</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HUMANA INC.</inf:issuerName><inf:cusip>444859102</inf:cusip><inf:isin>US4448591028</inf:isin><inf:meetingDate>04/17/2025</inf:meetingDate><inf:voteDescription>Election of Director: James A. Rechtin</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>18525</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>18525</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HUMANA INC.</inf:issuerName><inf:cusip>444859102</inf:cusip><inf:isin>US4448591028</inf:isin><inf:meetingDate>04/17/2025</inf:meetingDate><inf:voteDescription>Election of Director: Gordon Smith</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>18525</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>18525</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HUMANA INC.</inf:issuerName><inf:cusip>444859102</inf:cusip><inf:isin>US4448591028</inf:isin><inf:meetingDate>04/17/2025</inf:meetingDate><inf:voteDescription>The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>18525</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>18525</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>HUMANA INC.</inf:issuerName><inf:cusip>444859102</inf:cusip><inf:isin>US4448591028</inf:isin><inf:meetingDate>04/17/2025</inf:meetingDate><inf:voteDescription>Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2025 proxy statement.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>18525</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>18525</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IDEXX LABORATORIES, INC.</inf:issuerName><inf:cusip>45168D104</inf:cusip><inf:isin>US45168D1046</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>Election of Director: Stuart M. Essig</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6691</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6691</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IDEXX LABORATORIES, INC.</inf:issuerName><inf:cusip>45168D104</inf:cusip><inf:isin>US45168D1046</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>Election of Director: Jonathan J. Mazelsky</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6691</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6691</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IDEXX LABORATORIES, INC.</inf:issuerName><inf:cusip>45168D104</inf:cusip><inf:isin>US45168D1046</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>Election of Director: M. Anne Szostak</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6691</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6691</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IDEXX LABORATORIES, INC.</inf:issuerName><inf:cusip>45168D104</inf:cusip><inf:isin>US45168D1046</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year (Proposal Two).</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6691</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6691</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IDEXX LABORATORIES, INC.</inf:issuerName><inf:cusip>45168D104</inf:cusip><inf:isin>US45168D1046</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three).</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6691</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6691</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IDEXX LABORATORIES, INC.</inf:issuerName><inf:cusip>45168D104</inf:cusip><inf:isin>US45168D1046</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>Amend Certificate of Incorporation to Remove Supermajority Voting Provisions (Proposal Four).</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6691</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6691</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IDEXX LABORATORIES, INC.</inf:issuerName><inf:cusip>45168D104</inf:cusip><inf:isin>US45168D1046</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>Amend Certificate of Incorporation to Reflect New Delaware Law Provisions Allowing for Officer Exculpation (Proposal Five).</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6691</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6691</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IDEXX LABORATORIES, INC.</inf:issuerName><inf:cusip>45168D104</inf:cusip><inf:isin>US45168D1046</inf:isin><inf:meetingDate>05/07/2025</inf:meetingDate><inf:voteDescription>Shareholder Proposal Regarding the Annual Election of Directors (Proposal Six).</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6691</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6691</inf:sharesVoted><inf:managementRecommendation>NONE</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INCYTE CORPORATION</inf:issuerName><inf:cusip>45337C102</inf:cusip><inf:isin>US45337C1027</inf:isin><inf:meetingDate>06/10/2025</inf:meetingDate><inf:voteDescription>Election of Director: Julian C. Baker</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12036</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12036</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INCYTE CORPORATION</inf:issuerName><inf:cusip>45337C102</inf:cusip><inf:isin>US45337C1027</inf:isin><inf:meetingDate>06/10/2025</inf:meetingDate><inf:voteDescription>Election of Director: Jean-Jacques Bienaim&#xE9;</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12036</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12036</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INCYTE CORPORATION</inf:issuerName><inf:cusip>45337C102</inf:cusip><inf:isin>US45337C1027</inf:isin><inf:meetingDate>06/10/2025</inf:meetingDate><inf:voteDescription>Election of Director: Otis W. Brawley</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12036</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12036</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INCYTE CORPORATION</inf:issuerName><inf:cusip>45337C102</inf:cusip><inf:isin>US45337C1027</inf:isin><inf:meetingDate>06/10/2025</inf:meetingDate><inf:voteDescription>Election of Director: Paul J. Clancy</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12036</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12036</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INCYTE CORPORATION</inf:issuerName><inf:cusip>45337C102</inf:cusip><inf:isin>US45337C1027</inf:isin><inf:meetingDate>06/10/2025</inf:meetingDate><inf:voteDescription>Election of Director: Jacqualyn A. Fouse</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12036</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12036</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INCYTE CORPORATION</inf:issuerName><inf:cusip>45337C102</inf:cusip><inf:isin>US45337C1027</inf:isin><inf:meetingDate>06/10/2025</inf:meetingDate><inf:voteDescription>Election of Director: Edmund P. Harrigan</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12036</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12036</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INCYTE CORPORATION</inf:issuerName><inf:cusip>45337C102</inf:cusip><inf:isin>US45337C1027</inf:isin><inf:meetingDate>06/10/2025</inf:meetingDate><inf:voteDescription>Election of Director: Katherine A. High</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12036</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12036</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INCYTE CORPORATION</inf:issuerName><inf:cusip>45337C102</inf:cusip><inf:isin>US45337C1027</inf:isin><inf:meetingDate>06/10/2025</inf:meetingDate><inf:voteDescription>Election of Director: Herv&#xE9; Hoppenot</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12036</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12036</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INCYTE CORPORATION</inf:issuerName><inf:cusip>45337C102</inf:cusip><inf:isin>US45337C1027</inf:isin><inf:meetingDate>06/10/2025</inf:meetingDate><inf:voteDescription>Election of Director: Susanne Schaffert</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12036</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12036</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INCYTE CORPORATION</inf:issuerName><inf:cusip>45337C102</inf:cusip><inf:isin>US45337C1027</inf:isin><inf:meetingDate>06/10/2025</inf:meetingDate><inf:voteDescription>Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12036</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12036</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INCYTE CORPORATION</inf:issuerName><inf:cusip>45337C102</inf:cusip><inf:isin>US45337C1027</inf:isin><inf:meetingDate>06/10/2025</inf:meetingDate><inf:voteDescription>Approve amendments of the Company's Amended and Restated 2010 Stock Incentive Plan.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12036</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12036</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INCYTE CORPORATION</inf:issuerName><inf:cusip>45337C102</inf:cusip><inf:isin>US45337C1027</inf:isin><inf:meetingDate>06/10/2025</inf:meetingDate><inf:voteDescription>Approve an amendment of the Company's 1997 Employee Stock Purchase Plan.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12036</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12036</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INCYTE CORPORATION</inf:issuerName><inf:cusip>45337C102</inf:cusip><inf:isin>US45337C1027</inf:isin><inf:meetingDate>06/10/2025</inf:meetingDate><inf:voteDescription>Ratify the appointment of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12036</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12036</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INSMED INCORPORATED</inf:issuerName><inf:cusip>457669307</inf:cusip><inf:isin>US4576693075</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Leo Lee</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>39560</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>39560</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INSMED INCORPORATED</inf:issuerName><inf:cusip>457669307</inf:cusip><inf:isin>US4576693075</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: William H. Lewis</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>39560</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>39560</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INSMED INCORPORATED</inf:issuerName><inf:cusip>457669307</inf:cusip><inf:isin>US4576693075</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>An advisory vote on the 2024 compensation of our named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>39560</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>39560</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INSMED INCORPORATED</inf:issuerName><inf:cusip>457669307</inf:cusip><inf:isin>US4576693075</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>39560</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>39560</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INSMED INCORPORATED</inf:issuerName><inf:cusip>457669307</inf:cusip><inf:isin>US4576693075</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Approval of Amendment No. 2 to the Insmed Incorporated Amended and Restated 2019 Incentive Plan.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>39560</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>39560</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INSPIRE MEDICAL SYSTEMS, INC.</inf:issuerName><inf:cusip>457730109</inf:cusip><inf:isin>US4577301090</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Cynthia B. Burks</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>4482</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>4482</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INSPIRE MEDICAL SYSTEMS, INC.</inf:issuerName><inf:cusip>457730109</inf:cusip><inf:isin>US4577301090</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Timothy P. Herbert</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>4482</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>4482</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INSPIRE MEDICAL SYSTEMS, INC.</inf:issuerName><inf:cusip>457730109</inf:cusip><inf:isin>US4577301090</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Shawn T McCormick</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>4482</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>4482</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INSPIRE MEDICAL SYSTEMS, INC.</inf:issuerName><inf:cusip>457730109</inf:cusip><inf:isin>US4577301090</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>4482</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>4482</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INSPIRE MEDICAL SYSTEMS, INC.</inf:issuerName><inf:cusip>457730109</inf:cusip><inf:isin>US4577301090</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>4482</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>4482</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INTUITIVE SURGICAL, INC.</inf:issuerName><inf:cusip>46120E602</inf:cusip><inf:isin>US46120E6023</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Craig H. Barratt, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>53465</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>53465</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INTUITIVE SURGICAL, INC.</inf:issuerName><inf:cusip>46120E602</inf:cusip><inf:isin>US46120E6023</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Joseph C. Beery</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>53465</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>53465</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INTUITIVE SURGICAL, INC.</inf:issuerName><inf:cusip>46120E602</inf:cusip><inf:isin>US46120E6023</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Lewis Chew</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>53465</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>53465</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INTUITIVE SURGICAL, INC.</inf:issuerName><inf:cusip>46120E602</inf:cusip><inf:isin>US46120E6023</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Gary S. Guthart, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>53465</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>53465</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INTUITIVE SURGICAL, INC.</inf:issuerName><inf:cusip>46120E602</inf:cusip><inf:isin>US46120E6023</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Amal M. Johnson</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>53465</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>53465</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INTUITIVE SURGICAL, INC.</inf:issuerName><inf:cusip>46120E602</inf:cusip><inf:isin>US46120E6023</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Sreelakshmi Kolli</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>53465</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>53465</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INTUITIVE SURGICAL, INC.</inf:issuerName><inf:cusip>46120E602</inf:cusip><inf:isin>US46120E6023</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Amy L. Ladd, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>53465</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>53465</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INTUITIVE SURGICAL, INC.</inf:issuerName><inf:cusip>46120E602</inf:cusip><inf:isin>US46120E6023</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Keith R. Leonard, Jr.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>53465</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>53465</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INTUITIVE SURGICAL, INC.</inf:issuerName><inf:cusip>46120E602</inf:cusip><inf:isin>US46120E6023</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Jami Dover Nachtsheim</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>53465</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>53465</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INTUITIVE SURGICAL, INC.</inf:issuerName><inf:cusip>46120E602</inf:cusip><inf:isin>US46120E6023</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Monica P. Reed, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>53465</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>53465</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INTUITIVE SURGICAL, INC.</inf:issuerName><inf:cusip>46120E602</inf:cusip><inf:isin>US46120E6023</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: David J. Rosa</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>53465</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>53465</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INTUITIVE SURGICAL, INC.</inf:issuerName><inf:cusip>46120E602</inf:cusip><inf:isin>US46120E6023</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>To approve, by advisory vote, the compensation of the Company's Named Executive Officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>53465</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>53465</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INTUITIVE SURGICAL, INC.</inf:issuerName><inf:cusip>46120E602</inf:cusip><inf:isin>US46120E6023</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>53465</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>53465</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INTUITIVE SURGICAL, INC.</inf:issuerName><inf:cusip>46120E602</inf:cusip><inf:isin>US46120E6023</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>The amendment and restatement of the Amended and Restated 2010 Incentive Award Plan.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>53465</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>53465</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INTUITIVE SURGICAL, INC.</inf:issuerName><inf:cusip>46120E602</inf:cusip><inf:isin>US46120E6023</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>The stockholder proposal purportedly "to improve the executive compensation program," if properly presented at the Annual Meeting.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>53465</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>53465</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>INTUITIVE SURGICAL, INC.</inf:issuerName><inf:cusip>46120E602</inf:cusip><inf:isin>US46120E6023</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>The stockholder proposal that is titled "Shareholder approval requirement for excessive golden parachutes," if properly presented at the Annual Meeting.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>53465</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>53465</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IONIS PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>462222100</inf:cusip><inf:isin>US4622221004</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>Election of Director: Allene M. Diaz</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11840</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11840</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IONIS PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>462222100</inf:cusip><inf:isin>US4622221004</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>Election of Director: Michael Hayden</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11840</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11840</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IONIS PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>462222100</inf:cusip><inf:isin>US4622221004</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>Election of Director: Joseph Klein, III</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11840</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11840</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IONIS PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>462222100</inf:cusip><inf:isin>US4622221004</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>Election of Director: Joseph Loscalzo</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11840</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11840</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IONIS PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>462222100</inf:cusip><inf:isin>US4622221004</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>To make an advisory vote on executive compensation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11840</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11840</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IONIS PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>462222100</inf:cusip><inf:isin>US4622221004</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>To approve an amendment of the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under such plan by 4,000,000 shares to an aggregate of 42,500,000 shares.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11840</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11840</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IONIS PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>462222100</inf:cusip><inf:isin>US4622221004</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>To ratify the Audit Committee's selection of Ernst &amp; Young LLP as independent auditors for the 2025 fiscal year.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11840</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11840</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IQVIA HOLDINGS INC.</inf:issuerName><inf:cusip>46266C105</inf:cusip><inf:isin>US46266C1053</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Ari Bousbib</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6738</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6738</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IQVIA HOLDINGS INC.</inf:issuerName><inf:cusip>46266C105</inf:cusip><inf:isin>US46266C1053</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Carol J. Burt</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6738</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6738</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IQVIA HOLDINGS INC.</inf:issuerName><inf:cusip>46266C105</inf:cusip><inf:isin>US46266C1053</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: John G. Danhakl</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6738</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6738</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IQVIA HOLDINGS INC.</inf:issuerName><inf:cusip>46266C105</inf:cusip><inf:isin>US46266C1053</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: James A. Fasano</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6738</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6738</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IQVIA HOLDINGS INC.</inf:issuerName><inf:cusip>46266C105</inf:cusip><inf:isin>US46266C1053</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Colleen A. Goggins</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6738</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6738</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IQVIA HOLDINGS INC.</inf:issuerName><inf:cusip>46266C105</inf:cusip><inf:isin>US46266C1053</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: John M. Leonard, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6738</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6738</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IQVIA HOLDINGS INC.</inf:issuerName><inf:cusip>46266C105</inf:cusip><inf:isin>US46266C1053</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Leslie Wims Morris</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6738</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6738</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IQVIA HOLDINGS INC.</inf:issuerName><inf:cusip>46266C105</inf:cusip><inf:isin>US46266C1053</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Todd B. Sisitsky</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6738</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>6738</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IQVIA HOLDINGS INC.</inf:issuerName><inf:cusip>46266C105</inf:cusip><inf:isin>US46266C1053</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Sheila A. Stamps</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6738</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6738</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IQVIA HOLDINGS INC.</inf:issuerName><inf:cusip>46266C105</inf:cusip><inf:isin>US46266C1053</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay).</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6738</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6738</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IQVIA HOLDINGS INC.</inf:issuerName><inf:cusip>46266C105</inf:cusip><inf:isin>US46266C1053</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA's independent registered public accounting firm for 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6738</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6738</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IQVIA HOLDINGS INC.</inf:issuerName><inf:cusip>46266C105</inf:cusip><inf:isin>US46266C1053</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Approve a Company proposal to amend IQVIA's Certificate of Incorporation regarding officer exculpation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6738</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6738</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>IQVIA HOLDINGS INC.</inf:issuerName><inf:cusip>46266C105</inf:cusip><inf:isin>US46266C1053</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>If properly presented, a stockholder proposal concerning special stockholder meetings.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>6738</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>6738</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>JOHNSON &amp; JOHNSON</inf:issuerName><inf:cusip>478160104</inf:cusip><inf:isin>US4781601046</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Darius Adamczyk</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>83583</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>83583</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>JOHNSON &amp; JOHNSON</inf:issuerName><inf:cusip>478160104</inf:cusip><inf:isin>US4781601046</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Mary C. Beckerle</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>83583</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>83583</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>JOHNSON &amp; JOHNSON</inf:issuerName><inf:cusip>478160104</inf:cusip><inf:isin>US4781601046</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Jennifer A. Doudna</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>83583</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>83583</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>JOHNSON &amp; JOHNSON</inf:issuerName><inf:cusip>478160104</inf:cusip><inf:isin>US4781601046</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Joaquin Duato</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>83583</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>83583</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>JOHNSON &amp; JOHNSON</inf:issuerName><inf:cusip>478160104</inf:cusip><inf:isin>US4781601046</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Marillyn A. Hewson</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>83583</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>83583</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>JOHNSON &amp; JOHNSON</inf:issuerName><inf:cusip>478160104</inf:cusip><inf:isin>US4781601046</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Paula A. Johnson</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>83583</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>83583</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>JOHNSON &amp; JOHNSON</inf:issuerName><inf:cusip>478160104</inf:cusip><inf:isin>US4781601046</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Hubert Joly</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>83583</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>83583</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>JOHNSON &amp; JOHNSON</inf:issuerName><inf:cusip>478160104</inf:cusip><inf:isin>US4781601046</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Mark B. McClellan</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>83583</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>83583</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>JOHNSON &amp; JOHNSON</inf:issuerName><inf:cusip>478160104</inf:cusip><inf:isin>US4781601046</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Mark A. Weinberger</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>83583</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>83583</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>JOHNSON &amp; JOHNSON</inf:issuerName><inf:cusip>478160104</inf:cusip><inf:isin>US4781601046</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Nadja Y. West</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>83583</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>83583</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>JOHNSON &amp; JOHNSON</inf:issuerName><inf:cusip>478160104</inf:cusip><inf:isin>US4781601046</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Eugene A. Woods</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>83583</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>83583</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>JOHNSON &amp; JOHNSON</inf:issuerName><inf:cusip>478160104</inf:cusip><inf:isin>US4781601046</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Advisory Vote to Approve Named Executive Officer Compensation</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>83583</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>83583</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>JOHNSON &amp; JOHNSON</inf:issuerName><inf:cusip>478160104</inf:cusip><inf:isin>US4781601046</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>83583</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>83583</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>JOHNSON &amp; JOHNSON</inf:issuerName><inf:cusip>478160104</inf:cusip><inf:isin>US4781601046</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Shareholder opportunity to vote on excessive golden parachutes</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>83583</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>83583</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>JOHNSON &amp; JOHNSON</inf:issuerName><inf:cusip>478160104</inf:cusip><inf:isin>US4781601046</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Produce a human rights impact assessment</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>83583</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>83583</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>KYMERA THERAPEUTICS, INC.</inf:issuerName><inf:cusip>501575104</inf:cusip><inf:isin>US5015751044</inf:isin><inf:meetingDate>06/25/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Jeffrey Albers,J.D.,MBA</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>4580</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>4580</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>KYMERA THERAPEUTICS, INC.</inf:issuerName><inf:cusip>501575104</inf:cusip><inf:isin>US5015751044</inf:isin><inf:meetingDate>06/25/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Felix J. Baker, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>4580</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>ABSTAIN</inf:howVoted><inf:sharesVoted>4580</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>KYMERA THERAPEUTICS, INC.</inf:issuerName><inf:cusip>501575104</inf:cusip><inf:isin>US5015751044</inf:isin><inf:meetingDate>06/25/2025</inf:meetingDate><inf:voteDescription>To approve, on a non-binding advisory basis, the compensation of our named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>4580</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>4580</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>KYMERA THERAPEUTICS, INC.</inf:issuerName><inf:cusip>501575104</inf:cusip><inf:isin>US5015751044</inf:isin><inf:meetingDate>06/25/2025</inf:meetingDate><inf:voteDescription>To ratify the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>4580</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>4580</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LABCORP HOLDINGS INC.</inf:issuerName><inf:cusip>504922105</inf:cusip><inf:isin>US5049221055</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Kerrii B. Anderson</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6745</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6745</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LABCORP HOLDINGS INC.</inf:issuerName><inf:cusip>504922105</inf:cusip><inf:isin>US5049221055</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Jeffrey A. Davis</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6745</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6745</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LABCORP HOLDINGS INC.</inf:issuerName><inf:cusip>504922105</inf:cusip><inf:isin>US5049221055</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: D. Gary Gilliland, M.D., Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6745</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6745</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LABCORP HOLDINGS INC.</inf:issuerName><inf:cusip>504922105</inf:cusip><inf:isin>US5049221055</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Kirsten M. Kliphouse</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6745</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6745</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LABCORP HOLDINGS INC.</inf:issuerName><inf:cusip>504922105</inf:cusip><inf:isin>US5049221055</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Garheng Kong, M.D., Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6745</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6745</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LABCORP HOLDINGS INC.</inf:issuerName><inf:cusip>504922105</inf:cusip><inf:isin>US5049221055</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Peter M. Neupert</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6745</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6745</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LABCORP HOLDINGS INC.</inf:issuerName><inf:cusip>504922105</inf:cusip><inf:isin>US5049221055</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Richelle P. Parham</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6745</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6745</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LABCORP HOLDINGS INC.</inf:issuerName><inf:cusip>504922105</inf:cusip><inf:isin>US5049221055</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Paul B. Rothman, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6745</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6745</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LABCORP HOLDINGS INC.</inf:issuerName><inf:cusip>504922105</inf:cusip><inf:isin>US5049221055</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Adam H. Schechter</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6745</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6745</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LABCORP HOLDINGS INC.</inf:issuerName><inf:cusip>504922105</inf:cusip><inf:isin>US5049221055</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Kathryn E. Wengel</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6745</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6745</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LABCORP HOLDINGS INC.</inf:issuerName><inf:cusip>504922105</inf:cusip><inf:isin>US5049221055</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>To approve, by non-binding vote, the compensation of the Company's Named Executive Officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6745</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6745</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LABCORP HOLDINGS INC.</inf:issuerName><inf:cusip>504922105</inf:cusip><inf:isin>US5049221055</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>To approve the Company's 2025 Omnibus Incentive Plan.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6745</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6745</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LABCORP HOLDINGS INC.</inf:issuerName><inf:cusip>504922105</inf:cusip><inf:isin>US5049221055</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>To approve the Company's 2025 Employee Stock Purchase Plan.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6745</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6745</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LABCORP HOLDINGS INC.</inf:issuerName><inf:cusip>504922105</inf:cusip><inf:isin>US5049221055</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Ratification of the appointment of Deloitte and Touche LLP as Labcorp Holdings Inc.'s independent registered public accounting firm for the year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6745</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6745</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LEGEND BIOTECH CORPORATION</inf:issuerName><inf:cusip>52490G102</inf:cusip><inf:isin>US52490G1022</inf:isin><inf:meetingDate>10/21/2024</inf:meetingDate><inf:voteDescription>To receive the audited consolidated financial statements of the Company for the fiscal year ended December 31, 2023.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>22717</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>22717</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LEGEND BIOTECH CORPORATION</inf:issuerName><inf:cusip>52490G102</inf:cusip><inf:isin>US52490G1022</inf:isin><inf:meetingDate>10/21/2024</inf:meetingDate><inf:voteDescription>To ratify the appointment of Ernst &amp; Young LLP as independent auditor of the Company (the "Independent Auditor") for the fiscal year ending December 31, 2024.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>22717</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>22717</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LEGEND BIOTECH CORPORATION</inf:issuerName><inf:cusip>52490G102</inf:cusip><inf:isin>US52490G1022</inf:isin><inf:meetingDate>10/21/2024</inf:meetingDate><inf:voteDescription>To re-elect Ms. Ye Wang, whose term of office will expire pursuant to article 88(b) of the Company's memorandum of association, to serve as a Class I director of the Company for a full term of three (3) years.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>22717</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>22717</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LEGEND BIOTECH CORPORATION</inf:issuerName><inf:cusip>52490G102</inf:cusip><inf:isin>US52490G1022</inf:isin><inf:meetingDate>10/21/2024</inf:meetingDate><inf:voteDescription>To re-elect Dr. Darren Xiaohui Ji, whose term of office will expire pursuant to article 88(b) of the Company's memorandum of association, to serve as a Class I director of the Company for a full term of three (3) years.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>22717</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>22717</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LEGEND BIOTECH CORPORATION</inf:issuerName><inf:cusip>52490G102</inf:cusip><inf:isin>US52490G1022</inf:isin><inf:meetingDate>10/21/2024</inf:meetingDate><inf:voteDescription>To re-elect Dr. Ying Huang, whose term of office will expire pursuant to article 88(b) of the Company's memorandum of association, to serve as a Class I director of the Company for a full term of three (3) years.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>22717</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>22717</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LEGEND BIOTECH CORPORATION</inf:issuerName><inf:cusip>52490G102</inf:cusip><inf:isin>US52490G1022</inf:isin><inf:meetingDate>10/21/2024</inf:meetingDate><inf:voteDescription>To re-elect Tomas Heyman, whose term of office will expire pursuant to article 88(b) of the Company's memorandum of association, to serve as a Class I director of the Company for a full term of three (3) years.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>22717</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>22717</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LEGEND BIOTECH CORPORATION</inf:issuerName><inf:cusip>52490G102</inf:cusip><inf:isin>US52490G1022</inf:isin><inf:meetingDate>10/21/2024</inf:meetingDate><inf:voteDescription>To approve an amendment and restatement of the Company's 2020 Restricted Shares Plan to increase the aggregate number of ordinary shares reserved for issuance by 15,000,000 ordinary shares.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>22717</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>22717</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LEGEND BIOTECH CORPORATION</inf:issuerName><inf:cusip>52490G102</inf:cusip><inf:isin>US52490G1022</inf:isin><inf:meetingDate>10/21/2024</inf:meetingDate><inf:voteDescription>To authorize each of the directors and officers of the Company to take any and every action that might be necessary to effect the foregoing resolutions as such director or officer, in his or her absolute discretion, thinks fit.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>22717</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>22717</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LEGEND BIOTECH CORPORATION</inf:issuerName><inf:cusip>52490G102</inf:cusip><inf:isin>US52490G1022</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>To receive the audited consolidated financial statements of the Company for the fiscal year ended December 31, 2024.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10574</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10574</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LEGEND BIOTECH CORPORATION</inf:issuerName><inf:cusip>52490G102</inf:cusip><inf:isin>US52490G1022</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>To ratify the appointment of Ernst &amp; Young LLP as independent auditor of the Company (the "Independent Auditor") for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10574</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10574</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LEGEND BIOTECH CORPORATION</inf:issuerName><inf:cusip>52490G102</inf:cusip><inf:isin>US52490G1022</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>To re-elect Dr. Patrick Casey, whose term of office will expire pursuant to article 88(b) of the Company's memorandum of association, to serve as a Class II director of the Company for a full term of three (3) years.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10574</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10574</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LEGEND BIOTECH CORPORATION</inf:issuerName><inf:cusip>52490G102</inf:cusip><inf:isin>US52490G1022</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>To re-elect Yau Wai Man Philip, whose term of office will expire pursuant to article 88(b) of the Company's memorandum of association, to serve as a Class II director of the Company for a full term of three (3) years.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10574</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>10574</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LEGEND BIOTECH CORPORATION</inf:issuerName><inf:cusip>52490G102</inf:cusip><inf:isin>US52490G1022</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>To re-elect Dr. Fangliang Zhang, whose term of office will expire pursuant to article 88(b) of the Company's memorandum of association, to serve as a Class II director of the Company for a full term of three (3) years.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10574</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10574</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>LEGEND BIOTECH CORPORATION</inf:issuerName><inf:cusip>52490G102</inf:cusip><inf:isin>US52490G1022</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>To authorize each of the directors and officers of the Company to take any and every action that might be necessary to effect the foregoing resolutions as such director or officer, in his or her absolute discretion, thinks fit.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10574</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10574</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MASIMO CORPORATION</inf:issuerName><inf:cusip>574795100</inf:cusip><inf:isin>US5747951003</inf:isin><inf:meetingDate>09/19/2024</inf:meetingDate><inf:voteDescription>Company Recommended Nominee: Christopher Chavez</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21914</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>WITHHOLD</inf:howVoted><inf:sharesVoted>21914</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MASIMO CORPORATION</inf:issuerName><inf:cusip>574795100</inf:cusip><inf:isin>US5747951003</inf:isin><inf:meetingDate>09/19/2024</inf:meetingDate><inf:voteDescription>Company Recommended Nominee: Joe Kiani</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21914</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>WITHHOLD</inf:howVoted><inf:sharesVoted>21914</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MASIMO CORPORATION</inf:issuerName><inf:cusip>574795100</inf:cusip><inf:isin>US5747951003</inf:isin><inf:meetingDate>09/19/2024</inf:meetingDate><inf:voteDescription>Politan Group Nominee OPPOSED by the Company: William R. Jellison</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21914</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21914</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MASIMO CORPORATION</inf:issuerName><inf:cusip>574795100</inf:cusip><inf:isin>US5747951003</inf:isin><inf:meetingDate>09/19/2024</inf:meetingDate><inf:voteDescription>Politan Group Nominee OPPOSED by the Company: Darlene J.S. Solomon</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21914</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21914</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MASIMO CORPORATION</inf:issuerName><inf:cusip>574795100</inf:cusip><inf:isin>US5747951003</inf:isin><inf:meetingDate>09/19/2024</inf:meetingDate><inf:voteDescription>To ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 28, 2024.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21914</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21914</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MASIMO CORPORATION</inf:issuerName><inf:cusip>574795100</inf:cusip><inf:isin>US5747951003</inf:isin><inf:meetingDate>09/19/2024</inf:meetingDate><inf:voteDescription>To provide an advisory vote to approve the compensation of our named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21914</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21914</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MASIMO CORPORATION</inf:issuerName><inf:cusip>574795100</inf:cusip><inf:isin>US5747951003</inf:isin><inf:meetingDate>09/19/2024</inf:meetingDate><inf:voteDescription>Politan Group proposal to repeal any provision of, or amendment to, the Company's bylaws adopted by the Board without stockholder approval subsequent to April 20, 2023 and up to and including the date of the Annual Meeting.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>21914</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>21914</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MCKESSON CORPORATION</inf:issuerName><inf:cusip>58155Q103</inf:cusip><inf:isin>US58155Q1031</inf:isin><inf:meetingDate>07/31/2024</inf:meetingDate><inf:voteDescription>Election of Director for a one-year term: Richard H. Carmona, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>25023</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>25023</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MCKESSON CORPORATION</inf:issuerName><inf:cusip>58155Q103</inf:cusip><inf:isin>US58155Q1031</inf:isin><inf:meetingDate>07/31/2024</inf:meetingDate><inf:voteDescription>Election of Director for a one-year term: Dominic J. Caruso</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>25023</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>25023</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MCKESSON CORPORATION</inf:issuerName><inf:cusip>58155Q103</inf:cusip><inf:isin>US58155Q1031</inf:isin><inf:meetingDate>07/31/2024</inf:meetingDate><inf:voteDescription>Election of Director for a one-year term: W. Roy Dunbar</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>25023</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>25023</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MCKESSON CORPORATION</inf:issuerName><inf:cusip>58155Q103</inf:cusip><inf:isin>US58155Q1031</inf:isin><inf:meetingDate>07/31/2024</inf:meetingDate><inf:voteDescription>Election of Director for a one-year term: Deborah Dunsire, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>25023</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>25023</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MCKESSON CORPORATION</inf:issuerName><inf:cusip>58155Q103</inf:cusip><inf:isin>US58155Q1031</inf:isin><inf:meetingDate>07/31/2024</inf:meetingDate><inf:voteDescription>Election of Director for a one-year term: James H. Hinton</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>25023</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>25023</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MCKESSON CORPORATION</inf:issuerName><inf:cusip>58155Q103</inf:cusip><inf:isin>US58155Q1031</inf:isin><inf:meetingDate>07/31/2024</inf:meetingDate><inf:voteDescription>Election of Director for a one-year term: Donald R. Knauss</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>25023</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>25023</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MCKESSON CORPORATION</inf:issuerName><inf:cusip>58155Q103</inf:cusip><inf:isin>US58155Q1031</inf:isin><inf:meetingDate>07/31/2024</inf:meetingDate><inf:voteDescription>Election of Director for a one-year term: Bradley E. Lerman</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>25023</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>25023</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MCKESSON CORPORATION</inf:issuerName><inf:cusip>58155Q103</inf:cusip><inf:isin>US58155Q1031</inf:isin><inf:meetingDate>07/31/2024</inf:meetingDate><inf:voteDescription>Election of Director for a one-year term: Maria N. Martinez</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>25023</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>25023</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MCKESSON CORPORATION</inf:issuerName><inf:cusip>58155Q103</inf:cusip><inf:isin>US58155Q1031</inf:isin><inf:meetingDate>07/31/2024</inf:meetingDate><inf:voteDescription>Election of Director for a one-year term: Kevin M. Ozan</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>25023</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>25023</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MCKESSON CORPORATION</inf:issuerName><inf:cusip>58155Q103</inf:cusip><inf:isin>US58155Q1031</inf:isin><inf:meetingDate>07/31/2024</inf:meetingDate><inf:voteDescription>Election of Director for a one-year term: Brian S. Tyler</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>25023</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>25023</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MCKESSON CORPORATION</inf:issuerName><inf:cusip>58155Q103</inf:cusip><inf:isin>US58155Q1031</inf:isin><inf:meetingDate>07/31/2024</inf:meetingDate><inf:voteDescription>Election of Director for a one-year term: Kathleen Wilson-Thompson</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>25023</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>25023</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MCKESSON CORPORATION</inf:issuerName><inf:cusip>58155Q103</inf:cusip><inf:isin>US58155Q1031</inf:isin><inf:meetingDate>07/31/2024</inf:meetingDate><inf:voteDescription>Ratification of Appointment of Deloitte &amp; Touche LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>25023</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>25023</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MCKESSON CORPORATION</inf:issuerName><inf:cusip>58155Q103</inf:cusip><inf:isin>US58155Q1031</inf:isin><inf:meetingDate>07/31/2024</inf:meetingDate><inf:voteDescription>Advisory vote on Executive Compensation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>25023</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>25023</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MCKESSON CORPORATION</inf:issuerName><inf:cusip>58155Q103</inf:cusip><inf:isin>US58155Q1031</inf:isin><inf:meetingDate>07/31/2024</inf:meetingDate><inf:voteDescription>Approve Amendment to Certificate of Incorporation to Provide for Officer Exculpation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>25023</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>25023</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MCKESSON CORPORATION</inf:issuerName><inf:cusip>58155Q103</inf:cusip><inf:isin>US58155Q1031</inf:isin><inf:meetingDate>07/31/2024</inf:meetingDate><inf:voteDescription>Shareholder Proposal on Independent Board Chairman.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>25023</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>25023</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MCKESSON CORPORATION</inf:issuerName><inf:cusip>58155Q103</inf:cusip><inf:isin>US58155Q1031</inf:isin><inf:meetingDate>07/31/2024</inf:meetingDate><inf:voteDescription>Shareholder Proposal on Report on Risks of State Policies Restricting Reproductive Health Care.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>25023</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>25023</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MEDTRONIC PLC</inf:issuerName><inf:cusip>G5960L103</inf:cusip><inf:isin>IE00BTN1Y115</inf:isin><inf:meetingDate>10/17/2024</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2025 Annual General Meeting: Craig Arnold</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>71671</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>71671</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MEDTRONIC PLC</inf:issuerName><inf:cusip>G5960L103</inf:cusip><inf:isin>IE00BTN1Y115</inf:isin><inf:meetingDate>10/17/2024</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2025 Annual General Meeting: Scott C. Donnelly</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>71671</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>71671</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MEDTRONIC PLC</inf:issuerName><inf:cusip>G5960L103</inf:cusip><inf:isin>IE00BTN1Y115</inf:isin><inf:meetingDate>10/17/2024</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2025 Annual General Meeting: Lidia L. Fonseca</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>71671</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>71671</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MEDTRONIC PLC</inf:issuerName><inf:cusip>G5960L103</inf:cusip><inf:isin>IE00BTN1Y115</inf:isin><inf:meetingDate>10/17/2024</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2025 Annual General Meeting: Andrea J. Goldsmith, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>71671</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>71671</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MEDTRONIC PLC</inf:issuerName><inf:cusip>G5960L103</inf:cusip><inf:isin>IE00BTN1Y115</inf:isin><inf:meetingDate>10/17/2024</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2025 Annual General Meeting: Randall J. Hogan, III</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>71671</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>71671</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MEDTRONIC PLC</inf:issuerName><inf:cusip>G5960L103</inf:cusip><inf:isin>IE00BTN1Y115</inf:isin><inf:meetingDate>10/17/2024</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2025 Annual General Meeting: Gregory P. Lewis</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>71671</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>71671</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MEDTRONIC PLC</inf:issuerName><inf:cusip>G5960L103</inf:cusip><inf:isin>IE00BTN1Y115</inf:isin><inf:meetingDate>10/17/2024</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2025 Annual General Meeting: Kevin E. Lofton</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>71671</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>71671</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MEDTRONIC PLC</inf:issuerName><inf:cusip>G5960L103</inf:cusip><inf:isin>IE00BTN1Y115</inf:isin><inf:meetingDate>10/17/2024</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2025 Annual General Meeting: Geoffrey S. Martha</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>71671</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>71671</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MEDTRONIC PLC</inf:issuerName><inf:cusip>G5960L103</inf:cusip><inf:isin>IE00BTN1Y115</inf:isin><inf:meetingDate>10/17/2024</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2025 Annual General Meeting: Elizabeth G. Nabel, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>71671</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>71671</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MEDTRONIC PLC</inf:issuerName><inf:cusip>G5960L103</inf:cusip><inf:isin>IE00BTN1Y115</inf:isin><inf:meetingDate>10/17/2024</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2025 Annual General Meeting: Kendall J. Powell</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>71671</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>71671</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MEDTRONIC PLC</inf:issuerName><inf:cusip>G5960L103</inf:cusip><inf:isin>IE00BTN1Y115</inf:isin><inf:meetingDate>10/17/2024</inf:meetingDate><inf:voteDescription>Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2025 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>71671</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>71671</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MEDTRONIC PLC</inf:issuerName><inf:cusip>G5960L103</inf:cusip><inf:isin>IE00BTN1Y115</inf:isin><inf:meetingDate>10/17/2024</inf:meetingDate><inf:voteDescription>Approving, on an advisory basis, the Company's executive compensation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>71671</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>71671</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MEDTRONIC PLC</inf:issuerName><inf:cusip>G5960L103</inf:cusip><inf:isin>IE00BTN1Y115</inf:isin><inf:meetingDate>10/17/2024</inf:meetingDate><inf:voteDescription>Renewing the Board of Directors' authority to issue shares under Irish law.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>71671</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>71671</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MEDTRONIC PLC</inf:issuerName><inf:cusip>G5960L103</inf:cusip><inf:isin>IE00BTN1Y115</inf:isin><inf:meetingDate>10/17/2024</inf:meetingDate><inf:voteDescription>Renewing the Board of Directors' authority to opt out of pre-emption rights under Irish law.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>71671</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>71671</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MEDTRONIC PLC</inf:issuerName><inf:cusip>G5960L103</inf:cusip><inf:isin>IE00BTN1Y115</inf:isin><inf:meetingDate>10/17/2024</inf:meetingDate><inf:voteDescription>Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>71671</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>71671</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MERUS N.V.</inf:issuerName><inf:cusip>N5749R100</inf:cusip><inf:isin>NL0011606264</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Adoption of Merus N.V.'s Dutch statutory annual accounts for the financial year 2024.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MERUS N.V.</inf:issuerName><inf:cusip>N5749R100</inf:cusip><inf:isin>NL0011606264</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Appointment of KPMG Accountants N.V. as Merus N.V.'s external auditor for the financial year 2025 for purposes of Dutch law.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MERUS N.V.</inf:issuerName><inf:cusip>N5749R100</inf:cusip><inf:isin>NL0011606264</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Release of each member of Merus N.V.'s board of directors from liability for the exercise of their duties during the financial year 2024.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MERUS N.V.</inf:issuerName><inf:cusip>N5749R100</inf:cusip><inf:isin>NL0011606264</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Opportunity to make recommendations for nomination by Merus N.V.'s group of non-executive directors.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28920</inf:sharesVoted><inf:managementRecommendation>NONE</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MERUS N.V.</inf:issuerName><inf:cusip>N5749R100</inf:cusip><inf:isin>NL0011606264</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Re-appointment of Anand Mehra, M.D. as non-executive director.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>28920</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MERUS N.V.</inf:issuerName><inf:cusip>N5749R100</inf:cusip><inf:isin>NL0011606264</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Opportunity to make recommendations for nomination by Merus N.V.'s group of non-executive directors.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28920</inf:sharesVoted><inf:managementRecommendation>NONE</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MERUS N.V.</inf:issuerName><inf:cusip>N5749R100</inf:cusip><inf:isin>NL0011606264</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Re-appointment of Maxine Gowen, Ph.D. as non-executive director.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MERUS N.V.</inf:issuerName><inf:cusip>N5749R100</inf:cusip><inf:isin>NL0011606264</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Granting authorization to Merus N.V.'s board of directors to acquire shares (or depository receipts for such shares) in Merus N.V.'s capital.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MERUS N.V.</inf:issuerName><inf:cusip>N5749R100</inf:cusip><inf:isin>NL0011606264</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>METTLER-TOLEDO INTERNATIONAL INC.</inf:issuerName><inf:cusip>592688105</inf:cusip><inf:isin>US5926881054</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Roland Diggelmann</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>1170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>1170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>METTLER-TOLEDO INTERNATIONAL INC.</inf:issuerName><inf:cusip>592688105</inf:cusip><inf:isin>US5926881054</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Domitille Doat-Le Bigot</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>1170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>1170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>METTLER-TOLEDO INTERNATIONAL INC.</inf:issuerName><inf:cusip>592688105</inf:cusip><inf:isin>US5926881054</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Elisha W. Finney</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>1170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>1170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>METTLER-TOLEDO INTERNATIONAL INC.</inf:issuerName><inf:cusip>592688105</inf:cusip><inf:isin>US5926881054</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Michael A. Kelly</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>1170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>1170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>METTLER-TOLEDO INTERNATIONAL INC.</inf:issuerName><inf:cusip>592688105</inf:cusip><inf:isin>US5926881054</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Thomas P. Salice</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>1170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>1170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>METTLER-TOLEDO INTERNATIONAL INC.</inf:issuerName><inf:cusip>592688105</inf:cusip><inf:isin>US5926881054</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Brian Shepherd</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>1170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>1170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>METTLER-TOLEDO INTERNATIONAL INC.</inf:issuerName><inf:cusip>592688105</inf:cusip><inf:isin>US5926881054</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Wolfgang Wienand</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>1170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>1170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>METTLER-TOLEDO INTERNATIONAL INC.</inf:issuerName><inf:cusip>592688105</inf:cusip><inf:isin>US5926881054</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>Election of Director: Ingrid Zhang</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>1170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>1170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>METTLER-TOLEDO INTERNATIONAL INC.</inf:issuerName><inf:cusip>592688105</inf:cusip><inf:isin>US5926881054</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>1170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>1170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>METTLER-TOLEDO INTERNATIONAL INC.</inf:issuerName><inf:cusip>592688105</inf:cusip><inf:isin>US5926881054</inf:isin><inf:meetingDate>05/01/2025</inf:meetingDate><inf:voteDescription>ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>1170</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>1170</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MOONLAKE IMMUNOTHERAPEUTICS</inf:issuerName><inf:cusip>61559X104</inf:cusip><inf:isin>KY61559X1045</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Dr. Jorge S. da Silva</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6057</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6057</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MOONLAKE IMMUNOTHERAPEUTICS</inf:issuerName><inf:cusip>61559X104</inf:cusip><inf:isin>KY61559X1045</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Simon Sturge</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6057</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>ABSTAIN</inf:howVoted><inf:sharesVoted>6057</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MOONLAKE IMMUNOTHERAPEUTICS</inf:issuerName><inf:cusip>61559X104</inf:cusip><inf:isin>KY61559X1045</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Dr. Andrew Phillips</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6057</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>ABSTAIN</inf:howVoted><inf:sharesVoted>6057</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MOONLAKE IMMUNOTHERAPEUTICS</inf:issuerName><inf:cusip>61559X104</inf:cusip><inf:isin>KY61559X1045</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>Ratification, by ordinary resolution, of the selection of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6057</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6057</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>MOONLAKE IMMUNOTHERAPEUTICS</inf:issuerName><inf:cusip>61559X104</inf:cusip><inf:isin>KY61559X1045</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6057</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6057</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NATERA, INC.</inf:issuerName><inf:cusip>632307104</inf:cusip><inf:isin>US6323071042</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Roy Baynes</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11360</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11360</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NATERA, INC.</inf:issuerName><inf:cusip>632307104</inf:cusip><inf:isin>US6323071042</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Gail Marcus</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11360</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11360</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NATERA, INC.</inf:issuerName><inf:cusip>632307104</inf:cusip><inf:isin>US6323071042</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Ruth Williams-Brinkley</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11360</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11360</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NATERA, INC.</inf:issuerName><inf:cusip>632307104</inf:cusip><inf:isin>US6323071042</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>To ratify the appointment of Ernst &amp; Young LLP as Natera, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11360</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11360</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NATERA, INC.</inf:issuerName><inf:cusip>632307104</inf:cusip><inf:isin>US6323071042</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11360</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11360</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NATERA, INC.</inf:issuerName><inf:cusip>632307104</inf:cusip><inf:isin>US6323071042</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>To approve an amendment to Natera's Amended and Restated 2015 Equity Incentive Plan.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11360</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11360</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NEUROCRINE BIOSCIENCES, INC.</inf:issuerName><inf:cusip>64125C109</inf:cusip><inf:isin>US64125C1099</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Kyle W. Gano, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>23103</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>23103</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NEUROCRINE BIOSCIENCES, INC.</inf:issuerName><inf:cusip>64125C109</inf:cusip><inf:isin>US64125C1099</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Richard F. Pops</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>23103</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>23103</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NEUROCRINE BIOSCIENCES, INC.</inf:issuerName><inf:cusip>64125C109</inf:cusip><inf:isin>US64125C1099</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Shalini Sharp</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>23103</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>23103</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NEUROCRINE BIOSCIENCES, INC.</inf:issuerName><inf:cusip>64125C109</inf:cusip><inf:isin>US64125C1099</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Stephen A Sherwin M.D</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>23103</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>23103</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NEUROCRINE BIOSCIENCES, INC.</inf:issuerName><inf:cusip>64125C109</inf:cusip><inf:isin>US64125C1099</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Advisory vote on the compensation paid to the Company's named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>23103</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>23103</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NEUROCRINE BIOSCIENCES, INC.</inf:issuerName><inf:cusip>64125C109</inf:cusip><inf:isin>US64125C1099</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>To approve the Company's 2025 Equity Incentive Plan.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>23103</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>23103</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NEUROCRINE BIOSCIENCES, INC.</inf:issuerName><inf:cusip>64125C109</inf:cusip><inf:isin>US64125C1099</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>To approve an amendment and restatement of the Company's 2018 Employee Stock Purchase Plan.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>23103</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>23103</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NEUROCRINE BIOSCIENCES, INC.</inf:issuerName><inf:cusip>64125C109</inf:cusip><inf:isin>US64125C1099</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>To ratify the appointment of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>23103</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>23103</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NOVOCURE LIMITED</inf:issuerName><inf:cusip>G6674U108</inf:cusip><inf:isin>JE00BYSS4X48</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Election of Director: Ashley Cordova</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48448</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48448</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NOVOCURE LIMITED</inf:issuerName><inf:cusip>G6674U108</inf:cusip><inf:isin>JE00BYSS4X48</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Election of Director: Asaf Danziger</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48448</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48448</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NOVOCURE LIMITED</inf:issuerName><inf:cusip>G6674U108</inf:cusip><inf:isin>JE00BYSS4X48</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Election of Director: William Doyle</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48448</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48448</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NOVOCURE LIMITED</inf:issuerName><inf:cusip>G6674U108</inf:cusip><inf:isin>JE00BYSS4X48</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Election of Director: Jeryl Hilleman</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48448</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48448</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NOVOCURE LIMITED</inf:issuerName><inf:cusip>G6674U108</inf:cusip><inf:isin>JE00BYSS4X48</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Election of Director: David Hung</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48448</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48448</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NOVOCURE LIMITED</inf:issuerName><inf:cusip>G6674U108</inf:cusip><inf:isin>JE00BYSS4X48</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Election of Director: Kinyip Gabriel Leung</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48448</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48448</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NOVOCURE LIMITED</inf:issuerName><inf:cusip>G6674U108</inf:cusip><inf:isin>JE00BYSS4X48</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Election of Director: Martin Madden</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48448</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48448</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NOVOCURE LIMITED</inf:issuerName><inf:cusip>G6674U108</inf:cusip><inf:isin>JE00BYSS4X48</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Election of Director: Allyson Ocean</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48448</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48448</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NOVOCURE LIMITED</inf:issuerName><inf:cusip>G6674U108</inf:cusip><inf:isin>JE00BYSS4X48</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Election of Director: Timothy Scannell</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48448</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48448</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NOVOCURE LIMITED</inf:issuerName><inf:cusip>G6674U108</inf:cusip><inf:isin>JE00BYSS4X48</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Election of Director: Kristin Stafford</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48448</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48448</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NOVOCURE LIMITED</inf:issuerName><inf:cusip>G6674U108</inf:cusip><inf:isin>JE00BYSS4X48</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Election of Director: William Vernon</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48448</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48448</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NOVOCURE LIMITED</inf:issuerName><inf:cusip>G6674U108</inf:cusip><inf:isin>JE00BYSS4X48</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>The approval and ratification of the appointment, by the Audit Committee of our Board of Directors, of Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, as the auditor and independent registered public accounting firm of the Company for the Company's fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48448</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48448</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NOVOCURE LIMITED</inf:issuerName><inf:cusip>G6674U108</inf:cusip><inf:isin>JE00BYSS4X48</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>A non-binding advisory vote to approve executive compensation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48448</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48448</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NOVOCURE LIMITED</inf:issuerName><inf:cusip>G6674U108</inf:cusip><inf:isin>JE00BYSS4X48</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>The approval of our 2025 Employee Share Purchase Plan.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48448</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48448</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NURIX THERAPEUTICS, INC.</inf:issuerName><inf:cusip>67080M103</inf:cusip><inf:isin>US67080M1036</inf:isin><inf:meetingDate>05/19/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Judith A. Reinsdorf</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>45062</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>45062</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NURIX THERAPEUTICS, INC.</inf:issuerName><inf:cusip>67080M103</inf:cusip><inf:isin>US67080M1036</inf:isin><inf:meetingDate>05/19/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Edward C. Saltzman</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>45062</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>45062</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NURIX THERAPEUTICS, INC.</inf:issuerName><inf:cusip>67080M103</inf:cusip><inf:isin>US67080M1036</inf:isin><inf:meetingDate>05/19/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Roy D. Baynes</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>45062</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>45062</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NURIX THERAPEUTICS, INC.</inf:issuerName><inf:cusip>67080M103</inf:cusip><inf:isin>US67080M1036</inf:isin><inf:meetingDate>05/19/2025</inf:meetingDate><inf:voteDescription>Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending November 30, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>45062</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>45062</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NURIX THERAPEUTICS, INC.</inf:issuerName><inf:cusip>67080M103</inf:cusip><inf:isin>US67080M1036</inf:isin><inf:meetingDate>05/19/2025</inf:meetingDate><inf:voteDescription>To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>45062</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>45062</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NUVALENT, INC.</inf:issuerName><inf:cusip>670703107</inf:cusip><inf:isin>US6707031075</inf:isin><inf:meetingDate>06/18/2025</inf:meetingDate><inf:voteDescription>Election of Class I Director: Grant Bogle</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28266</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28266</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NUVALENT, INC.</inf:issuerName><inf:cusip>670703107</inf:cusip><inf:isin>US6707031075</inf:isin><inf:meetingDate>06/18/2025</inf:meetingDate><inf:voteDescription>Election of Class I Director: James R. Porter, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28266</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28266</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NUVALENT, INC.</inf:issuerName><inf:cusip>670703107</inf:cusip><inf:isin>US6707031075</inf:isin><inf:meetingDate>06/18/2025</inf:meetingDate><inf:voteDescription>Election of Class I Director: Anna Protopapas</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28266</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28266</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NUVALENT, INC.</inf:issuerName><inf:cusip>670703107</inf:cusip><inf:isin>US6707031075</inf:isin><inf:meetingDate>06/18/2025</inf:meetingDate><inf:voteDescription>To approve, on an advisory basis, the compensation paid to our named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28266</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28266</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>NUVALENT, INC.</inf:issuerName><inf:cusip>670703107</inf:cusip><inf:isin>US6707031075</inf:isin><inf:meetingDate>06/18/2025</inf:meetingDate><inf:voteDescription>To ratify the appointment of KPMG LLP as Nuvalent, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28266</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28266</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ORCHESTRA BIOMED HOLDINGS, INC.</inf:issuerName><inf:cusip>68572M106</inf:cusip><inf:isin>US68572M1062</inf:isin><inf:meetingDate>06/24/2025</inf:meetingDate><inf:voteDescription>Election of Class II Director: Chris Cleary</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16476</inf:sharesVoted><inf:sharesOnLoan>1600</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16476</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ORCHESTRA BIOMED HOLDINGS, INC.</inf:issuerName><inf:cusip>68572M106</inf:cusip><inf:isin>US68572M1062</inf:isin><inf:meetingDate>06/24/2025</inf:meetingDate><inf:voteDescription>Election of Class II Director: Pamela Connealy</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16476</inf:sharesVoted><inf:sharesOnLoan>1600</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>WITHHOLD</inf:howVoted><inf:sharesVoted>16476</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ORCHESTRA BIOMED HOLDINGS, INC.</inf:issuerName><inf:cusip>68572M106</inf:cusip><inf:isin>US68572M1062</inf:isin><inf:meetingDate>06/24/2025</inf:meetingDate><inf:voteDescription>Election of Class II Director: David Pacitti</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16476</inf:sharesVoted><inf:sharesOnLoan>1600</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16476</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ORCHESTRA BIOMED HOLDINGS, INC.</inf:issuerName><inf:cusip>68572M106</inf:cusip><inf:isin>US68572M1062</inf:isin><inf:meetingDate>06/24/2025</inf:meetingDate><inf:voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>16476</inf:sharesVoted><inf:sharesOnLoan>1600</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>16476</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PENUMBRA, INC.</inf:issuerName><inf:cusip>70975L107</inf:cusip><inf:isin>US70975L1070</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Janet Leeds</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12105</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12105</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PENUMBRA, INC.</inf:issuerName><inf:cusip>70975L107</inf:cusip><inf:isin>US70975L1070</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Thomas Wilder</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12105</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>ABSTAIN</inf:howVoted><inf:sharesVoted>12105</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PENUMBRA, INC.</inf:issuerName><inf:cusip>70975L107</inf:cusip><inf:isin>US70975L1070</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Penumbra, Inc. for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12105</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12105</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PENUMBRA, INC.</inf:issuerName><inf:cusip>70975L107</inf:cusip><inf:isin>US70975L1070</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>To approve, on an advisory basis, the compensation of Penumbra, Inc.'s named executive officers as disclosed in the proxy statement.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12105</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12105</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PENUMBRA, INC.</inf:issuerName><inf:cusip>70975L107</inf:cusip><inf:isin>US70975L1070</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>To approve an amendment to Penumbra, Inc.'s Restated Certificate of Incorporation to phase in the declassification of Penumbra, Inc.'s Board of Directors.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12105</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12105</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PENUMBRA, INC.</inf:issuerName><inf:cusip>70975L107</inf:cusip><inf:isin>US70975L1070</inf:isin><inf:meetingDate>05/28/2025</inf:meetingDate><inf:voteDescription>To approve an amendment to Penumbra, Inc.'s Restated Certificate of Incorporation to eliminate the supermajority voting requirements.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12105</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12105</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PFIZER INC.</inf:issuerName><inf:cusip>717081103</inf:cusip><inf:isin>US7170811035</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Ronald E. Blaylock</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>219920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>219920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PFIZER INC.</inf:issuerName><inf:cusip>717081103</inf:cusip><inf:isin>US7170811035</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Albert Bourla</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>219920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>219920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PFIZER INC.</inf:issuerName><inf:cusip>717081103</inf:cusip><inf:isin>US7170811035</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Mortimer J. Buckley</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>219920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>219920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PFIZER INC.</inf:issuerName><inf:cusip>717081103</inf:cusip><inf:isin>US7170811035</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Susan Desmond-Hellmann</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>219920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>219920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PFIZER INC.</inf:issuerName><inf:cusip>717081103</inf:cusip><inf:isin>US7170811035</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Joseph J. Echevarria</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>219920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>219920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PFIZER INC.</inf:issuerName><inf:cusip>717081103</inf:cusip><inf:isin>US7170811035</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Scott Gottlieb</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>219920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>219920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PFIZER INC.</inf:issuerName><inf:cusip>717081103</inf:cusip><inf:isin>US7170811035</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Susan Hockfield</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>219920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>219920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PFIZER INC.</inf:issuerName><inf:cusip>717081103</inf:cusip><inf:isin>US7170811035</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Dan R. Littman</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>219920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>219920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PFIZER INC.</inf:issuerName><inf:cusip>717081103</inf:cusip><inf:isin>US7170811035</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Shantanu Narayen</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>219920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>219920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PFIZER INC.</inf:issuerName><inf:cusip>717081103</inf:cusip><inf:isin>US7170811035</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Suzanne Nora Johnson</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>219920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>219920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PFIZER INC.</inf:issuerName><inf:cusip>717081103</inf:cusip><inf:isin>US7170811035</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: James Quincey</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>219920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>219920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PFIZER INC.</inf:issuerName><inf:cusip>717081103</inf:cusip><inf:isin>US7170811035</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: James C. Smith</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>219920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>219920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PFIZER INC.</inf:issuerName><inf:cusip>717081103</inf:cusip><inf:isin>US7170811035</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Election of Director: Cyrus Taraporevala</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>219920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>219920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PFIZER INC.</inf:issuerName><inf:cusip>717081103</inf:cusip><inf:isin>US7170811035</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Ratify the selection of KPMG LLP as independent registered public accounting firm for 2025</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>219920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>219920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PFIZER INC.</inf:issuerName><inf:cusip>717081103</inf:cusip><inf:isin>US7170811035</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>2025 advisory approval of executive compensation</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>219920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>219920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PFIZER INC.</inf:issuerName><inf:cusip>717081103</inf:cusip><inf:isin>US7170811035</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Shareholder Vote Regarding Golden Parachutes</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>219920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>219920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PFIZER INC.</inf:issuerName><inf:cusip>717081103</inf:cusip><inf:isin>US7170811035</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>Issue a Report Evaluating the Risks Related to Religious Discrimination Against Employees</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIVERSITY, EQUITY, AND INCLUSION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>219920</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>219920</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PROTAGONIST THERAPEUTICS, INC.</inf:issuerName><inf:cusip>74366E102</inf:cusip><inf:isin>US74366E1029</inf:isin><inf:meetingDate>06/20/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Harold E. Selick, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>19831</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>ABSTAIN</inf:howVoted><inf:sharesVoted>19831</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PROTAGONIST THERAPEUTICS, INC.</inf:issuerName><inf:cusip>74366E102</inf:cusip><inf:isin>US74366E1029</inf:isin><inf:meetingDate>06/20/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Bryan Giraudo</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>19831</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>ABSTAIN</inf:howVoted><inf:sharesVoted>19831</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PROTAGONIST THERAPEUTICS, INC.</inf:issuerName><inf:cusip>74366E102</inf:cusip><inf:isin>US74366E1029</inf:isin><inf:meetingDate>06/20/2025</inf:meetingDate><inf:voteDescription>To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>19831</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>19831</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PROTAGONIST THERAPEUTICS, INC.</inf:issuerName><inf:cusip>74366E102</inf:cusip><inf:isin>US74366E1029</inf:isin><inf:meetingDate>06/20/2025</inf:meetingDate><inf:voteDescription>To ratify the selection of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>19831</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>19831</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PTC THERAPEUTICS, INC.</inf:issuerName><inf:cusip>69366J200</inf:cusip><inf:isin>US69366J2006</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Allan Jacobson, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>19817</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>19817</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PTC THERAPEUTICS, INC.</inf:issuerName><inf:cusip>69366J200</inf:cusip><inf:isin>US69366J2006</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: David P. Southwell</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>19817</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>19817</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PTC THERAPEUTICS, INC.</inf:issuerName><inf:cusip>69366J200</inf:cusip><inf:isin>US69366J2006</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Alethia Young</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>19817</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>19817</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PTC THERAPEUTICS, INC.</inf:issuerName><inf:cusip>69366J200</inf:cusip><inf:isin>US69366J2006</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>19817</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>19817</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>PTC THERAPEUTICS, INC.</inf:issuerName><inf:cusip>69366J200</inf:cusip><inf:isin>US69366J2006</inf:isin><inf:meetingDate>06/17/2025</inf:meetingDate><inf:voteDescription>Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>19817</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>19817</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>QUEST DIAGNOSTICS INCORPORATED</inf:issuerName><inf:cusip>74834L100</inf:cusip><inf:isin>US74834L1008</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Robert B. Carter</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11479</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11479</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>QUEST DIAGNOSTICS INCORPORATED</inf:issuerName><inf:cusip>74834L100</inf:cusip><inf:isin>US74834L1008</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: James E. Davis</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11479</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11479</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>QUEST DIAGNOSTICS INCORPORATED</inf:issuerName><inf:cusip>74834L100</inf:cusip><inf:isin>US74834L1008</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Luis A. Diaz, Jr., M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11479</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11479</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>QUEST DIAGNOSTICS INCORPORATED</inf:issuerName><inf:cusip>74834L100</inf:cusip><inf:isin>US74834L1008</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Tracey C. Doi</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11479</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11479</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>QUEST DIAGNOSTICS INCORPORATED</inf:issuerName><inf:cusip>74834L100</inf:cusip><inf:isin>US74834L1008</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Vicky B. Gregg</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11479</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11479</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>QUEST DIAGNOSTICS INCORPORATED</inf:issuerName><inf:cusip>74834L100</inf:cusip><inf:isin>US74834L1008</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Wright L. Lassiter, III</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11479</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11479</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>QUEST DIAGNOSTICS INCORPORATED</inf:issuerName><inf:cusip>74834L100</inf:cusip><inf:isin>US74834L1008</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Timothy L. Main</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11479</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11479</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>QUEST DIAGNOSTICS INCORPORATED</inf:issuerName><inf:cusip>74834L100</inf:cusip><inf:isin>US74834L1008</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Denise M. Morrison</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11479</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11479</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>QUEST DIAGNOSTICS INCORPORATED</inf:issuerName><inf:cusip>74834L100</inf:cusip><inf:isin>US74834L1008</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Gary M. Pfeiffer</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11479</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11479</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>QUEST DIAGNOSTICS INCORPORATED</inf:issuerName><inf:cusip>74834L100</inf:cusip><inf:isin>US74834L1008</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Timothy M. Ring</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11479</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11479</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>QUEST DIAGNOSTICS INCORPORATED</inf:issuerName><inf:cusip>74834L100</inf:cusip><inf:isin>US74834L1008</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>An advisory resolution to approve the executive officer compensation disclosed in the Company's 2025 proxy statement</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11479</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11479</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>QUEST DIAGNOSTICS INCORPORATED</inf:issuerName><inf:cusip>74834L100</inf:cusip><inf:isin>US74834L1008</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Ratification of the appointment of our independent registered public accounting firm for 2025</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>11479</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>11479</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>QUEST DIAGNOSTICS INCORPORATED</inf:issuerName><inf:cusip>74834L100</inf:cusip><inf:isin>US74834L1008</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Stockholder proposal, as described in the accompanying proxy statement, if properly presented at the Annual Meeting</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>11479</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>11479</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REGENERON PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>75886F107</inf:cusip><inf:isin>US75886F1075</inf:isin><inf:meetingDate>06/13/2025</inf:meetingDate><inf:voteDescription>Election of Director: Bonnie L. Bassler, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10842</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10842</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REGENERON PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>75886F107</inf:cusip><inf:isin>US75886F1075</inf:isin><inf:meetingDate>06/13/2025</inf:meetingDate><inf:voteDescription>Election of Director: Michael S. Brown, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10842</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10842</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REGENERON PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>75886F107</inf:cusip><inf:isin>US75886F1075</inf:isin><inf:meetingDate>06/13/2025</inf:meetingDate><inf:voteDescription>Election of Director: Leonard S. Schleifer, M.D., Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10842</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10842</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REGENERON PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>75886F107</inf:cusip><inf:isin>US75886F1075</inf:isin><inf:meetingDate>06/13/2025</inf:meetingDate><inf:voteDescription>Election of Director: George D. Yancopoulos, M.D., Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10842</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10842</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REGENERON PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>75886F107</inf:cusip><inf:isin>US75886F1075</inf:isin><inf:meetingDate>06/13/2025</inf:meetingDate><inf:voteDescription>Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10842</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10842</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REGENERON PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>75886F107</inf:cusip><inf:isin>US75886F1075</inf:isin><inf:meetingDate>06/13/2025</inf:meetingDate><inf:voteDescription>Proposal to approve, on an advisory basis, executive compensation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10842</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10842</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REGENERON PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>75886F107</inf:cusip><inf:isin>US75886F1075</inf:isin><inf:meetingDate>06/13/2025</inf:meetingDate><inf:voteDescription>Proposal to approve an amendment to the Company's Certificate of Incorporation to declassify the board of directors.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10842</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10842</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REGENERON PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>75886F107</inf:cusip><inf:isin>US75886F1075</inf:isin><inf:meetingDate>06/13/2025</inf:meetingDate><inf:voteDescription>Proposal to approve an amendment to Article IV, Section 2(e)(8) of the Certificate of Incorporation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10842</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10842</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REGENERON PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>75886F107</inf:cusip><inf:isin>US75886F1075</inf:isin><inf:meetingDate>06/13/2025</inf:meetingDate><inf:voteDescription>Proposal to approve an amendment to Article VI of the Certificate of Incorporation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10842</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10842</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REGENXBIO INC.</inf:issuerName><inf:cusip>75901B107</inf:cusip><inf:isin>US75901B1070</inf:isin><inf:meetingDate>05/30/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Allan Fox</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>18875</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>18875</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REGENXBIO INC.</inf:issuerName><inf:cusip>75901B107</inf:cusip><inf:isin>US75901B1070</inf:isin><inf:meetingDate>05/30/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Alexandra G. Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>18875</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>18875</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REGENXBIO INC.</inf:issuerName><inf:cusip>75901B107</inf:cusip><inf:isin>US75901B1070</inf:isin><inf:meetingDate>05/30/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Curran Simpson</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>18875</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>18875</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REGENXBIO INC.</inf:issuerName><inf:cusip>75901B107</inf:cusip><inf:isin>US75901B1070</inf:isin><inf:meetingDate>05/30/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Jennifer Zachary</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>18875</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>18875</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REGENXBIO INC.</inf:issuerName><inf:cusip>75901B107</inf:cusip><inf:isin>US75901B1070</inf:isin><inf:meetingDate>05/30/2025</inf:meetingDate><inf:voteDescription>To ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the Company's independent registered public accounting firm for the year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>18875</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>18875</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REGENXBIO INC.</inf:issuerName><inf:cusip>75901B107</inf:cusip><inf:isin>US75901B1070</inf:isin><inf:meetingDate>05/30/2025</inf:meetingDate><inf:voteDescription>Advisory vote on the compensation paid to the Company's named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>18875</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>18875</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REGENXBIO INC.</inf:issuerName><inf:cusip>75901B107</inf:cusip><inf:isin>US75901B1070</inf:isin><inf:meetingDate>05/30/2025</inf:meetingDate><inf:voteDescription>Advisory vote on the frequency of future stockholder advisory votes on the compensation paid to the Company's named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>18875</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>1 YEAR</inf:howVoted><inf:sharesVoted>18875</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REGENXBIO INC.</inf:issuerName><inf:cusip>75901B107</inf:cusip><inf:isin>US75901B1070</inf:isin><inf:meetingDate>05/30/2025</inf:meetingDate><inf:voteDescription>To approve the REGENXBIO Inc. 2025 Equity Incentive Plan.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>18875</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>18875</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REPLIGEN CORPORATION</inf:issuerName><inf:cusip>759916109</inf:cusip><inf:isin>US7599161095</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Olivier Loeillot</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12836</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12836</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REPLIGEN CORPORATION</inf:issuerName><inf:cusip>759916109</inf:cusip><inf:isin>US7599161095</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Tony J. Hunt</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12836</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12836</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REPLIGEN CORPORATION</inf:issuerName><inf:cusip>759916109</inf:cusip><inf:isin>US7599161095</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Karen A. Dawes</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12836</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12836</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REPLIGEN CORPORATION</inf:issuerName><inf:cusip>759916109</inf:cusip><inf:isin>US7599161095</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Nicolas M. Barthelemy</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12836</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12836</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REPLIGEN CORPORATION</inf:issuerName><inf:cusip>759916109</inf:cusip><inf:isin>US7599161095</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Carrie Eglinton Manner</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12836</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12836</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REPLIGEN CORPORATION</inf:issuerName><inf:cusip>759916109</inf:cusip><inf:isin>US7599161095</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Konstantin Konstantinov, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12836</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12836</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REPLIGEN CORPORATION</inf:issuerName><inf:cusip>759916109</inf:cusip><inf:isin>US7599161095</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Martin D. Madaus, D.V.M., Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12836</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12836</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REPLIGEN CORPORATION</inf:issuerName><inf:cusip>759916109</inf:cusip><inf:isin>US7599161095</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Rohin Mhatre, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12836</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12836</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REPLIGEN CORPORATION</inf:issuerName><inf:cusip>759916109</inf:cusip><inf:isin>US7599161095</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Glenn P. Muir</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12836</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12836</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REPLIGEN CORPORATION</inf:issuerName><inf:cusip>759916109</inf:cusip><inf:isin>US7599161095</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Election of Director: Margaret A. Pax</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12836</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12836</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REPLIGEN CORPORATION</inf:issuerName><inf:cusip>759916109</inf:cusip><inf:isin>US7599161095</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Ratification of the selection of Ernst &amp; Young LLP as Repligen Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12836</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12836</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REPLIGEN CORPORATION</inf:issuerName><inf:cusip>759916109</inf:cusip><inf:isin>US7599161095</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12836</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12836</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>REPLIGEN CORPORATION</inf:issuerName><inf:cusip>759916109</inf:cusip><inf:isin>US7599161095</inf:isin><inf:meetingDate>05/15/2025</inf:meetingDate><inf:voteDescription>Approval of an amendment to the Corporation's certificate of incorporation to limit the liability of certain officers of the company as permitted by Delaware law.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>12836</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>12836</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>RHYTHM PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>76243J105</inf:cusip><inf:isin>US76243J1051</inf:isin><inf:meetingDate>09/18/2024</inf:meetingDate><inf:voteDescription>DIRECTOR: Stuart A. Arbuckle</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>49466</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>49466</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>RHYTHM PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>76243J105</inf:cusip><inf:isin>US76243J1051</inf:isin><inf:meetingDate>09/18/2024</inf:meetingDate><inf:voteDescription>DIRECTOR: Christophe R. Jean</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>49466</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>49466</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>RHYTHM PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>76243J105</inf:cusip><inf:isin>US76243J1051</inf:isin><inf:meetingDate>09/18/2024</inf:meetingDate><inf:voteDescription>DIRECTOR: Lynn A. Tetrault</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>49466</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>49466</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>RHYTHM PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>76243J105</inf:cusip><inf:isin>US76243J1051</inf:isin><inf:meetingDate>09/18/2024</inf:meetingDate><inf:voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2024.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>49466</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>49466</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>RHYTHM PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>76243J105</inf:cusip><inf:isin>US76243J1051</inf:isin><inf:meetingDate>09/18/2024</inf:meetingDate><inf:voteDescription>Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>49466</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>49466</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>RHYTHM PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>76243J105</inf:cusip><inf:isin>US76243J1051</inf:isin><inf:meetingDate>09/18/2024</inf:meetingDate><inf:voteDescription>Reapproval of the Rhythm Pharmaceuticals, Inc. 2017 Equity Incentive Plan.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>49466</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>49466</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>RHYTHM PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>76243J105</inf:cusip><inf:isin>US76243J1051</inf:isin><inf:meetingDate>06/24/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Jennifer Good</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>49466</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>49466</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>RHYTHM PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>76243J105</inf:cusip><inf:isin>US76243J1051</inf:isin><inf:meetingDate>06/24/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Edward T. Mathers</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>49466</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>ABSTAIN</inf:howVoted><inf:sharesVoted>49466</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>RHYTHM PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>76243J105</inf:cusip><inf:isin>US76243J1051</inf:isin><inf:meetingDate>06/24/2025</inf:meetingDate><inf:voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>49466</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>49466</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>RHYTHM PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>76243J105</inf:cusip><inf:isin>US76243J1051</inf:isin><inf:meetingDate>06/24/2025</inf:meetingDate><inf:voteDescription>Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>49466</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>49466</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>RHYTHM PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>76243J105</inf:cusip><inf:isin>US76243J1051</inf:isin><inf:meetingDate>06/24/2025</inf:meetingDate><inf:voteDescription>Approval of an amendment to our Amended and Restated Certificate of Incorporation to provide for exculpation of officers from breaches of fiduciary duty to the fullest extent permitted by the General Corporation Law of the State of Delaware (the "Officer Exculpation Proposal").</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>49466</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>49466</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>RHYTHM PHARMACEUTICALS, INC.</inf:issuerName><inf:cusip>76243J105</inf:cusip><inf:isin>US76243J1051</inf:isin><inf:meetingDate>06/24/2025</inf:meetingDate><inf:voteDescription>Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve the Officer Exculpation Amendment.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>49466</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>49466</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ROIVANT SCIENCES LTD</inf:issuerName><inf:cusip>G76279101</inf:cusip><inf:isin>BMG762791017</inf:isin><inf:meetingDate>09/10/2024</inf:meetingDate><inf:voteDescription>DIRECTOR: Ilan Oren</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>57525</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>ABSTAIN</inf:howVoted><inf:sharesVoted>57525</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ROIVANT SCIENCES LTD</inf:issuerName><inf:cusip>G76279101</inf:cusip><inf:isin>BMG762791017</inf:isin><inf:meetingDate>09/10/2024</inf:meetingDate><inf:voteDescription>DIRECTOR: James C. Momtazee</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>57525</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>57525</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ROIVANT SCIENCES LTD</inf:issuerName><inf:cusip>G76279101</inf:cusip><inf:isin>BMG762791017</inf:isin><inf:meetingDate>09/10/2024</inf:meetingDate><inf:voteDescription>DIRECTOR: Mayukh Sukhatme</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>57525</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>57525</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ROIVANT SCIENCES LTD</inf:issuerName><inf:cusip>G76279101</inf:cusip><inf:isin>BMG762791017</inf:isin><inf:meetingDate>09/10/2024</inf:meetingDate><inf:voteDescription>To ratify the selection by the Audit Committee of the Board of Directors of Ernst &amp; Young LLP as Roivant's independent registered public accounting firm for Roivant's fiscal year ending March 31, 2025, to appoint Ernst &amp; Young LLP as auditor for statutory purposes under the Bermuda Companies Act 1981, as amended, for Roivant's fiscal year ending March 31, 2025, and to authorize the Board of Directors, through the Audit Committee, to set the remuneration for Ernst &amp; Young LLP as Roivant's auditor for Roivant's fiscal year ending March 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>57525</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>57525</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ROIVANT SCIENCES LTD</inf:issuerName><inf:cusip>G76279101</inf:cusip><inf:isin>BMG762791017</inf:isin><inf:meetingDate>09/10/2024</inf:meetingDate><inf:voteDescription>To cast a non-binding, advisory vote to approve the compensation of our named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>57525</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>57525</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ROIVANT SCIENCES LTD</inf:issuerName><inf:cusip>G76279101</inf:cusip><inf:isin>BMG762791017</inf:isin><inf:meetingDate>09/10/2024</inf:meetingDate><inf:voteDescription>To cast a non-binding, advisory vote on the frequency of future non-binding, advisory votes to approve the compensation of our named executive officers every.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>57525</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>1 YEAR</inf:howVoted><inf:sharesVoted>57525</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>FOR SHAREHOLDERS NOT HOLDING SHARES DIRECTLY WITH A FRENCH CUSTODIAN, VOTING INSTRUCTIONS WILL BE FORWARDED TO YOUR GLOBAL CUSTODIAN ON VOTE DEADLINE DATE. THE GLOBAL CUSTODIAN AS THE REGISTERED INTERMEDIARY WILL SIGN THE PROXY CARD AND FORWARD TO THE LOCAL CUSTODIAN FOR LODGMENT.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>18 MAR 2025: FOR FRENCH MEETINGS 'ABSTAIN' IS A VALID VOTING OPTION. FOR ANY ADDITIONAL RESOLUTIONS RAISED AT THE MEETING THE VOTING INSTRUCTION WILL DEFAULT TO 'AGAINST.' IF YOUR CUSTODIAN IS COMPLETING THE PROXY CARD, THE VOTING INSTRUCTION WILL DEFAULT TO THE PREFERENCE OF YOUR CUSTODIAN AND PLEASE NOTE THAT IF YOU HOLD CREST DEPOSITORY INTERESTS (CDIS) AND PARTICIPATE AT THIS MEETING, YOU (OR YOUR CREST SPONSORED MEMBER/CUSTODIAN) WILL BE REQUIRED TO INSTRUCT A TRANSFER OF THE RELEVANT CDIS TO THE ESCROW ACCOUNT SPECIFIED IN THE ASSOCIATED CORPORATE EVENT IN THE CREST SYSTEM. THIS TRANSFER WILL NEED TO BE COMPLETED BY THE SPECIFIED CREST SYSTEM DEADLINE. ONCE THIS TRANSFER HAS SETTLED, THE CDIS WILL BE BLOCKED IN THE CREST SYSTEM. THE CDIS WILL TYPICALLY BE RELEASED FROM ESCROW AS SOON AS PRACTICABLE ON RECORD DATE +1 DAY (OR ON MEETING DATE +1 DAY IF NO RECORD DATE APPLIES) UNLESS OTHERWISE SPECIFIED, AND ONLY AFTER THE AGENT HAS CONFIRMED AVAILABILITY OF THE POSITION. IN ORDER FOR A VOTE TO BE ACCEPTED, THE VOTED POSITION MUST BE BLOCKED IN THE REQUIRED ESCROW ACCOUNT IN THE CREST SYSTEM. BY VOTING ON THIS MEETING, YOUR CREST SPONSORED MEMBER/CUSTODIAN MAY USE YOUR VOTE INSTRUCTION AS THE AUTHORIZATION TO TAKE THE NECESSARY ACTION WHICH WILL INCLUDE TRANSFERRING YOUR INSTRUCTED POSITION TO ESCROW. PLEASE CONTACT YOUR CREST SPONSORED MEMBER/CUSTODIAN DIRECTLY FOR FURTHER INFORMATION ON THE CUSTODY PROCESS AND WHETHER OR NOT THEY REQUIRE SEPARATE INSTRUCTIONS FROM YOU</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>18 MAR 2025: VOTING MUST BE LODGED WITH SHAREHOLDER DETAILS AS PROVIDED BY YOUR CUSTODIAN BANK. IF NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTIONS MAY BE REJECTED AND PLEASE NOTE SHARE BLOCKING WILL APPLY FOR ANY VOTED POSITIONS SETTLING THROUGH EUROCLEAR BANK</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>24 MAR 2025: FOR SHAREHOLDERS HOLDING SHARES DIRECTLY REGISTERED IN THEIR OWN NAME ON THE COMPANY SHARE REGISTER, YOU SHOULD RECEIVE A PROXY CARD/VOTING FORM DIRECTLY FROM THE ISSUER. PLEASE SUBMIT YOUR VOTE DIRECTLY BACK TO THE ISSUER VIA THE PROXY CARD/VOTING FORM, DO NOT SUBMIT YOUR VOTE VIA BROADRIDGE SYSTEMS/PLATFORMS OR YOUR INSTRUCTIONS MAY BE REJECTED. PLEASE NOTE THAT THIS IS A REVISION DUE TO ADDITION OF COMMENTS AND RECEIPT OF UPDATED BALO LINK. IF YOU HAVE ALREADY SENT IN YOUR VOTES, PLEASE DO NOT VOTE AGAIN UNLESS YOU DECIDE TO AMEND YOUR ORIGINAL INSTRUCTIONS. THANK YOU</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>APPROVE FINANCIAL STATEMENTS AND STATUTORY REPORTS</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>APPROVE CONSOLIDATED FINANCIAL STATEMENTS AND STATUTORY REPORTS</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>APPROVE ALLOCATION OF INCOME AND DIVIDENDS OF EUR 3.92 PER SHARE</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>APPROVE TRANSACTION WITH L'OREAL RE: SHARE REPURCHASE AGREEMENT</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>EXTRAORDINARY TRANSACTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>RATIFY APPOINTMENT OF JEAN-PAUL KRESS AS DIRECTOR</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>REELECT CAROLE FERRAND AS DIRECTOR</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>REELECT BARBARA LAVERNOS AS DIRECTOR</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>REELECT EMILE VOEST AS DIRECTOR</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>REELECT ANTOINE YVER AS DIRECTOR</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>APPROVE COMPENSATION REPORT OF CORPORATE OFFICERS</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>APPROVE COMPENSATION OF FREDERIC OUDEA, CHAIRMAN OF THE BOARD</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>APPROVE COMPENSATION OF PAUL HUDSON, CEO</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>APPROVE REMUNERATION POLICY OF DIRECTORS</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>APPROVE REMUNERATION POLICY OF CHAIRMAN OF THE BOARD</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>APPROVE REMUNERATION POLICY OF CEO</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>AUTHORIZE REPURCHASE OF UP TO 10 PERCENT OF ISSUED SHARE CAPITAL</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>AUTHORIZE DECREASE IN SHARE CAPITAL VIA CANCELLATION OF REPURCHASED SHARES</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>AUTHORIZE ISSUANCE OF EQUITY OR EQUITY-LINKED SECURITIES WITH PREEMPTIVE RIGHTS (RIGHTS ISSUE) UP TO AGGREGATE NOMINAL AMOUNT OF EUR 997 MILLION</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>AUTHORIZE ISSUANCE OF EQUITY OR EQUITY-LINKED SECURITIES WITHOUT PREEMPTIVE RIGHTS UP TO AGGREGATE NOMINAL AMOUNT OF EUR 240 MILLION</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>APPROVE ISSUANCE OF EQUITY OR EQUITY-LINKED SECURITIES FOR PRIVATE PLACEMENTS, UP TO AGGREGATE NOMINAL AMOUNT OF EUR 240 MILLION</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>APPROVE ISSUANCE OF DEBT SECURITIES GIVING ACCESS TO NEW SHARES OF SUBSIDIARIES AND/OR DEBT SECURITIES, UP TO AGGREGATE AMOUNT OF EUR 7 BILLION</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>AUTHORIZE BOARD TO INCREASE CAPITAL IN THE EVENT OF ADDITIONAL DEMAND RELATED TO DELEGATION SUBMITTED TO SHAREHOLDER VOTE UNDER ITEMS 18, 19, AND 20</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>AUTHORIZE CAPITAL INCREASE OF UP TO 10 PERCENT OF ISSUED CAPITAL FOR CONTRIBUTIONS IN KIND</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>EXTRAORDINARY TRANSACTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>AUTHORIZE CAPITALIZATION OF RESERVES OF UP TO EUR 500 MILLION FOR BONUS ISSUE OR INCREASE IN PAR VALUE</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>AUTHORIZE CAPITAL ISSUANCES FOR USE IN EMPLOYEE STOCK PURCHASE PLANS</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>AUTHORIZE CAPITAL ISSUANCES FOR USE IN EMPLOYEE STOCK PURCHASE PLANS RESERVED FOR EMPLOYEES AND CORPORATE OFFICERS OF INTERNATIONAL SUBSIDIARIES</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>AMEND ARTICLES 3 AND 13 OF BYLAWS</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>AUTHORIZE FILING OF REQUIRED DOCUMENTS/OTHER FORMALITIES</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24768</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>24 MAR 2025: PLEASE NOTE THAT IMPORTANT ADDITIONAL MEETING INFORMATION IS AVAILABLE BY CLICKING ON THE MATERIAL URL LINK: https://www.journal-officiel.gouv.fr/telechargements/BALO/pdf/2025/0314/202503142500650.pdf</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>17 MAR 2025: INTERMEDIARY CLIENTS ONLY - PLEASE NOTE THAT IF YOU ARE CLASSIFIED AS AN INTERMEDIARY CLIENT UNDER THE SHAREHOLDER RIGHTS DIRECTIVE II, YOU SHOULD BE PROVIDING THE UNDERLYING SHAREHOLDER INFORMATION AT THE VOTE INSTRUCTION LEVEL. IF YOU ARE UNSURE ON HOW TO PROVIDE THIS LEVEL OF DATA TO BROADRIDGE OUTSIDE OF PROXYEDGE, PLEASE SPEAK TO YOUR DEDICATED CLIENT SERVICE REPRESENTATIVE FOR ASSISTANCE</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SANOFI SA</inf:issuerName><inf:cusip>F5548N101</inf:cusip><inf:isin>FR0000120578</inf:isin><inf:meetingDate>04/30/2025</inf:meetingDate><inf:voteDescription>17 MAR 2025: DELETION OF THE COMMENT</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24768</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SCHOLAR ROCK HOLDING CORPORATION</inf:issuerName><inf:cusip>80706P103</inf:cusip><inf:isin>US80706P1030</inf:isin><inf:meetingDate>05/22/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: S. Akkaraju, M.D, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17280</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>17280</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SCHOLAR ROCK HOLDING CORPORATION</inf:issuerName><inf:cusip>80706P103</inf:cusip><inf:isin>US80706P1030</inf:isin><inf:meetingDate>05/22/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Director withdrawn</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17280</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>ABSTAIN</inf:howVoted><inf:sharesVoted>17280</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SCHOLAR ROCK HOLDING CORPORATION</inf:issuerName><inf:cusip>80706P103</inf:cusip><inf:isin>US80706P1030</inf:isin><inf:meetingDate>05/22/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Joshua Reed</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17280</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>ABSTAIN</inf:howVoted><inf:sharesVoted>17280</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SCHOLAR ROCK HOLDING CORPORATION</inf:issuerName><inf:cusip>80706P103</inf:cusip><inf:isin>US80706P1030</inf:isin><inf:meetingDate>05/22/2025</inf:meetingDate><inf:voteDescription>This proposal has been withdrawn.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17280</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>ABSTAIN</inf:howVoted><inf:sharesVoted>17280</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SCHOLAR ROCK HOLDING CORPORATION</inf:issuerName><inf:cusip>80706P103</inf:cusip><inf:isin>US80706P1030</inf:isin><inf:meetingDate>05/22/2025</inf:meetingDate><inf:voteDescription>To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17280</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>17280</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STERIS PLC</inf:issuerName><inf:cusip>G8473T100</inf:cusip><inf:isin>IE00BFY8C754</inf:isin><inf:meetingDate>08/01/2024</inf:meetingDate><inf:voteDescription>Re-election of Director: Dr. Esther M. Alegria</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>9642</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>9642</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STERIS PLC</inf:issuerName><inf:cusip>G8473T100</inf:cusip><inf:isin>IE00BFY8C754</inf:isin><inf:meetingDate>08/01/2024</inf:meetingDate><inf:voteDescription>Re-election of Director: Richard C. Breeden</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>9642</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>9642</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STERIS PLC</inf:issuerName><inf:cusip>G8473T100</inf:cusip><inf:isin>IE00BFY8C754</inf:isin><inf:meetingDate>08/01/2024</inf:meetingDate><inf:voteDescription>Re-election of Director: Daniel A. Carestio</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>9642</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>9642</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STERIS PLC</inf:issuerName><inf:cusip>G8473T100</inf:cusip><inf:isin>IE00BFY8C754</inf:isin><inf:meetingDate>08/01/2024</inf:meetingDate><inf:voteDescription>Re-election of Director: Cynthia L. Feldmann</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>9642</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>9642</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STERIS PLC</inf:issuerName><inf:cusip>G8473T100</inf:cusip><inf:isin>IE00BFY8C754</inf:isin><inf:meetingDate>08/01/2024</inf:meetingDate><inf:voteDescription>Re-election of Director: Christopher S. Holland</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>9642</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>9642</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STERIS PLC</inf:issuerName><inf:cusip>G8473T100</inf:cusip><inf:isin>IE00BFY8C754</inf:isin><inf:meetingDate>08/01/2024</inf:meetingDate><inf:voteDescription>Re-election of Director: Dr. Jacqueline B. Kosecoff</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>9642</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>9642</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STERIS PLC</inf:issuerName><inf:cusip>G8473T100</inf:cusip><inf:isin>IE00BFY8C754</inf:isin><inf:meetingDate>08/01/2024</inf:meetingDate><inf:voteDescription>Re-election of Director: Paul E. Martin</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>9642</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>9642</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STERIS PLC</inf:issuerName><inf:cusip>G8473T100</inf:cusip><inf:isin>IE00BFY8C754</inf:isin><inf:meetingDate>08/01/2024</inf:meetingDate><inf:voteDescription>Re-election of Director: Dr. Nirav R. Shah</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>9642</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>9642</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STERIS PLC</inf:issuerName><inf:cusip>G8473T100</inf:cusip><inf:isin>IE00BFY8C754</inf:isin><inf:meetingDate>08/01/2024</inf:meetingDate><inf:voteDescription>Re-election of Director: Dr. Mohsen M. Sohi</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>9642</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>9642</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STERIS PLC</inf:issuerName><inf:cusip>G8473T100</inf:cusip><inf:isin>IE00BFY8C754</inf:isin><inf:meetingDate>08/01/2024</inf:meetingDate><inf:voteDescription>Re-election of Director: Dr. Richard M. Steeves</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>9642</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>9642</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STERIS PLC</inf:issuerName><inf:cusip>G8473T100</inf:cusip><inf:isin>IE00BFY8C754</inf:isin><inf:meetingDate>08/01/2024</inf:meetingDate><inf:voteDescription>To ratify the appointment of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for the year ending March 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>9642</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>9642</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STERIS PLC</inf:issuerName><inf:cusip>G8473T100</inf:cusip><inf:isin>IE00BFY8C754</inf:isin><inf:meetingDate>08/01/2024</inf:meetingDate><inf:voteDescription>To appoint Ernst &amp; Young Chartered Accountants as the Company's statutory auditor under Irish law to hold office until the conclusion of the Company's next annual general meeting.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>9642</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>9642</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STERIS PLC</inf:issuerName><inf:cusip>G8473T100</inf:cusip><inf:isin>IE00BFY8C754</inf:isin><inf:meetingDate>08/01/2024</inf:meetingDate><inf:voteDescription>To authorize the Board of Directors of the Company or the Audit Committee of the Board of Directors to determine the remuneration of Ernst &amp; Young Chartered Accountants as the Company's statutory auditor under Irish law.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>9642</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>9642</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STERIS PLC</inf:issuerName><inf:cusip>G8473T100</inf:cusip><inf:isin>IE00BFY8C754</inf:isin><inf:meetingDate>08/01/2024</inf:meetingDate><inf:voteDescription>To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed pursuant to the disclosure rules of the U.S. Securities and Exchange Commission, including the compensation discussion and analysis and the tabular and narrative disclosure contained in the Company's proxy statement dated June 12, 2024.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>9642</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>9642</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STERIS PLC</inf:issuerName><inf:cusip>G8473T100</inf:cusip><inf:isin>IE00BFY8C754</inf:isin><inf:meetingDate>08/01/2024</inf:meetingDate><inf:voteDescription>To approve a proposal renewing the Board of Director's authority to issue shares under Irish law.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>9642</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>9642</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STERIS PLC</inf:issuerName><inf:cusip>G8473T100</inf:cusip><inf:isin>IE00BFY8C754</inf:isin><inf:meetingDate>08/01/2024</inf:meetingDate><inf:voteDescription>To approve a proposal renewing the Board of Director's authority to opt-out of statutory pre-emption rights under Irish law.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>9642</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>9642</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STOKE THERAPEUTICS, INC.</inf:issuerName><inf:cusip>86150R107</inf:cusip><inf:isin>US86150R1077</inf:isin><inf:meetingDate>06/03/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Edward M. Kaye, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>70495</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>70495</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STOKE THERAPEUTICS, INC.</inf:issuerName><inf:cusip>86150R107</inf:cusip><inf:isin>US86150R1077</inf:isin><inf:meetingDate>06/03/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Seth L. Harrison, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>70495</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>70495</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STOKE THERAPEUTICS, INC.</inf:issuerName><inf:cusip>86150R107</inf:cusip><inf:isin>US86150R1077</inf:isin><inf:meetingDate>06/03/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: A. O. Tzianabos, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>70495</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>70495</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STOKE THERAPEUTICS, INC.</inf:issuerName><inf:cusip>86150R107</inf:cusip><inf:isin>US86150R1077</inf:isin><inf:meetingDate>06/03/2025</inf:meetingDate><inf:voteDescription>To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>70495</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>70495</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STOKE THERAPEUTICS, INC.</inf:issuerName><inf:cusip>86150R107</inf:cusip><inf:isin>US86150R1077</inf:isin><inf:meetingDate>06/03/2025</inf:meetingDate><inf:voteDescription>To approve, on an advisory basis, the compensation of the Company's named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>70495</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>70495</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STOKE THERAPEUTICS, INC.</inf:issuerName><inf:cusip>86150R107</inf:cusip><inf:isin>US86150R1077</inf:isin><inf:meetingDate>06/03/2025</inf:meetingDate><inf:voteDescription>To indicate, on an advisory basis, the preferred frequency of future stockholder advisory votes to approve the compensation of the Company's named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>70495</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>1 YEAR</inf:howVoted><inf:sharesVoted>70495</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STRUCTURE THERAPEUTICS, INC.</inf:issuerName><inf:cusip>86366E106</inf:cusip><inf:isin>US86366E1064</inf:isin><inf:meetingDate>06/23/2025</inf:meetingDate><inf:voteDescription>Election of Class II Director to hold office until the 2028 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Eric Dobmeier</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>14399</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>14399</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STRUCTURE THERAPEUTICS, INC.</inf:issuerName><inf:cusip>86366E106</inf:cusip><inf:isin>US86366E1064</inf:isin><inf:meetingDate>06/23/2025</inf:meetingDate><inf:voteDescription>Election of Class II Director to hold office until the 2028 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Joanne Waldstreicher, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>14399</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>14399</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STRUCTURE THERAPEUTICS, INC.</inf:issuerName><inf:cusip>86366E106</inf:cusip><inf:isin>US86366E1064</inf:isin><inf:meetingDate>06/23/2025</inf:meetingDate><inf:voteDescription>To ratify the appointment by the Audit Committee of the Board of Directors of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>14399</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>14399</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STRUCTURE THERAPEUTICS, INC.</inf:issuerName><inf:cusip>86366E106</inf:cusip><inf:isin>US86366E1064</inf:isin><inf:meetingDate>06/23/2025</inf:meetingDate><inf:voteDescription>TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>14399</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>14399</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STRUCTURE THERAPEUTICS, INC.</inf:issuerName><inf:cusip>86366E106</inf:cusip><inf:isin>US86366E1064</inf:isin><inf:meetingDate>06/23/2025</inf:meetingDate><inf:voteDescription>TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>14399</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>1 YEAR</inf:howVoted><inf:sharesVoted>14399</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STRYKER CORPORATION</inf:issuerName><inf:cusip>863667101</inf:cusip><inf:isin>US8636671013</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director: Mary K. Brainerd</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48820</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48820</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STRYKER CORPORATION</inf:issuerName><inf:cusip>863667101</inf:cusip><inf:isin>US8636671013</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director: Giovanni Caforio, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48820</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48820</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STRYKER CORPORATION</inf:issuerName><inf:cusip>863667101</inf:cusip><inf:isin>US8636671013</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director: Kevin A. Lobo (Chair of the Board, Chief Executive Officer and President)</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48820</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48820</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STRYKER CORPORATION</inf:issuerName><inf:cusip>863667101</inf:cusip><inf:isin>US8636671013</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director: Emmanuel P. Maceda</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48820</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48820</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STRYKER CORPORATION</inf:issuerName><inf:cusip>863667101</inf:cusip><inf:isin>US8636671013</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director: Sherilyn S. McCoy (Lead Independent Director)</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48820</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48820</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STRYKER CORPORATION</inf:issuerName><inf:cusip>863667101</inf:cusip><inf:isin>US8636671013</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director: Rachel M. Ruggeri</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48820</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48820</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STRYKER CORPORATION</inf:issuerName><inf:cusip>863667101</inf:cusip><inf:isin>US8636671013</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director: Andrew K. Silvernail</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48820</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48820</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STRYKER CORPORATION</inf:issuerName><inf:cusip>863667101</inf:cusip><inf:isin>US8636671013</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director: Lisa M. Skeete Tatum</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48820</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48820</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STRYKER CORPORATION</inf:issuerName><inf:cusip>863667101</inf:cusip><inf:isin>US8636671013</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director: Ronda E. Stryker</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48820</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48820</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STRYKER CORPORATION</inf:issuerName><inf:cusip>863667101</inf:cusip><inf:isin>US8636671013</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Election of Director: Rajeev Suri</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48820</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48820</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STRYKER CORPORATION</inf:issuerName><inf:cusip>863667101</inf:cusip><inf:isin>US8636671013</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Ratification of Appointment of Ernst &amp; Young LLP as Our Independent Registered Public Accounting Firm for 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48820</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48820</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STRYKER CORPORATION</inf:issuerName><inf:cusip>863667101</inf:cusip><inf:isin>US8636671013</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Approval of the 2011 Long-Term Incentive Plan, as Amended and Restated.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48820</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48820</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STRYKER CORPORATION</inf:issuerName><inf:cusip>863667101</inf:cusip><inf:isin>US8636671013</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Approval of the 2011 Performance Incentive Award Plan, as Amended and Restated.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48820</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48820</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STRYKER CORPORATION</inf:issuerName><inf:cusip>863667101</inf:cusip><inf:isin>US8636671013</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Approval of the 2008 Stock Purchase Plan, as Amended and Restated.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48820</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48820</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STRYKER CORPORATION</inf:issuerName><inf:cusip>863667101</inf:cusip><inf:isin>US8636671013</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Advisory Vote to Approve Named Executive Officer Compensation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>48820</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>48820</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>STRYKER CORPORATION</inf:issuerName><inf:cusip>863667101</inf:cusip><inf:isin>US8636671013</inf:isin><inf:meetingDate>05/08/2025</inf:meetingDate><inf:voteDescription>Shareholder Proposal to Support Transparency in Political Spending.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>48820</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>48820</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SUMMIT THERAPEUTICS INC.</inf:issuerName><inf:cusip>86627T108</inf:cusip><inf:isin>US86627T1088</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>Election of Director: Robert W. Duggan</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17225</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>17225</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SUMMIT THERAPEUTICS INC.</inf:issuerName><inf:cusip>86627T108</inf:cusip><inf:isin>US86627T1088</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>Election of Director: Mahkam Zanganeh</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17225</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>17225</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SUMMIT THERAPEUTICS INC.</inf:issuerName><inf:cusip>86627T108</inf:cusip><inf:isin>US86627T1088</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>Election of Director: Manmeet S. Soni</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17225</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>17225</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SUMMIT THERAPEUTICS INC.</inf:issuerName><inf:cusip>86627T108</inf:cusip><inf:isin>US86627T1088</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>Election of Director: Kenneth A. Clark</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17225</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>17225</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SUMMIT THERAPEUTICS INC.</inf:issuerName><inf:cusip>86627T108</inf:cusip><inf:isin>US86627T1088</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>Election of Director: Robert Booth</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17225</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>17225</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SUMMIT THERAPEUTICS INC.</inf:issuerName><inf:cusip>86627T108</inf:cusip><inf:isin>US86627T1088</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>Election of Director: Alessandra Cesano</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17225</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>17225</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SUMMIT THERAPEUTICS INC.</inf:issuerName><inf:cusip>86627T108</inf:cusip><inf:isin>US86627T1088</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>Election of Director: Yu (Michelle) Xia</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17225</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>17225</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SUMMIT THERAPEUTICS INC.</inf:issuerName><inf:cusip>86627T108</inf:cusip><inf:isin>US86627T1088</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>Election of Director: Mostafa Ronaghi</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17225</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>17225</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SUMMIT THERAPEUTICS INC.</inf:issuerName><inf:cusip>86627T108</inf:cusip><inf:isin>US86627T1088</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>Election of Director: Jeff Huber</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17225</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>17225</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SUMMIT THERAPEUTICS INC.</inf:issuerName><inf:cusip>86627T108</inf:cusip><inf:isin>US86627T1088</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>Ratification of the appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17225</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>17225</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>SUMMIT THERAPEUTICS INC.</inf:issuerName><inf:cusip>86627T108</inf:cusip><inf:isin>US86627T1088</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>Approval, by a non-binding advisory vote, of the compensation of our named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>17225</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>17225</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>TEVA PHARMACEUTICAL INDUSTRIES LIMITED</inf:issuerName><inf:cusip>881624209</inf:cusip><inf:isin>US8816242098</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve until Teva's 2027 Annual Meeting: Chen Lichtenstein</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>227585</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>227585</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>TEVA PHARMACEUTICAL INDUSTRIES LIMITED</inf:issuerName><inf:cusip>881624209</inf:cusip><inf:isin>US8816242098</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve until Teva's 2028 Annual Meeting: Amir Elstein</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>227585</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>227585</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>TEVA PHARMACEUTICAL INDUSTRIES LIMITED</inf:issuerName><inf:cusip>881624209</inf:cusip><inf:isin>US8816242098</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve until Teva's 2028 Annual Meeting: Roberto A. Mignone</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>227585</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>227585</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>TEVA PHARMACEUTICAL INDUSTRIES LIMITED</inf:issuerName><inf:cusip>881624209</inf:cusip><inf:isin>US8816242098</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve until Teva's 2028 Annual Meeting: Dr. Perry D. Nisen</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>227585</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>227585</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>TEVA PHARMACEUTICAL INDUSTRIES LIMITED</inf:issuerName><inf:cusip>881624209</inf:cusip><inf:isin>US8816242098</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>Election of Director to serve until Teva's 2028 Annual Meeting: Dr. Tal Zaks</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>227585</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>227585</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>TEVA PHARMACEUTICAL INDUSTRIES LIMITED</inf:issuerName><inf:cusip>881624209</inf:cusip><inf:isin>US8816242098</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>227585</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>227585</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>TEVA PHARMACEUTICAL INDUSTRIES LIMITED</inf:issuerName><inf:cusip>881624209</inf:cusip><inf:isin>US8816242098</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>To approve an amended compensation policy with respect to the terms of office and employment of Teva's executive officers and directors</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>227585</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>227585</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>TEVA PHARMACEUTICAL INDUSTRIES LIMITED</inf:issuerName><inf:cusip>881624209</inf:cusip><inf:isin>US8816242098</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>To approve an amendment to the terms of office and employment of Teva's president and chief executive officer</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>227585</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>227585</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>TEVA PHARMACEUTICAL INDUSTRIES LIMITED</inf:issuerName><inf:cusip>881624209</inf:cusip><inf:isin>US8816242098</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>To approve the compensation to be provided to Teva's non- employee directors</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>227585</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>227585</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>TEVA PHARMACEUTICAL INDUSTRIES LIMITED</inf:issuerName><inf:cusip>881624209</inf:cusip><inf:isin>US8816242098</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>To approve the compensation to be provided to Teva's non- executive chairman of the board</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>227585</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>227585</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>TEVA PHARMACEUTICAL INDUSTRIES LIMITED</inf:issuerName><inf:cusip>881624209</inf:cusip><inf:isin>US8816242098</inf:isin><inf:meetingDate>06/05/2025</inf:meetingDate><inf:voteDescription>To appoint, Kesselman &amp; Kesselman, a member of PriceWaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's 2026 annual meeting of shareholders.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>227585</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>227585</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE CIGNA GROUP</inf:issuerName><inf:cusip>125523100</inf:cusip><inf:isin>US1255231003</inf:isin><inf:meetingDate>04/23/2025</inf:meetingDate><inf:voteDescription>Election of Director: David M. Cordani</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10161</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10161</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE CIGNA GROUP</inf:issuerName><inf:cusip>125523100</inf:cusip><inf:isin>US1255231003</inf:isin><inf:meetingDate>04/23/2025</inf:meetingDate><inf:voteDescription>Election of Director: Eric J. Foss</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10161</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10161</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE CIGNA GROUP</inf:issuerName><inf:cusip>125523100</inf:cusip><inf:isin>US1255231003</inf:isin><inf:meetingDate>04/23/2025</inf:meetingDate><inf:voteDescription>Election of Director: Retired Maj. Gen. Elder Granger, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10161</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10161</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE CIGNA GROUP</inf:issuerName><inf:cusip>125523100</inf:cusip><inf:isin>US1255231003</inf:isin><inf:meetingDate>04/23/2025</inf:meetingDate><inf:voteDescription>Election of Director: Neesha Hathi</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10161</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10161</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE CIGNA GROUP</inf:issuerName><inf:cusip>125523100</inf:cusip><inf:isin>US1255231003</inf:isin><inf:meetingDate>04/23/2025</inf:meetingDate><inf:voteDescription>Election of Director: George Kurian</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10161</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10161</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE CIGNA GROUP</inf:issuerName><inf:cusip>125523100</inf:cusip><inf:isin>US1255231003</inf:isin><inf:meetingDate>04/23/2025</inf:meetingDate><inf:voteDescription>Election of Director: Kathleen M. Mazzarella</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10161</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10161</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE CIGNA GROUP</inf:issuerName><inf:cusip>125523100</inf:cusip><inf:isin>US1255231003</inf:isin><inf:meetingDate>04/23/2025</inf:meetingDate><inf:voteDescription>Election of Director: Mark B. McClellan, M.D., Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10161</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10161</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE CIGNA GROUP</inf:issuerName><inf:cusip>125523100</inf:cusip><inf:isin>US1255231003</inf:isin><inf:meetingDate>04/23/2025</inf:meetingDate><inf:voteDescription>Election of Director: Philip O. Ozuah, M.D., Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10161</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10161</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE CIGNA GROUP</inf:issuerName><inf:cusip>125523100</inf:cusip><inf:isin>US1255231003</inf:isin><inf:meetingDate>04/23/2025</inf:meetingDate><inf:voteDescription>Election of Director: Kimberly A. Ross</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10161</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10161</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE CIGNA GROUP</inf:issuerName><inf:cusip>125523100</inf:cusip><inf:isin>US1255231003</inf:isin><inf:meetingDate>04/23/2025</inf:meetingDate><inf:voteDescription>Election of Director: Eric C. Wiseman</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10161</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10161</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE CIGNA GROUP</inf:issuerName><inf:cusip>125523100</inf:cusip><inf:isin>US1255231003</inf:isin><inf:meetingDate>04/23/2025</inf:meetingDate><inf:voteDescription>Election of Director: Donna F. Zarcone</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10161</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10161</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE CIGNA GROUP</inf:issuerName><inf:cusip>125523100</inf:cusip><inf:isin>US1255231003</inf:isin><inf:meetingDate>04/23/2025</inf:meetingDate><inf:voteDescription>Advisory approval of executive compensation</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10161</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10161</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE CIGNA GROUP</inf:issuerName><inf:cusip>125523100</inf:cusip><inf:isin>US1255231003</inf:isin><inf:meetingDate>04/23/2025</inf:meetingDate><inf:voteDescription>Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group's independent registered public accounting firm for 2025</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10161</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10161</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE CIGNA GROUP</inf:issuerName><inf:cusip>125523100</inf:cusip><inf:isin>US1255231003</inf:isin><inf:meetingDate>04/23/2025</inf:meetingDate><inf:voteDescription>Shareholder proposal - Support Special Shareholder Meeting Improvement</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>10161</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>10161</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE COOPER COMPANIES, INC.</inf:issuerName><inf:cusip>216648501</inf:cusip><inf:isin>US2166485019</inf:isin><inf:meetingDate>04/02/2025</inf:meetingDate><inf:voteDescription>Election of Director: Robert S. Weiss</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>46363</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>46363</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE COOPER COMPANIES, INC.</inf:issuerName><inf:cusip>216648501</inf:cusip><inf:isin>US2166485019</inf:isin><inf:meetingDate>04/02/2025</inf:meetingDate><inf:voteDescription>Election of Director: Colleen E. Jay</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>46363</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>46363</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE COOPER COMPANIES, INC.</inf:issuerName><inf:cusip>216648501</inf:cusip><inf:isin>US2166485019</inf:isin><inf:meetingDate>04/02/2025</inf:meetingDate><inf:voteDescription>Election of Director: Lawrence E. Kurzius</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>46363</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>46363</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE COOPER COMPANIES, INC.</inf:issuerName><inf:cusip>216648501</inf:cusip><inf:isin>US2166485019</inf:isin><inf:meetingDate>04/02/2025</inf:meetingDate><inf:voteDescription>Election of Director: Cynthia L. Lucchese</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>46363</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>46363</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE COOPER COMPANIES, INC.</inf:issuerName><inf:cusip>216648501</inf:cusip><inf:isin>US2166485019</inf:isin><inf:meetingDate>04/02/2025</inf:meetingDate><inf:voteDescription>Election of Director: Teresa S. Madden</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>46363</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>46363</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE COOPER COMPANIES, INC.</inf:issuerName><inf:cusip>216648501</inf:cusip><inf:isin>US2166485019</inf:isin><inf:meetingDate>04/02/2025</inf:meetingDate><inf:voteDescription>Election of Director: Maria Rivas, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>46363</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>46363</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE COOPER COMPANIES, INC.</inf:issuerName><inf:cusip>216648501</inf:cusip><inf:isin>US2166485019</inf:isin><inf:meetingDate>04/02/2025</inf:meetingDate><inf:voteDescription>Election of Director: Albert G. White III</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>46363</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>46363</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE COOPER COMPANIES, INC.</inf:issuerName><inf:cusip>216648501</inf:cusip><inf:isin>US2166485019</inf:isin><inf:meetingDate>04/02/2025</inf:meetingDate><inf:voteDescription>Approve an amendment to our Second Restated Certificate of Incorporation to provide for the exculpation of officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>46363</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>46363</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE COOPER COMPANIES, INC.</inf:issuerName><inf:cusip>216648501</inf:cusip><inf:isin>US2166485019</inf:isin><inf:meetingDate>04/02/2025</inf:meetingDate><inf:voteDescription>Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending October 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>46363</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>46363</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THE COOPER COMPANIES, INC.</inf:issuerName><inf:cusip>216648501</inf:cusip><inf:isin>US2166485019</inf:isin><inf:meetingDate>04/02/2025</inf:meetingDate><inf:voteDescription>Approve, on a non-binding, advisory basis, the compensation of our Named Executive Officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>46363</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>46363</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THERMO FISHER SCIENTIFIC INC.</inf:issuerName><inf:cusip>883556102</inf:cusip><inf:isin>US8835561023</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Marc N. Casper</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>38164</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>38164</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THERMO FISHER SCIENTIFIC INC.</inf:issuerName><inf:cusip>883556102</inf:cusip><inf:isin>US8835561023</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Nelson J. Chai</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>38164</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>38164</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THERMO FISHER SCIENTIFIC INC.</inf:issuerName><inf:cusip>883556102</inf:cusip><inf:isin>US8835561023</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Ruby R. Chandy</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>38164</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>38164</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THERMO FISHER SCIENTIFIC INC.</inf:issuerName><inf:cusip>883556102</inf:cusip><inf:isin>US8835561023</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: C. Martin Harris</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>38164</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>38164</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THERMO FISHER SCIENTIFIC INC.</inf:issuerName><inf:cusip>883556102</inf:cusip><inf:isin>US8835561023</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Tyler Jacks</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>38164</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>38164</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THERMO FISHER SCIENTIFIC INC.</inf:issuerName><inf:cusip>883556102</inf:cusip><inf:isin>US8835561023</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Jennifer M. Johnson</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>38164</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>38164</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THERMO FISHER SCIENTIFIC INC.</inf:issuerName><inf:cusip>883556102</inf:cusip><inf:isin>US8835561023</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: R. Alexandra Keith</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>38164</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>38164</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THERMO FISHER SCIENTIFIC INC.</inf:issuerName><inf:cusip>883556102</inf:cusip><inf:isin>US8835561023</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Karen S. Lynch</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>38164</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>38164</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THERMO FISHER SCIENTIFIC INC.</inf:issuerName><inf:cusip>883556102</inf:cusip><inf:isin>US8835561023</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: James C. Mullen</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>38164</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>38164</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THERMO FISHER SCIENTIFIC INC.</inf:issuerName><inf:cusip>883556102</inf:cusip><inf:isin>US8835561023</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Debora L. Spar</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>38164</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>38164</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THERMO FISHER SCIENTIFIC INC.</inf:issuerName><inf:cusip>883556102</inf:cusip><inf:isin>US8835561023</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Scott M. Sperling</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>38164</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>38164</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THERMO FISHER SCIENTIFIC INC.</inf:issuerName><inf:cusip>883556102</inf:cusip><inf:isin>US8835561023</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Dion J. Weisler</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>38164</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>38164</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THERMO FISHER SCIENTIFIC INC.</inf:issuerName><inf:cusip>883556102</inf:cusip><inf:isin>US8835561023</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>An advisory vote to approve named executive officer compensation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>38164</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>38164</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THERMO FISHER SCIENTIFIC INC.</inf:issuerName><inf:cusip>883556102</inf:cusip><inf:isin>US8835561023</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>38164</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>38164</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>THERMO FISHER SCIENTIFIC INC.</inf:issuerName><inf:cusip>883556102</inf:cusip><inf:isin>US8835561023</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Shareholder Proposal.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType></inf:voteCategory><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>38164</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>38164</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>TSCAN THERAPEUTICS, INC.</inf:issuerName><inf:cusip>89854M101</inf:cusip><inf:isin>US89854M1018</inf:isin><inf:meetingDate>06/30/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Stephen Biggar</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>49480</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>49480</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>TSCAN THERAPEUTICS, INC.</inf:issuerName><inf:cusip>89854M101</inf:cusip><inf:isin>US89854M1018</inf:isin><inf:meetingDate>06/30/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Gavin MacBeath</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>49480</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>49480</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>TSCAN THERAPEUTICS, INC.</inf:issuerName><inf:cusip>89854M101</inf:cusip><inf:isin>US89854M1018</inf:isin><inf:meetingDate>06/30/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Garry Nicholson</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>49480</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>49480</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>TSCAN THERAPEUTICS, INC.</inf:issuerName><inf:cusip>89854M101</inf:cusip><inf:isin>US89854M1018</inf:isin><inf:meetingDate>06/30/2025</inf:meetingDate><inf:voteDescription>To ratify the appointment of Deloitte &amp; Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>49480</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>49480</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UCB SA</inf:issuerName><inf:cusip>B93562120</inf:cusip><inf:isin>BE0003739530</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>VOTING MUST BE LODGED WITH BENEFICIAL OWNER DETAILS AS PROVIDED BY YOUR CUSTODIAN BANK. ACCOUNTS WITH MULTIPLE BENEFICIAL OWNERS WILL REQUIRE DISCLOSURE OF EACH BENEFICIAL OWNER NAME, ADDRESS AND SHARE POSITION</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8455</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UCB SA</inf:issuerName><inf:cusip>B93562120</inf:cusip><inf:isin>BE0003739530</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>A BENEFICIAL OWNER SIGNED POWER OF ATTORNEY (POA) MAY BE REQUIRED TO LODGE VOTING INSTRUCTIONS. IF NO POA IS SUBMITTED, YOUR INSTRUCTIONS MAY BE REJECTED</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8455</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UCB SA</inf:issuerName><inf:cusip>B93562120</inf:cusip><inf:isin>BE0003739530</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>VOTING MUST BE LODGED WITH SHAREHOLDER DETAILS AS PROVIDED BY YOUR CUSTODIAN BANK. IF NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTIONS MAY BE REJECTED</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8455</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UCB SA</inf:issuerName><inf:cusip>B93562120</inf:cusip><inf:isin>BE0003739530</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>REPORT OF THE BOARD OF DIRECTORS ON THE ANNUAL ACCOUNTS FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2024</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8455</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UCB SA</inf:issuerName><inf:cusip>B93562120</inf:cusip><inf:isin>BE0003739530</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>REPORT OF THE STATUTORY AUDITOR ON THE ANNUAL ACCOUNTS FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2024</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8455</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UCB SA</inf:issuerName><inf:cusip>B93562120</inf:cusip><inf:isin>BE0003739530</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>COMMUNICATION OF THE CONSOLIDATED ANNUAL ACCOUNTS OF THE UCB GROUP RELATING TO THE FINANCIAL YEAR ENDED 31 DECEMBER 2024 AND THE CONSOLIDATED REPORT OF THE BOARD OF DIRECTORS ON THESE ACCOUNTS. SUCH DOCUMENTS ARE INCLUDED IN THE INTEGRATED ANNUAL REPORT</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8455</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UCB SA</inf:issuerName><inf:cusip>B93562120</inf:cusip><inf:isin>BE0003739530</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>APPROVAL OF THE ANNUAL ACCOUNTS OF UCB SA/NV FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2024 AND APPROPRIATION OF THE RESULTS (INCLUDING THE APPROVAL OF A GROSS DIVIDEND OF 1.39 PER SHARE)</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8455</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8455</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UCB SA</inf:issuerName><inf:cusip>B93562120</inf:cusip><inf:isin>BE0003739530</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>APPROVAL OF THE REMUNERATION REPORT FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2024</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8455</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8455</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UCB SA</inf:issuerName><inf:cusip>B93562120</inf:cusip><inf:isin>BE0003739530</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>APPROVAL OF THE REMUNERATION POLICY 2025</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8455</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8455</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UCB SA</inf:issuerName><inf:cusip>B93562120</inf:cusip><inf:isin>BE0003739530</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>DISCHARGE IN FAVOUR OF THE DIRECTORS</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8455</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8455</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UCB SA</inf:issuerName><inf:cusip>B93562120</inf:cusip><inf:isin>BE0003739530</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>DISCHARGE IN FAVOUR OF THE STATUTORY AUDITOR</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8455</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8455</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UCB SA</inf:issuerName><inf:cusip>B93562120</inf:cusip><inf:isin>BE0003739530</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>THE GENERAL MEETING RENEWS THE APPOINTMENT OF MR. JONATHAN PEACOCK AS DIRECTOR FOR A TERM OF FOUR YEARS UNTIL THE CLOSE OF THE ORDINARY GENERAL MEETING OF 2029.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8455</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8455</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UCB SA</inf:issuerName><inf:cusip>B93562120</inf:cusip><inf:isin>BE0003739530</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>THE GENERAL MEETING ACKNOWLEDGES THAT, MR JOHATHAN PEACOCK QUALIFIES AS AN INDEPENDENT DIRECTOR ACCORDING TO THE INDEPENDENCE CRITERIA PROVIDED FOR BY ARTICLE 7:87 OF THE BELGIAN CODE OF COMPANIES AND ASSOCIATIONS, BY PROVISION 3.5 OF THE 2020 BELGIAN</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8455</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8455</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UCB SA</inf:issuerName><inf:cusip>B93562120</inf:cusip><inf:isin>BE0003739530</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>A) THE GENERAL MEETING APPOINTS MRS. FIONA POWRIE AS DIRECTOR FOR A TERM STARTING ON 1 JANUARY 2026 AND ENDING AT THE CLOSE OF THE ORDINARY GENERAL MEETING OF 2029</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8455</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8455</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UCB SA</inf:issuerName><inf:cusip>B93562120</inf:cusip><inf:isin>BE0003739530</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>THE GENERAL MEETING ACKNOWLEDGES THAT MRS. FIONA POWRIE QUALIFIES AS AN INDEPENDENT DIRECTOR ACCORDING TO THE INDEPENDENCE CRITERIA PROVIDED FOR BY ARTICLE 7:87 OF THE BELGIAN CODE OF COMPANIES AND ASSOCIATIONS, BY PROVISION 3.5 OF THE 2020 BELGIAN CORP</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8455</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8455</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UCB SA</inf:issuerName><inf:cusip>B93562120</inf:cusip><inf:isin>BE0003739530</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>THE GENERAL MEETING APPOINTS MR. STEFAAN HEYLEN AS DIRECTOR FOR A TERM OF FOUR YEARS UNTIL THE CLOSE OF THE ORDINARY GENERAL MEETING OF 2029</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8455</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8455</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UCB SA</inf:issuerName><inf:cusip>B93562120</inf:cusip><inf:isin>BE0003739530</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>RENEWAL OF APPROVAL OF A CHANGE OF CONTROL PROVISIONS IN THE EMTN PROGRAM - ART. 7:151 OF THE BCCA</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8455</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>8455</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UCB SA</inf:issuerName><inf:cusip>B93562120</inf:cusip><inf:isin>BE0003739530</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>INTERMEDIARY CLIENTS ONLY - PLEASE NOTE THAT IF YOU ARE CLASSIFIED AS AN INTERMEDIARY CLIENT UNDER THE SHAREHOLDER RIGHTS DIRECTIVE II, YOU SHOULD BE PROVIDING THE UNDERLYING SHAREHOLDER INFORMATION AT THE VOTE INSTRUCTION LEVEL. IF YOU ARE UNSURE ON HOW TO PROVIDE THIS LEVEL OF DATA TO BROADRIDGE OUTSIDE OF PROXYEDGE, PLEASE SPEAK TO YOUR DEDICATED CLIENT SERVICE REPRESENTATIVE FOR ASSISTANCE</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8455</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UCB SA</inf:issuerName><inf:cusip>B93562120</inf:cusip><inf:isin>BE0003739530</inf:isin><inf:meetingDate>04/24/2025</inf:meetingDate><inf:voteDescription>04 APR 2025: PLEASE NOTE THAT THIS IS A REVISION DUE TO CHANGE IN NUMBERING OF ALL RESOLUTIONS AND CHANGE IN NUMBERING OF RESOLUTIONS 9.1A TO 9.2B. IF YOU HAVE ALREADY SENT IN YOUR VOTES, PLEASE DO NOT VOTE AGAIN UNLESS YOU DECIDE TO AMEND YOUR ORIGINAL INSTRUCTIONS. THANK YOU</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>8455</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UNITEDHEALTH GROUP INCORPORATED</inf:issuerName><inf:cusip>91324P102</inf:cusip><inf:isin>US91324P1021</inf:isin><inf:meetingDate>06/02/2025</inf:meetingDate><inf:voteDescription>Election of Director: Charles Baker</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6460</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6460</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UNITEDHEALTH GROUP INCORPORATED</inf:issuerName><inf:cusip>91324P102</inf:cusip><inf:isin>US91324P1021</inf:isin><inf:meetingDate>06/02/2025</inf:meetingDate><inf:voteDescription>Election of Director: Timothy Flynn</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6460</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6460</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UNITEDHEALTH GROUP INCORPORATED</inf:issuerName><inf:cusip>91324P102</inf:cusip><inf:isin>US91324P1021</inf:isin><inf:meetingDate>06/02/2025</inf:meetingDate><inf:voteDescription>Election of Director: Paul Garcia</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6460</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6460</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UNITEDHEALTH GROUP INCORPORATED</inf:issuerName><inf:cusip>91324P102</inf:cusip><inf:isin>US91324P1021</inf:isin><inf:meetingDate>06/02/2025</inf:meetingDate><inf:voteDescription>Election of Director: Kristen Gil</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6460</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6460</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UNITEDHEALTH GROUP INCORPORATED</inf:issuerName><inf:cusip>91324P102</inf:cusip><inf:isin>US91324P1021</inf:isin><inf:meetingDate>06/02/2025</inf:meetingDate><inf:voteDescription>Election of Director: Stephen Hemsley</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6460</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6460</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UNITEDHEALTH GROUP INCORPORATED</inf:issuerName><inf:cusip>91324P102</inf:cusip><inf:isin>US91324P1021</inf:isin><inf:meetingDate>06/02/2025</inf:meetingDate><inf:voteDescription>Election of Director: Michele Hooper</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6460</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6460</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UNITEDHEALTH GROUP INCORPORATED</inf:issuerName><inf:cusip>91324P102</inf:cusip><inf:isin>US91324P1021</inf:isin><inf:meetingDate>06/02/2025</inf:meetingDate><inf:voteDescription>Election of Director: F. William McNabb III</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6460</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6460</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UNITEDHEALTH GROUP INCORPORATED</inf:issuerName><inf:cusip>91324P102</inf:cusip><inf:isin>US91324P1021</inf:isin><inf:meetingDate>06/02/2025</inf:meetingDate><inf:voteDescription>Election of Director: Valerie Montgomery Rice, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6460</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6460</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UNITEDHEALTH GROUP INCORPORATED</inf:issuerName><inf:cusip>91324P102</inf:cusip><inf:isin>US91324P1021</inf:isin><inf:meetingDate>06/02/2025</inf:meetingDate><inf:voteDescription>Election of Director: John Noseworthy, M.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6460</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6460</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UNITEDHEALTH GROUP INCORPORATED</inf:issuerName><inf:cusip>91324P102</inf:cusip><inf:isin>US91324P1021</inf:isin><inf:meetingDate>06/02/2025</inf:meetingDate><inf:voteDescription>Election of Director: Andrew Witty</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6460</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>ABSTAIN</inf:howVoted><inf:sharesVoted>6460</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UNITEDHEALTH GROUP INCORPORATED</inf:issuerName><inf:cusip>91324P102</inf:cusip><inf:isin>US91324P1021</inf:isin><inf:meetingDate>06/02/2025</inf:meetingDate><inf:voteDescription>Advisory approval of the Company's executive compensation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6460</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6460</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UNITEDHEALTH GROUP INCORPORATED</inf:issuerName><inf:cusip>91324P102</inf:cusip><inf:isin>US91324P1021</inf:isin><inf:meetingDate>06/02/2025</inf:meetingDate><inf:voteDescription>Ratification of the appointment of Deloitte &amp; Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6460</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6460</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>UNITEDHEALTH GROUP INCORPORATED</inf:issuerName><inf:cusip>91324P102</inf:cusip><inf:isin>US91324P1021</inf:isin><inf:meetingDate>06/02/2025</inf:meetingDate><inf:voteDescription>If properly presented at the 2025 Annual Meeting of Shareholders, the shareholder proposal requesting a shareholder vote regarding excessive golden parachutes.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>6460</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>6460</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VAXCYTE, INC.</inf:issuerName><inf:cusip>92243G108</inf:cusip><inf:isin>US92243G1085</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: John Furey</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>7730</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>7730</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VAXCYTE, INC.</inf:issuerName><inf:cusip>92243G108</inf:cusip><inf:isin>US92243G1085</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Jacks Lee</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>7730</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>7730</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VAXCYTE, INC.</inf:issuerName><inf:cusip>92243G108</inf:cusip><inf:isin>US92243G1085</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Heath Lukatch, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>7730</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>7730</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VAXCYTE, INC.</inf:issuerName><inf:cusip>92243G108</inf:cusip><inf:isin>US92243G1085</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>Ratification of the appointment of Deloitte &amp; Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>7730</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>7730</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VAXCYTE, INC.</inf:issuerName><inf:cusip>92243G108</inf:cusip><inf:isin>US92243G1085</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>7730</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>7730</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VAXCYTE, INC.</inf:issuerName><inf:cusip>92243G108</inf:cusip><inf:isin>US92243G1085</inf:isin><inf:meetingDate>06/12/2025</inf:meetingDate><inf:voteDescription>Approval of the amendment and restatement of the Company's Amended and Restated Certificate of Incorporation to provide for officer exculpation as permitted by recent amendments to the Delaware General Corporation Law.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>7730</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>7730</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VERTEX PHARMACEUTICALS INCORPORATED</inf:issuerName><inf:cusip>92532F100</inf:cusip><inf:isin>US92532F1003</inf:isin><inf:meetingDate>05/14/2025</inf:meetingDate><inf:voteDescription>Election of Director: Sangeeta Bhatia</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28074</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28074</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VERTEX PHARMACEUTICALS INCORPORATED</inf:issuerName><inf:cusip>92532F100</inf:cusip><inf:isin>US92532F1003</inf:isin><inf:meetingDate>05/14/2025</inf:meetingDate><inf:voteDescription>Election of Director: Lloyd Carney</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28074</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28074</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VERTEX PHARMACEUTICALS INCORPORATED</inf:issuerName><inf:cusip>92532F100</inf:cusip><inf:isin>US92532F1003</inf:isin><inf:meetingDate>05/14/2025</inf:meetingDate><inf:voteDescription>Election of Director: Alan Garber</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28074</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28074</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VERTEX PHARMACEUTICALS INCORPORATED</inf:issuerName><inf:cusip>92532F100</inf:cusip><inf:isin>US92532F1003</inf:isin><inf:meetingDate>05/14/2025</inf:meetingDate><inf:voteDescription>Election of Director: Reshma Kewalramani</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28074</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28074</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VERTEX PHARMACEUTICALS INCORPORATED</inf:issuerName><inf:cusip>92532F100</inf:cusip><inf:isin>US92532F1003</inf:isin><inf:meetingDate>05/14/2025</inf:meetingDate><inf:voteDescription>Election of Director: Michel Lagarde</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28074</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28074</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VERTEX PHARMACEUTICALS INCORPORATED</inf:issuerName><inf:cusip>92532F100</inf:cusip><inf:isin>US92532F1003</inf:isin><inf:meetingDate>05/14/2025</inf:meetingDate><inf:voteDescription>Election of Director: Jeffrey Leiden</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28074</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28074</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VERTEX PHARMACEUTICALS INCORPORATED</inf:issuerName><inf:cusip>92532F100</inf:cusip><inf:isin>US92532F1003</inf:isin><inf:meetingDate>05/14/2025</inf:meetingDate><inf:voteDescription>Election of Director: Diana McKenzie</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28074</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28074</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VERTEX PHARMACEUTICALS INCORPORATED</inf:issuerName><inf:cusip>92532F100</inf:cusip><inf:isin>US92532F1003</inf:isin><inf:meetingDate>05/14/2025</inf:meetingDate><inf:voteDescription>Election of Director: Bruce Sachs</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28074</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28074</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VERTEX PHARMACEUTICALS INCORPORATED</inf:issuerName><inf:cusip>92532F100</inf:cusip><inf:isin>US92532F1003</inf:isin><inf:meetingDate>05/14/2025</inf:meetingDate><inf:voteDescription>Election of Director: Jennifer Schneider</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28074</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28074</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VERTEX PHARMACEUTICALS INCORPORATED</inf:issuerName><inf:cusip>92532F100</inf:cusip><inf:isin>US92532F1003</inf:isin><inf:meetingDate>05/14/2025</inf:meetingDate><inf:voteDescription>Election of Director: Nancy Thornberry</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28074</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28074</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VERTEX PHARMACEUTICALS INCORPORATED</inf:issuerName><inf:cusip>92532F100</inf:cusip><inf:isin>US92532F1003</inf:isin><inf:meetingDate>05/14/2025</inf:meetingDate><inf:voteDescription>Election of Director: Suketu Upadhyay</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28074</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28074</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VERTEX PHARMACEUTICALS INCORPORATED</inf:issuerName><inf:cusip>92532F100</inf:cusip><inf:isin>US92532F1003</inf:isin><inf:meetingDate>05/14/2025</inf:meetingDate><inf:voteDescription>Ratification of Ernst &amp; Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28074</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28074</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VERTEX PHARMACEUTICALS INCORPORATED</inf:issuerName><inf:cusip>92532F100</inf:cusip><inf:isin>US92532F1003</inf:isin><inf:meetingDate>05/14/2025</inf:meetingDate><inf:voteDescription>Advisory vote to approve named executive officer compensation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>28074</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>28074</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VERTEX PHARMACEUTICALS INCORPORATED</inf:issuerName><inf:cusip>92532F100</inf:cusip><inf:isin>US92532F1003</inf:isin><inf:meetingDate>05/14/2025</inf:meetingDate><inf:voteDescription>Shareholder proposal, if properly presented at the meeting, regarding excessive golden parachutes.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>28074</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>28074</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VIKING THERAPEUTICS INC</inf:issuerName><inf:cusip>92686J106</inf:cusip><inf:isin>US92686J1060</inf:isin><inf:meetingDate>05/20/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Matthew W. Foehr</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>9142</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>ABSTAIN</inf:howVoted><inf:sharesVoted>9142</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VIKING THERAPEUTICS INC</inf:issuerName><inf:cusip>92686J106</inf:cusip><inf:isin>US92686J1060</inf:isin><inf:meetingDate>05/20/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Charles A. Rowland, Jr.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>9142</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>9142</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VIKING THERAPEUTICS INC</inf:issuerName><inf:cusip>92686J106</inf:cusip><inf:isin>US92686J1060</inf:isin><inf:meetingDate>05/20/2025</inf:meetingDate><inf:voteDescription>RATIFICATION OF THE SELECTION OF CBIZ CPAS P.C. AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>9142</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>9142</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VIKING THERAPEUTICS INC</inf:issuerName><inf:cusip>92686J106</inf:cusip><inf:isin>US92686J1060</inf:isin><inf:meetingDate>05/20/2025</inf:meetingDate><inf:voteDescription>TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>9142</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>9142</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VIR BIOTECHNOLOGY, INC.</inf:issuerName><inf:cusip>92764N102</inf:cusip><inf:isin>US92764N1028</inf:isin><inf:meetingDate>05/29/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2028 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Jeffrey S. Hatfield</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>20570</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>20570</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VIR BIOTECHNOLOGY, INC.</inf:issuerName><inf:cusip>92764N102</inf:cusip><inf:isin>US92764N1028</inf:isin><inf:meetingDate>05/29/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the 2028 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Saira Ramasastry</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>20570</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>20570</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VIR BIOTECHNOLOGY, INC.</inf:issuerName><inf:cusip>92764N102</inf:cusip><inf:isin>US92764N1028</inf:isin><inf:meetingDate>05/29/2025</inf:meetingDate><inf:voteDescription>To approve, on an advisory basis, the compensation of the Company's named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>20570</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>20570</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VIR BIOTECHNOLOGY, INC.</inf:issuerName><inf:cusip>92764N102</inf:cusip><inf:isin>US92764N1028</inf:isin><inf:meetingDate>05/29/2025</inf:meetingDate><inf:voteDescription>To ratify the appointment by the Audit Committee of the Board of Directors of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>20570</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>20570</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VOYAGER THERAPEUTICS, INC.</inf:issuerName><inf:cusip>92915B106</inf:cusip><inf:isin>US92915B1061</inf:isin><inf:meetingDate>06/03/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Grace E. Col&#xF3;n, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32205</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32205</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VOYAGER THERAPEUTICS, INC.</inf:issuerName><inf:cusip>92915B106</inf:cusip><inf:isin>US92915B1061</inf:isin><inf:meetingDate>06/03/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Catherine J. Mackey PhD</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32205</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32205</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VOYAGER THERAPEUTICS, INC.</inf:issuerName><inf:cusip>92915B106</inf:cusip><inf:isin>US92915B1061</inf:isin><inf:meetingDate>06/03/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: Glenn Pierce, M.D., PhD</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32205</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32205</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VOYAGER THERAPEUTICS, INC.</inf:issuerName><inf:cusip>92915B106</inf:cusip><inf:isin>US92915B1061</inf:isin><inf:meetingDate>06/03/2025</inf:meetingDate><inf:voteDescription>DIRECTOR: George Scangos, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32205</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32205</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VOYAGER THERAPEUTICS, INC.</inf:issuerName><inf:cusip>92915B106</inf:cusip><inf:isin>US92915B1061</inf:isin><inf:meetingDate>06/03/2025</inf:meetingDate><inf:voteDescription>To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32205</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32205</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VOYAGER THERAPEUTICS, INC.</inf:issuerName><inf:cusip>92915B106</inf:cusip><inf:isin>US92915B1061</inf:isin><inf:meetingDate>06/03/2025</inf:meetingDate><inf:voteDescription>To ratify the appointment of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32205</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32205</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VOYAGER THERAPEUTICS, INC.</inf:issuerName><inf:cusip>92915B106</inf:cusip><inf:isin>US92915B1061</inf:isin><inf:meetingDate>06/03/2025</inf:meetingDate><inf:voteDescription>To approve the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32205</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32205</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>VOYAGER THERAPEUTICS, INC.</inf:issuerName><inf:cusip>92915B106</inf:cusip><inf:isin>US92915B1061</inf:isin><inf:meetingDate>06/03/2025</inf:meetingDate><inf:voteDescription>To approve the Voyager Therapeutics, Inc. Amended and Restated 2015 Employee Stock Purchase Plan.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>32205</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>32205</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WATERS CORPORATION</inf:issuerName><inf:cusip>941848103</inf:cusip><inf:isin>US9418481035</inf:isin><inf:meetingDate>05/22/2025</inf:meetingDate><inf:voteDescription>Election of Director: Dr. Flemming Ornskov, M.D., M.P.H.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>20065</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>20065</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WATERS CORPORATION</inf:issuerName><inf:cusip>941848103</inf:cusip><inf:isin>US9418481035</inf:isin><inf:meetingDate>05/22/2025</inf:meetingDate><inf:voteDescription>Election of Director: Linda Baddour</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>20065</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>20065</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WATERS CORPORATION</inf:issuerName><inf:cusip>941848103</inf:cusip><inf:isin>US9418481035</inf:isin><inf:meetingDate>05/22/2025</inf:meetingDate><inf:voteDescription>Election of Director: Udit Batra, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>20065</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>20065</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WATERS CORPORATION</inf:issuerName><inf:cusip>941848103</inf:cusip><inf:isin>US9418481035</inf:isin><inf:meetingDate>05/22/2025</inf:meetingDate><inf:voteDescription>Election of Director: Dan Brennan</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>20065</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>20065</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WATERS CORPORATION</inf:issuerName><inf:cusip>941848103</inf:cusip><inf:isin>US9418481035</inf:isin><inf:meetingDate>05/22/2025</inf:meetingDate><inf:voteDescription>Election of Director: Richard Fearon</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>20065</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>20065</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WATERS CORPORATION</inf:issuerName><inf:cusip>941848103</inf:cusip><inf:isin>US9418481035</inf:isin><inf:meetingDate>05/22/2025</inf:meetingDate><inf:voteDescription>Election of Director: Pearl S. Huang, Ph.D.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>20065</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>20065</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WATERS CORPORATION</inf:issuerName><inf:cusip>941848103</inf:cusip><inf:isin>US9418481035</inf:isin><inf:meetingDate>05/22/2025</inf:meetingDate><inf:voteDescription>Election of Director: Wei Jiang</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>20065</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>20065</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WATERS CORPORATION</inf:issuerName><inf:cusip>941848103</inf:cusip><inf:isin>US9418481035</inf:isin><inf:meetingDate>05/22/2025</inf:meetingDate><inf:voteDescription>Election of Director: Heather Knight</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>20065</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>20065</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WATERS CORPORATION</inf:issuerName><inf:cusip>941848103</inf:cusip><inf:isin>US9418481035</inf:isin><inf:meetingDate>05/22/2025</inf:meetingDate><inf:voteDescription>Election of Director: Christopher A. Kuebler</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>20065</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>20065</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WATERS CORPORATION</inf:issuerName><inf:cusip>941848103</inf:cusip><inf:isin>US9418481035</inf:isin><inf:meetingDate>05/22/2025</inf:meetingDate><inf:voteDescription>Election of Director: Mark Vergnano</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>20065</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>20065</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WATERS CORPORATION</inf:issuerName><inf:cusip>941848103</inf:cusip><inf:isin>US9418481035</inf:isin><inf:meetingDate>05/22/2025</inf:meetingDate><inf:voteDescription>To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>20065</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>20065</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WATERS CORPORATION</inf:issuerName><inf:cusip>941848103</inf:cusip><inf:isin>US9418481035</inf:isin><inf:meetingDate>05/22/2025</inf:meetingDate><inf:voteDescription>To approve, on a non-binding, advisory basis, the compensation of the Company's executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>20065</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>20065</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WATERS CORPORATION</inf:issuerName><inf:cusip>941848103</inf:cusip><inf:isin>US9418481035</inf:isin><inf:meetingDate>05/22/2025</inf:meetingDate><inf:voteDescription>To approve the Company's Amended and Restated 2009 Employee Stock Purchase Plan.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>20065</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>20065</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WEST PHARMACEUTICAL SERVICES, INC.</inf:issuerName><inf:cusip>955306105</inf:cusip><inf:isin>US9553061055</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Mark A. Buthman</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10207</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10207</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WEST PHARMACEUTICAL SERVICES, INC.</inf:issuerName><inf:cusip>955306105</inf:cusip><inf:isin>US9553061055</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: William F. Feehery</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10207</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10207</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WEST PHARMACEUTICAL SERVICES, INC.</inf:issuerName><inf:cusip>955306105</inf:cusip><inf:isin>US9553061055</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Robert F. Friel</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10207</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10207</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WEST PHARMACEUTICAL SERVICES, INC.</inf:issuerName><inf:cusip>955306105</inf:cusip><inf:isin>US9553061055</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Eric M. Green</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10207</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10207</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WEST PHARMACEUTICAL SERVICES, INC.</inf:issuerName><inf:cusip>955306105</inf:cusip><inf:isin>US9553061055</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Janet B. Haugen</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10207</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10207</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WEST PHARMACEUTICAL SERVICES, INC.</inf:issuerName><inf:cusip>955306105</inf:cusip><inf:isin>US9553061055</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Thomas W. Hofmann</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10207</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10207</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WEST PHARMACEUTICAL SERVICES, INC.</inf:issuerName><inf:cusip>955306105</inf:cusip><inf:isin>US9553061055</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Molly E. Joseph</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10207</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10207</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WEST PHARMACEUTICAL SERVICES, INC.</inf:issuerName><inf:cusip>955306105</inf:cusip><inf:isin>US9553061055</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Deborah L. V. Keller</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10207</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10207</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WEST PHARMACEUTICAL SERVICES, INC.</inf:issuerName><inf:cusip>955306105</inf:cusip><inf:isin>US9553061055</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Myla P. Lai-Goldman</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10207</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10207</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WEST PHARMACEUTICAL SERVICES, INC.</inf:issuerName><inf:cusip>955306105</inf:cusip><inf:isin>US9553061055</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Stephen H. Lockhart</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10207</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10207</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WEST PHARMACEUTICAL SERVICES, INC.</inf:issuerName><inf:cusip>955306105</inf:cusip><inf:isin>US9553061055</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Douglas A. Michels</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10207</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10207</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WEST PHARMACEUTICAL SERVICES, INC.</inf:issuerName><inf:cusip>955306105</inf:cusip><inf:isin>US9553061055</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Election of Director: Paolo Pucci</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10207</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10207</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WEST PHARMACEUTICAL SERVICES, INC.</inf:issuerName><inf:cusip>955306105</inf:cusip><inf:isin>US9553061055</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Advisory vote to approve named executive officer compensation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10207</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10207</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WEST PHARMACEUTICAL SERVICES, INC.</inf:issuerName><inf:cusip>955306105</inf:cusip><inf:isin>US9553061055</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Amend and Restate Our Amended and Restated Articles of Incorporation to Add a Right For Shareholders to call a Special Meeting.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10207</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10207</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WEST PHARMACEUTICAL SERVICES, INC.</inf:issuerName><inf:cusip>955306105</inf:cusip><inf:isin>US9553061055</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Amend and Restate Our 2016 Omnibus Incentive Compensation Plan.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10207</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10207</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>WEST PHARMACEUTICAL SERVICES, INC.</inf:issuerName><inf:cusip>955306105</inf:cusip><inf:isin>US9553061055</inf:isin><inf:meetingDate>05/06/2025</inf:meetingDate><inf:voteDescription>Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>10207</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>10207</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>XENON PHARMACEUTICALS INC</inf:issuerName><inf:cusip>98420N105</inf:cusip><inf:isin>CA98420N1050</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Dawn Svoronos</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24916</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24916</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>XENON PHARMACEUTICALS INC</inf:issuerName><inf:cusip>98420N105</inf:cusip><inf:isin>CA98420N1050</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Gillian Cannon</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24916</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24916</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>XENON PHARMACEUTICALS INC</inf:issuerName><inf:cusip>98420N105</inf:cusip><inf:isin>CA98420N1050</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Steven Gannon</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24916</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24916</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>XENON PHARMACEUTICALS INC</inf:issuerName><inf:cusip>98420N105</inf:cusip><inf:isin>CA98420N1050</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Elizabeth Garofalo</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24916</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24916</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>XENON PHARMACEUTICALS INC</inf:issuerName><inf:cusip>98420N105</inf:cusip><inf:isin>CA98420N1050</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Justin Gover</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24916</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24916</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>XENON PHARMACEUTICALS INC</inf:issuerName><inf:cusip>98420N105</inf:cusip><inf:isin>CA98420N1050</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Patrick Machado</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24916</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24916</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>XENON PHARMACEUTICALS INC</inf:issuerName><inf:cusip>98420N105</inf:cusip><inf:isin>CA98420N1050</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Ian Mortimer</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24916</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24916</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>XENON PHARMACEUTICALS INC</inf:issuerName><inf:cusip>98420N105</inf:cusip><inf:isin>CA98420N1050</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>Election of Director to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Gary Patou</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24916</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24916</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>XENON PHARMACEUTICALS INC</inf:issuerName><inf:cusip>98420N105</inf:cusip><inf:isin>CA98420N1050</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>To approve, on an advisory basis, the compensation of the Corporation's named executive officers.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24916</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24916</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>XENON PHARMACEUTICALS INC</inf:issuerName><inf:cusip>98420N105</inf:cusip><inf:isin>CA98420N1050</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>To appoint PricewaterhouseCoopers LLP ("PwC") as the Corporation's auditor to hold office until the next annual meeting of the Corporation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24916</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24916</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>XENON PHARMACEUTICALS INC</inf:issuerName><inf:cusip>98420N105</inf:cusip><inf:isin>CA98420N1050</inf:isin><inf:meetingDate>06/04/2025</inf:meetingDate><inf:voteDescription>To authorize the Audit Committee of the board of directors of the Corporation to fix the remuneration to be paid to the auditors of the Corporation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>24916</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>24916</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>VOTING INSTRUCTIONS FOR MOST MEETINGS ARE CAST BY THE REGISTRAR IN ACCORDANCE WITH YOUR VOTING INSTRUCTIONS. FOR THE SMALL NUMBER OF MEETINGS WHERE THERE IS NO REGISTRAR, YOUR VOTING INSTRUCTIONS WILL BE CAST BY THE CHAIRMAN OF THE BOARD (OR A BOARD MEMBER) AS PROXY. THE CHAIRMAN (OR A BOARD MEMBER) MAY CHOOSE TO ONLY CAST PRO-MANAGEMENT VOTING INSTRUCTIONS. TO GUARANTEE YOUR VOTING INSTRUCTIONS AGAINST MANAGEMENT ARE CAST, YOU MAY SUBMIT A REQUEST TO ATTEND THE MEETING IN PERSON. THE SUB CUSTODIAN BANKS OFFER REPRESENTATION SERVICES FOR AN ADDED FEE, IF REQUESTED.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>SPLIT AND PARTIAL VOTING IS NOT AUTHORIZED FOR A BENEFICIAL OWNER IN THE DANISH MARKET.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>VOTING MUST BE LODGED WITH SHAREHOLDER DETAILS AS PROVIDED BY YOUR CUSTODIAN BANK. IF NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTIONS MAY BE REJECTED.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>PLEASE NOTE THAT SHAREHOLDERS ARE ALLOWED TO VOTE 'IN FAVOR' OR 'ABSTAIN' ONLY FOR RESOLUTION NUMBERS 4.01 TO 4.07 AND 5.01. THANK YOU.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>THE BOARD OF DIRECTORS PROPOSES THAT THE BOARD OF DIRECTORS' REPORT ON THE COMPANY'S ACTIVITIES IN THE PAST FINANCIAL YEAR IS NOTED BY THE GENERAL MEETING. MANAGEMENT'S REPORT ON THE COMPANY'S ACTIVITIES IN THE PAST FINANCIAL YEAR</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>THE BOARD OF DIRECTORS PROPOSES THAT THE ANNUAL REPORT 2024 IS APPROVED BY THE GENERAL MEETING. APPROVAL OF THE AUDITED ANNUAL REPORT 2024</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6909</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>RESOLUTION ON THE COVER OF LOSS IN ACCORDANCE WITH THE APPROVED ANNUAL REPORT 2024</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6909</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>ELECTION OF MEMBERS TO THE BOARD OF DIRECTOR: RE-ELECTION OF ALF GUNNAR MARTIN NICKLASSON</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6909</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>ELECTION OF MEMBERS TO THE BOARD OF DIRECTOR: RE-ELECTION OF KIRSTEN AARUP DREJER</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6909</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>ELECTION OF MEMBERS TO THE BOARD OF DIRECTOR: RE-ELECTION OF JEFFREY BERKOWITZ</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6909</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>ELECTION OF MEMBERS TO THE BOARD OF DIRECTOR: RE-ELECTION OF LEONARD KRUIMER</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6909</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>ELECTION OF MEMBERS TO THE BOARD OF DIRECTOR: RE-ELECTION OF BERNADETTE MARY CONNAUGHTON</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6909</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>ELECTION OF MEMBERS TO THE BOARD OF DIRECTOR: RE-ELECTION OF ELAINE SULLIVAN</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6909</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>ELECTION OF MEMBERS TO THE BOARD OF DIRECTOR: RE-ELECTION OF ENRIQUE CONTERNO</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6909</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>ELECTION OF THE AUDITOR: THE BOARD OF DIRECTORS PROPOSES THAT PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB ("PWC") BE RE-ELECTED AS THE COMPANY'S AUDITOR FOR BOTH FINANCIAL AND SUSTAINABILITY REPORTING PURPOSES IN ACCORDANCE WITH THE RECOMMENDATION OF THE COMPANY'S AUDIT COMMITTEE. THE AUDIT COMMITTEE HAS NOT BEEN INFLUENCED BY THIRD PARTIES AND HAS NOT BEEN SUBJECT TO ANY AGREEMENT WITH THIRD PARTIES THAT LIMITS THE GENERAL MEETING TO ELECTING CERTAIN AUDITORS OR AUDIT FIRMS AS AUDITOR. RE-ELECTION OF PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6909</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>THE BOARD OF DIRECTORS PROPOSES THAT THE GENERAL MEETING AUTHORIZES THE COMPANY TO ACQUIRE, DURING THE PERIOD UNTIL THE NEXT ANNUAL GENERAL MEETING, TREASURY SHARES, PROVIDED THE ACQUISITION, PURSUANT TO SECTION 197 OF THE DANISH COMPANIES ACT, CAN BE FINANCED BY FUNDS THAT COULD OTHERWISE BE DISTRIBUTED AS ORDINARY DIVIDENDS. THE COMPANY'S AGGREGATED ACQUISITION OF TREASURY SHARES SHALL NOT EXCEED A TOTAL NOMINAL VALUE OF 10% OF THE COMPANY'S SHARE CAPITAL AT ANY GIVEN TIME. THE ACQUISITION PRICE FOR SUCH TREASURY SHARES MAY NOT DEVIATE BY MORE THAN 10% FROM THE QUOTED PRICE FOR THE COMPANY'S SHARES ON NASDAQ COPENHAGEN AT THE TIME OF ACQUISITION. AUTHORIZATION FOR THE COMPANY TO ACQUIRE TREASURY SHARES</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6909</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>PROPOSAL FROM THE BOARD OF DIRECTORS TO APPROVE THE COMPANY'S REMUNERATION REPORT BY ADVISORY VOTE</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>6909</inf:sharesVoted><inf:managementRecommendation>AGAINST</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>PROPOSAL FROM THE BOARD OF DIRECTORS TO APPROVE THE FEES FOR THE BOARD OF DIRECTORS FOR THE FINANCIAL YEAR 2025</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>COMPENSATION</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6909</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>PROPOSAL FROM THE BOARD OF DIRECTORS TO APPROVE A NEW AUTHORIZATION TO INCREASE THE SHARE CAPITAL OF THE COMPANY BY WAY OF CASH CONTRIBUTION WITHOUT PRE-EMPTION RIGHTS FOR THE COMPANY'S EXISTING SHAREHOLDERS AND AT MARKET PRICE</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6909</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>PROPOSAL FROM THE BOARD OF DIRECTORS TO APPROVE A NEW AUTHORIZATION TO INCREASE THE SHARE CAPITAL OF THE COMPANY BY WAY OF CASH CONTRIBUTION WITH PRE-EMPTION RIGHTS FOR THE COMPANY'S EXISTING SHAREHOLDERS</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6909</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>PROPOSAL FROM THE BOARD OF DIRECTORS TO RENEW AND INCREASE THE EXISTING AUTHORIZATION TO ISSUE WARRANTS</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CAPITAL STRUCTURE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>6909</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>ANY OTHER BUSINESS</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>INTERMEDIARY CLIENTS ONLY - PLEASE NOTE THAT IF YOU ARE CLASSIFIED AS AN INTERMEDIARY CLIENT UNDER THE SHAREHOLDER RIGHTS DIRECTIVE II, YOU SHOULD BE PROVIDING THE UNDERLYING SHAREHOLDER INFORMATION AT THE VOTE INSTRUCTION LEVEL. IF YOU ARE UNSURE ON HOW TO PROVIDE THIS LEVEL OF DATA TO BROADRIDGE OUTSIDE OF PROXYEDGE, PLEASE SPEAK TO YOUR DEDICATED CLIENT SERVICE REPRESENTATIVE FOR ASSISTANCE</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>21 FEB 2025: PLEASE NOTE THAT IF YOU HOLD CREST DEPOSITORY INTERESTS (CDIS) AND PARTICIPATE AT THIS MEETING, YOU (OR YOUR CREST SPONSORED MEMBER/CUSTODIAN) WILL BE REQUIRED TO INSTRUCT A TRANSFER OF THE RELEVANT CDIS TO THE ESCROW ACCOUNT SPECIFIED IN THE ASSOCIATED CORPORATE EVENT IN THE CREST SYSTEM. THIS TRANSFER WILL NEED TO BE COMPLETED BY THE SPECIFIED CREST SYSTEM DEADLINE. ONCE THIS TRANSFER HAS SETTLED, THE CDIS WILL BE BLOCKED IN THE CREST SYSTEM. THE CDIS WILL TYPICALLY BE RELEASED FROM ESCROW AS SOON AS PRACTICABLE ON RECORD DATE +1 DAY (OR ON MEETING DATE +1 DAY IF NO RECORD DATE APPLIES) UNLESS OTHERWISE SPECIFIED, AND ONLY AFTER THE AGENT HAS CONFIRMED AVAILABILITY OF THE POSITION. IN ORDER FOR A VOTE TO BE ACCEPTED, THE VOTED POSITION MUST BE BLOCKED IN THE REQUIRED ESCROW ACCOUNT IN THE CREST SYSTEM. BY VOTING ON THIS MEETING, YOUR CREST SPONSORED MEMBER/CUSTODIAN MAY USE YOUR VOTE INSTRUCTION AS THE AUTHORIZATION TO TAKE THE NECESSARY ACTION WHICH WILL INCLUDE TRANSFERRING YOUR INSTRUCTED POSITION TO ESCROW. PLEASE CONTACT YOUR CREST SPONSORED MEMBER/CUSTODIAN DIRECTLY FOR FURTHER INFORMATION ON THE CUSTODY PROCESS AND WHETHER OR NOT THEY REQUIRE SEPARATE INSTRUCTIONS FROM YOU</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>21 FEB 2025: PLEASE NOTE SHARE BLOCKING WILL APPLY FOR ANY VOTED POSITIONS SETTLING THROUGH EUROCLEAR BANK</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZEALAND PHARMA A/S</inf:issuerName><inf:cusip>K9898X127</inf:cusip><inf:isin>DK0060257814</inf:isin><inf:meetingDate>03/27/2025</inf:meetingDate><inf:voteDescription>19 MAR 2025: PLEASE NOTE THAT THIS IS A REVISION DUE TO ADDITION OF COMMENTS AND REVISION DUE TO CHANGE IN NUMBERING FOR ALL RESOLUTIONS. IF YOU HAVE ALREADY SENT IN YOUR VOTES, PLEASE DO NOT VOTE AGAIN UNLESS YOU DECIDE TO AMEND YOUR ORIGINAL INSTRUCTIONS. THANK YOU</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>6909</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZOETIS INC.</inf:issuerName><inf:cusip>98978V103</inf:cusip><inf:isin>US98978V1035</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Paul M. Bisaro</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31654</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31654</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZOETIS INC.</inf:issuerName><inf:cusip>98978V103</inf:cusip><inf:isin>US98978V1035</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Vanessa Broadhurst</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31654</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31654</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZOETIS INC.</inf:issuerName><inf:cusip>98978V103</inf:cusip><inf:isin>US98978V1035</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Frank A. D'Amelio</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31654</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31654</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZOETIS INC.</inf:issuerName><inf:cusip>98978V103</inf:cusip><inf:isin>US98978V1035</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Gavin D.K. Hattersley</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31654</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31654</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZOETIS INC.</inf:issuerName><inf:cusip>98978V103</inf:cusip><inf:isin>US98978V1035</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Sanjay Khosla</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31654</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31654</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZOETIS INC.</inf:issuerName><inf:cusip>98978V103</inf:cusip><inf:isin>US98978V1035</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Antoinette R. Leatherberry</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31654</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31654</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZOETIS INC.</inf:issuerName><inf:cusip>98978V103</inf:cusip><inf:isin>US98978V1035</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Michael B. McCallister</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31654</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31654</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZOETIS INC.</inf:issuerName><inf:cusip>98978V103</inf:cusip><inf:isin>US98978V1035</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Gregory Norden</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31654</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31654</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZOETIS INC.</inf:issuerName><inf:cusip>98978V103</inf:cusip><inf:isin>US98978V1035</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Louise M. Parent</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31654</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31654</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZOETIS INC.</inf:issuerName><inf:cusip>98978V103</inf:cusip><inf:isin>US98978V1035</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Kristin C. Peck</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31654</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31654</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZOETIS INC.</inf:issuerName><inf:cusip>98978V103</inf:cusip><inf:isin>US98978V1035</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Willie M. Reed</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31654</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31654</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZOETIS INC.</inf:issuerName><inf:cusip>98978V103</inf:cusip><inf:isin>US98978V1035</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Election of Director: Mark Stetter</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31654</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31654</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZOETIS INC.</inf:issuerName><inf:cusip>98978V103</inf:cusip><inf:isin>US98978V1035</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Advisory vote to approve our executive compensation.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31654</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31654</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZOETIS INC.</inf:issuerName><inf:cusip>98978V103</inf:cusip><inf:isin>US98978V1035</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2025.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>AUDIT-RELATED</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>ISSUER</inf:voteSource><inf:sharesVoted>31654</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>FOR</inf:howVoted><inf:sharesVoted>31654</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
<inf:proxyTable><inf:issuerName>ZOETIS INC.</inf:issuerName><inf:cusip>98978V103</inf:cusip><inf:isin>US98978V1035</inf:isin><inf:meetingDate>05/21/2025</inf:meetingDate><inf:voteDescription>Shareholder proposal regarding a special shareholder meeting improvement.</inf:voteDescription><inf:voteCategories><inf:voteCategory><inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType></inf:voteCategory></inf:voteCategories><inf:voteSource>SECURITY HOLDER</inf:voteSource><inf:sharesVoted>31654</inf:sharesVoted><inf:sharesOnLoan>0</inf:sharesOnLoan><inf:vote><inf:voteRecord><inf:howVoted>AGAINST</inf:howVoted><inf:sharesVoted>31654</inf:sharesVoted><inf:managementRecommendation>FOR</inf:managementRecommendation></inf:voteRecord></inf:vote><inf:voteManager><inf:otherManagers><inf:otherManager>19</inf:otherManager></inf:otherManagers></inf:voteManager></inf:proxyTable>
</inf:proxyVoteTable>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
